|
|
·|û¡Ghung120110149413 µoªí®É¶¡:2020/6/24 ¤U¤È 02:11:23
|
¥«³õº¨£·sÃÄ(¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸) Àø®Ä¤ÀªR p=0.009 6634 ªYÄ£ ªÑ¥»: 3.832»õ ¥Dn·~°È: ¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo ¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤) ¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤) Ä~Äò©¹¤U¬Ý...! ============================================================================= ²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ) ¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ« 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.µL¦w¥þ©Ê°ÝÃD ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x ¬ãµo¶¥¬q: 1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á 2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ Àø®Ä¤ÀªR¡G 1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n 2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009) ============================================================================= ²£«~02¡GSNP-630 ¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE) 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~ ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡ 4.µL¦w¥þ©Ê°ÝÃD ¬ãµo¶¥¬q: 1.Á{§É«e 2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C 3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C Àø®Ä¤ÀªR¡G 1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05 ============================================================================= ²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯) ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯) ²£«~Àu¶Õ: 1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê 2.¸Ñ¨M¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs) 3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ« 2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^ 3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O ¬ãµo¶¥¬q: 1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç 2.¤w¥Ó½ÐUSFDA¼Ï纽Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D 3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç ============================================================================= ²£«~04¡GSNP-830/ SNP-840 ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B««×¯kµh) ²£«~Àu¶Õ: 1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è 2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è 2.½Æ¤è¤w¥Ñ¬ü°êFDAn¨D°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä 3.¦³¨Ï¥Î±M§Q¡A¥iקï©Î§R°£FDA¨x¬rĵ»y 4.¥i¼W¥[¤AñQÓi×ô¾¯¶q ¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A°§C¦¨Å}°Æ§@¥Î 5.¤GªÌ¾Ü¤@±ÂÅv 6.¥i¼W¥[¥«¦û²v ¬ãµo¶¥¬q: 1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ýn¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ ============================================================================= ***************************************************************************** SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G 1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 ============================================================================= ***************************************************************************** ¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G 1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv 2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv 3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv ============================================================================= ***************************************************************************** ¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@p¹º §Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó ¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ùȱo´Á«Ý¡A¦³¾÷·|¬O ¤U¤@Ó ¦X¤@ ÄÆªÑ ----------------------------------------------------------------------------- ¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×) |
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/17 ¤W¤È 10:56:28²Ä 1709 ½g¦^À³
|
0¤äÃĪ«¤W¥«ªºNASHÃĪ«¡A«e¼³«áÄ~ªººGªp¤ñ·R´þÃĪ«(¤W¥«~40ºØªvÀøÃĪ«)ÁÙ±~ºG! ------------------------------------------------------------------------------------------------- ·|û¡Gªü§»10146981 µoªí®É¶¡:2022/2/12 ¤U¤È 07:55:31²Ä 1695 ½g¦^À³ ¸²µå¤ý¤]¨Ó·m¯×ªÕ¨x°Ó¾÷ ªYÄ£n¥[ªo³á |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/17 ¤W¤È 09:52:04²Ä 1708 ½g¦^À³
|
¬Q¤Ñ¥Õ®c«aª¬¯f¬rÀ³¹ï¨ó½ÕûJeff Zientsªí¥Ü:¬ü°ê¥¿±µªñ¡§·s«a¯f¬r¤£¬O¦M¾÷¡¨ªº¶¥¬q ..¡¨ ¡§Á`²Î©M§Ú̪º·s«a¯f¬r¹Î¶¤¥¿¦b¿n·¥³W¹º³oÓ¥¼¨Ó¡C¡¨ ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤W¤È 10:08:56²Ä 1702 ½g¦^À³ °ê·|¦@©MÄÒn¨D«ôµn¦b¤£¿ð©ó 3 ¤ë 15 ¤é¤§«e¦V°ê·|´£¥æ¤@¥÷p¹º¡C (´XÓ¥Á¥DÄÒ¦Û®a¦{¤]´£¥X¦P¼Ën¨D) ¬ü°ê¦³¥i¯àÄ~¥_¼Ú»P¼Ú·ù«á«Å¥¬¸Ñ°£??? ....................................................................................... ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤W¤È 08:29:28²Ä 1700 ½g¦^À³ 2022.2.14 °ê·|¦@©MÄÒ¤H¤wn¨D«ôµnÁ`²Îµ²§ô COVID ªº¤½¦@½Ã¥Íºò«æª¬ºA(PHE)¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤U¤È 11:43:30²Ä 1707 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/25 ¤W¤È 08:44:55²Ä 854 ½g¦^À³ ¦]¬°¬ü°êFDA¤w¹ï(¤j§Å)¾~¤ùÃþ¤îµhÃĪ«¶}îÔ¡A(¤p§Å)APAPÃĪ«¥«³õ¥²±N¥ÑµäÁY«¦^¦¨ªø>40»õ¬ü¤¸! --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/5 ¤W¤È 10:26:06²Ä 700 ½g¦^À³ ¦]¬°¾Ö¦³§O¤H¸ó¤£¹Lªº325mg½Æ¤è»ÙêªùÂe¡AAPAP§t¶q´£°ª>325mg/500mg¬Æ¦Ü§ó°ª(®ÄªG§ó¦n)!!! ´N¯à¦A·m¦^³QNSAIDªü´µ¤ÇÆF /Opioidsªü¤ùÃĪ««I»kªº¥«³õ ------------------------------------------------------------------------------------------ 2021.11.1 Âå¥Í´£¨Ñ¶V¨Ó¶V¦h[³B¤è]¾¯¶qªº«D³B¤è¤îµhÃĵ¹±wªÌ----·m¦^³QNSAIDªü´µ¤ÇÆF /Opioidsªü¤ùÃĪ««I»kªº¥«³õ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤U¤È 11:25:30²Ä 1706 ½g¦^À³
|
1. 2022.1.31 FDA发¥¬2022¦~药«~«ü«n¨î©w计¦E new.qq.com/omn/20220205/20220205A0A4AX00.html 临§É/医学:¡§开发¥Î¤_«æ©Ê¯kµhªº«Dªü¤ù类镇µh药¡¨¡A¥Ñ¤_ªü¤ù类药ª«¦MÉó¤´µM³y¦¨严«¯}§¥©M¦º¤`¡A寻§ä§ó¦h«Dªü¤ù类药 ª«产«~¦ü¥G ¬O¥Ø标¤è¦V¡C 2. Âå¥Í´£¨Ñ [¶V¨Ó¶V¦h][³B¤è]¾¯¶qªº«D³B¤è¤îµhÃĵ¹±wªÌ!(§Ú̵LºÃ±N¶}©l¬Ý¨ì«DÍrÅé§Üª¢ÃÄ©M¹ï¤A酰®ò°ò×ôªº¤£¨}¨Æ¥ó ¼W¥[) 2021.11.1 ¥Î©ó´À¥Nªü¤ùÃþÃĪ«ªº Advil¡BTylenol ©MÃþ¦ü¤îµhÃĦs¦b·ÀI «D³B¤èÂíµhÃÄ¥i¯à«D±`¦³®Ä¡A¦ý¤j¾¯¶q¤]¦³¯ÊÂI www.scientificamerican.com/article/advil-tylenol-and-similar-painkillers-used-to-replace-opioids-carry-risks/ ...(ªü¤ùÃþÃĪ«)¦b¼Æ¥H¸Upªº¹L¶q¦º¤`©M¼Æ¤Q»õ¬ü¤¸ªº¶D³^¤§«á¡AÂåÀø¾÷ºc±o¨ì¤FÃö©óªü¤ùÃþÃĪ«ªº³Æ§Ñ¿ý¡CÂå¥Í¤£¦A¬°«æ©Ê¯kµh¶} OxyContin ©Î Percocet¡A¦Ó¬O¬°±wªÌ´£¨Ñ¶V¨Ó¶V¦h¦a³B¤è¾¯¶qªº«D³B¤è¤îµhÃÄ¡G¹ï¤A酰®ò°ò×ô (Tylenol) ©M¥¬¬¥ªâ (Motrin ©Î Advil) µ¥«DÍrÅé§Üª¢ÃÄ (NSAID) ...¡§ÀHµÛ³oºØÅý¤HÌ»·Â÷ªü¤ùÃþÃĪ«ªººÆ¨g¼ö¼é¡A§Ú̵LºÃ±N¶}©l¬Ý¨ì«DÍrÅé§Üª¢ÃÄ©M¹ï¤A酰®ò°ò×ôªº¤£¨}¨Æ¥ó¼W¥[¡C³o¬O¤£¥iÁקKªº¡A¡¨´µ©ZºÖ¤j¾Ç¯kµhÂå¾Ç¥D¥ô¨v®¦¡P³Á°ò (Sean Mackey) »¡¡C -------------------------------------------------------------------------------------------- ¸Ñ¨M1¡A«o±a¨Ó2 ªº[«DÍrÅé§Üª¢ÃÄ©M¹ï¤A酰®ò°ò×ôªº¤£¨}¨Æ¥ó¼W¥[]---¦p¦¹Áٺ⤣¤W¤G¥þ¨ä¬ü! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/2/15 ¤U¤È 08:01:53²Ä 1705 ½g¦^À³
|
¤µ¤Ñ¬Ì]¡A©ú¤Ñ·sÄ£¶Ü?§ÖÂI¥ú©vÄ£¯ª§r~ R¤j¤]¦³§ë¥_·¥§r¡A§Q®`¤F |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤W¤È 10:37:35²Ä 1704 ½g¦^À³
|
¦³ÂI¼x¥ü¦ýÁÙ¤£°÷©ú½T! 2022.02.15 ¸¨¤J¤Z¹Ð¡H¬ü¬Ì±¡«æ·Ù ¬Ì]ªÑ¶°Åé¤j¸õ¤ô .... ¥þ°ê·s¼W½T¶E¼Æ¨³³t¤U°¡CÀHµÛ³ÌÁV¿|ªº¬Ì±¡¤j¶Õ¤w¥h¡A¶g¤@(14¤é)½÷·ç(Pfizer)¡BBioNTech¡B²ö¼w¯Ç(Moderna)¡BNovavaxµ¥¬Ì]ªÑ¶°Åé¤U®À¡A¥i¥H»¡¬O¬Ì]ªÑ¸¨¤J¤Z¹Ð¡C ¬ü°ê¥Õ®cº®u¨¾¬Ì±M®a¦ò©_ªí¥Ü¡A¬ü°ê¥¿¦b²æÂ÷COVID-19¬Ì±¡¡u¥þ±¤j¬y¦æ¡vªº¶¥¬q¡C ............................................................................................. ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤W¤È 10:21:48²Ä 1703 ½g¦^À³ «¥¬è±æ¤W«Ò·|Åý99.999...%ªº¤H§Æ±æ[·s«a¯f¬r·P«_¤Æ]¦¨¯u! ¦ý³o¹ï0.0000...1%ªº§ë¸êªÌ»P´X®a¤jÃļt´N¬O¾µ¹Ú! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤W¤È 10:21:48²Ä 1703 ½g¦^À³
|
«¥¬è±æ¤W«Ò·|Åý99.999...%ªº¤H§Æ±æ[·s«a¯f¬r·P«_¤Æ]¦¨¯u! ¦ý³o¹ï0.0000...1%ªº§ë¸êªÌ»P´X®a¤jÃļt´N¬O¾µ¹Ú! ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤W¤È 09:13:24²Ä 1701 ½g¦^À³ 2022.1.14 ·s«a¯f¬r¬y·P¤Æ¡H¡@¿ù¡I±M®a±j½Õ¡G¬O¡u·P«_¤Æ¡v |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤W¤È 10:08:56²Ä 1702 ½g¦^À³
|
°ê·|¦@©MÄÒn¨D«ôµn¦b¤£¿ð©ó 3 ¤ë 15 ¤é¤§«e¦V°ê·|´£¥æ¤@¥÷p¹º¡C (´XÓ¥Á¥DÄÒ¦Û®a¦{¤]´£¥X¦P¼Ën¨D) ¬ü°ê¦³¥i¯àÄ~¥_¼Ú»P¼Ú·ù«á«Å¥¬¸Ñ°£??? ....................................................................................... ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤W¤È 08:29:28²Ä 1700 ½g¦^À³ 2022.2.14 °ê·|¦@©MÄÒ¤H¤wn¨D«ôµnÁ`²Îµ²§ô COVID ªº¤½¦@½Ã¥Íºò«æª¬ºA(PHE)¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤W¤È 09:13:24²Ä 1701 ½g¦^À³
|
2022.1.14 ·s«a¯f¬r¬y·P¤Æ¡H¡@¿ù¡I±M®a±j½Õ¡G¬O¡u·P«_¤Æ¡v www.healthnews.com.tw/news/article/52561 .... ¡u§Ú¤£¤Ó¦P·N¬y·P¤Æ¡A¬y·Pªº¦º¤`²v¸û°ª¡A·s«aªÍª¢Åܦ¨¡y·P«_¤Æ¡z¤~¬OÁͶաC¡v ..¡u¬y·P¦º¤`²v¥§¡¬°¤d¤À¤§¤@¡A¦ý³o4ºØ«aª¬¯f¬r¤Þµoªº·P«_´X¥G¨S¦³¦º¤`²v¡A§Ú»{¬°·s«a¯f¬r±N¨Ó·|¦¨¬°²Ä5ºØ¡A¦]¬°¥¦ªº¥Íª«¯S©Ê¥»¨Ó´N¦p¦P«aª¬¯f¬r¡C¡v¥¼¨Ó·s«a¯f¬r·|¤£°±¬ðÅÜ¡B¤£°±¬ï³z©Ê·P¬V¡A¦ý´N¹³·P«_¤@¼Ë¡A®¨®¨¦a¨Ó¡B»´»´¦a¨«¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤W¤È 08:29:28²Ä 1700 ½g¦^À³
|
2022.2.14 °ê·|¦@©MÄÒ¤H¤wn¨D«ôµnÁ`²Îµ²§ô COVID ªº¤½¦@½Ã¥Íºò«æª¬ºA(PHE)¡C www.npr.org/2022/02/14/1080303338/republicans-call-on-biden-to-end-covids-public-health-emergency-designation ¡§§ÚÌ¥¿¦bÁÚ¦V¤@Ó·s«a¯f¬r¤£·|ÂZ¶Ã§Ṳ́é±`¥Í¬¡ªº®É¥N¡A¤@Ó·s«a¯f¬r¤£·|¦¨¬°«ùÄò¦M¾÷¦Ó¬O§ÚÌ¥i¥H¨¾½d©MªvÀøªº®É¥N¡A¡¨¥Õ®c·s«a¯f¬rÀ³¹ï³¡ªùªN¥±¸Ì¡P»ô®¦¯ý¡]Jeffrey Zients¡^¨ó½Õû¦b©P¤TªºÂ²³ø¤¤»¡¡C ¡§¾¨ºÞ¦b¤j¬y¦æ¶}©l®É¡APHE ªÖ©w¬O¥²nªº¡A¦ý¥¦Á`¬O·N¨ýµÛ¼È®Éªº¡C§ÚÌ°ê®a²{¦bªº±¡ªp»P³Ìªì¨î©w PHE ®É¤j¤£¬Û¦P¡C¡¨ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤W¤È 07:39:59²Ä 1699 ½g¦^À³
|
©ú¦~¥¿¦¡¤W¥«---¤£µL¥i¯à = ¥_·¥ªºÃĤµ¦~©³«e¤W¥«¤£¬O°ÝÃD¡C 111.02.06 ¥_·¥:¬ü°êFDAµ¹¤©¥»¤½¥qªÍ¶¡¥ÖÀù·sÃĬãµo¤ÎÃÄÃҥӽЧֳt¼f¬d¸ê®æ¡A ¨Ãn¨D¥»¤½¥qªñ´Á¤½¥¬EAP¯S³\±wªÌ¥ÎÃĪº¬Fµ¦¤Î¿ìªk ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/8 ¤W¤È 06:13:10²Ä 10269 ½g¦^À³ ©ú¦~¥¿¦¡¤W¥«---¤£µL¥i¯à!!! 1.[§Ú¤£¬OÃį«]¹q¼v¤¤¨º¤ä¯«ÃÄ. ¥ì°¨´À¥§¡]®æ¦C½Ã¡A¿ÕµØ¡^ªº¾ú¥vÃÒ©ú¤F FDA ·í«eÃĪ«§åãµ{§Çªº®Ä²v....¦]¬°¥¦³Q¸m©ó¨ã¦³©t¨àÃľAÀ³¯gªº¥[³t§åã³~®|¡C¦¹¥~¡A¥ì°¨´À¥§ªº NDA ÀH«á¦b 2.5 Ӥ뤺Àò±o§åã¡A³o¬O¥ô¦ó§ÜÀùÃĪ«Àò±o§å㪺³Ìµu®É¶¡¡C 2.ADI-PEG 20(2014¦~7¤ë¨ú±oFDAªÍ¶¡¥ÖÀù©t¨àÃÄ»{ÃÒ¡A2014¦~12¤ë¨ú±o¼Ú·ù©t¨àÃÄ»{ÃÒ) ¥_·¥¬P(6550) ADI-PEG 20ªÍ¶¡¥ÖÀù¤T´Á¸ÕÅç¼Æ¾Ú«G²´±N³°Äò¦V¬ü°êFDA¡B¼Ú·ù©M¥xÆW¥Ó½ÐÃÄÃÒ.www.genetinfo.com/investment/featured/item/47993.html -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/8 ¤W¤È 05:27:01²Ä 1500 ½g¦^À³ Ãĵثe¨®¤§Å²¡A¤w¶R¥_·¥¸¹¨®²¼! 2021-12-07 00:43 ¸gÀÙ¤é³ø / §ë¸ê¤H¤]Ãöª`¥¿¤åºX¤U¨âÓ¤pª÷Âû¥_·¥¬P¤Î¥¿°ò±¾µPpµe¡A³¯ÂE¤åªí¥Ü¡A¥¿°ò¬OµL½u¼Ò²Õ«~µP¡A«ùªÑ¶W¹L¤T¦¨¡A¹w¦ô2022¦~¤W¥«Âd¡A¥_·¥¬P¬OÀù¯gÃÄ·~¡AÁ{§ÉÃĤw¦³¤TÓ¶i¤J¸ÕÅç¡A¨ä¤¤¤@Ó±N¦b©ú¦~8¤ë§¹¥þ¸Ñª¼´£¥XÃÄÃҥӽСA¹w¦ô©ú¦~¥i±æ¥¿¦¡¤W¥«¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/2/14 ¤U¤È 06:24:53²Ä 1698 ½g¦^À³
|
¾Ç²z¤uªº´N¬O¬Ý¼Æ¾Ú»¡¸Ü¡A¤§«e´N¬O¤Ó²z©Ê¬Ý¼Æ¾Ú¡A¤~·|¶R¨ìÄ_0/¬u²±/¥_·¥/¦w¦¨¡A¦Ó«á©ñ¤F°ê³»Âà·sÃÄ ³Ìªñ·sÃĤS³Q¤j½L¥´¤U¨Ó~~~OTC§ÖÂI¥[¤JÀ禬§r~~§Æ³o¦¸¥i¥H²z©Ê©M·P©Ê¬ÒÅU! ---------------------------------- Á{§É¬O¬ì¾Ç¡A¬ì¾Ç¬O¬Ý¼Æ¾Úªº¡A¦Ó¤£¬O¤@¥y¡un¸ò½÷·çPK¡v |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/13 ¤U¤È 05:49:50²Ä 1697 ½g¦^À³
|
Á{§É¬O¬ì¾Ç¡A¬ì¾Ç¬O¬Ý¼Æ¾Úªº¡A¦Ó¤£¬O¤@¥y¡un¸ò½÷·çPK¡v! Gºô¡G¡u¬Ý¬Ý¤é¥»¤½¥qÁ{§É¸ÕÅçµ¹ªº¼Æ¾Ú¡A¬Û¸û¥xÆW´N¤@Ó²³æ¤½§i¥´µo§ë¸ê¤H¡v www.shionogi.com/content/dam/shionogi/jp/investors/ir-library/presentation-materials/fy2021/20220207_3.pdf ÆQ³¥¸q»¡©ú·|ªº¼Æ¾Ú¡AS-217622¦b°§C¯f¬r¸ü¶q»PPaxlovid±µªñ¡A¥i¥H»¡¬O¤@ÓÅå³ß¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/13 ¤W¤È 10:12:50²Ä 1696 ½g¦^À³
|
¤é¥»ÆQ³¥¸q S-217622pµe¥Ó½Ð¤é¥»EUA¬O¥ÎP2b¼Æ¾Ú¡A¤£¬O¥ÎP2a(60¤H)¼Æ¾Ú(¤£¾å±o¦w¼¢¾¯¬O¤£¬O¥Î½÷·çPaxlovid?«Ý¬d) S-217622»P½÷·çPaxlovid (PF-07321332) ¤@¼Ë¡A³£¬O§í¨î3CL³J¥Õ酶¡A³o¬O¤@ºØ¶È¦s¦b©ó SARS-CoV-2 ¯f¬r¤¤ªº³J¥Õ¤ô¸Ñ酶¡C 2/3 ´ÁÁ{§É¸ÕÅç(©Û¦¬1929¤H) rctportal.niph.go.jp/en/detail?trial_id=jRCT2031210350 2022.2.7 www.bloombergquint.com/onweb/shionogi-s-covid-19-pill-ready-to-move-to-next-trial-phase Á`µôIsao Teshirogi»¡:Ä~©P¤G§¹¦¨²Ä 2b ¶¥¬q«á¡AShionogi p¹º¥»¤ë¶}©l²Ä 3 ¶¥¬q¥þ²y¸ÕÅç¡CTeshirogi »¡¡A¸ÕÅç 2b ¶¥¬qªº¼Æ¾Ú±N¦b´X¶g¤º·Ç³Æ¦n´£¥æ¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2022/2/12 ¤U¤È 07:55:31²Ä 1695 ½g¦^À³
|
¸²µå¤ý¤]¨Ó·m¯×ªÕ¨x°Ó¾÷ ªYÄ£n¥[ªo³á ¸²µå¤ý¥Í§Þ¤µ¤é¤½¥¬1¤ë¾ãÅé¦X¨ÖÀ禬7»õ¤¸¡A¬ð¯}ªñ2¦~¨ü¬Ì±¡¼vÅT³æ¤ë¦P´Á³Ì°ª¡A¦~¼W17.99%¡C¤T¤j¨Æ·~Åé1¤ëªí²{¦P¨B¥¿¦¨ªø¡C¦¹¥~¡A¿W¥ß¬ãµo´Óª«·sÃÄGKAC¡A¤w¦V¬ü°ê¹«~ÃĪ«ºÞ²z§½¥Ó½Ð¶i¦æ«D°sºë©Ê¯×ªÕ¨xª¢¤HÅé¤G´ÁÁ{§É¸ÕÅç¼f¬d¡A¥i±æº¸ó¥X«O°·¹«~»â°ì¡A·m§ð¥þ²y¦Ê»õ¬ü¤¸ªº¯×ªÕ¨x¥«³õ¡C GKAC¬°¸²µå¤ý¥Í§Þ100%¿W®a¯À§÷¡A°w¹ï«D°sºë©Ê¯×ªÕ¨x¯f±w¨x¥\¯à¥i¦³ÅãµÛ§ïµ½¡C«D°sºë©Ê¯×ªÕ©Ê¨x¯f¬O·í¤µ¥þ²y²Ä¤@¤j¨xŦ¯e¯f¡A¦¹¯f¯g¬O¯×ªÕ¨xª¢¡B¨xµw¤Æ¡B¨xÀùµo®iªºªì´Á¯f¨_¡A¥Ø«e¨S¦³¥ô¦ó¦³®ÄªvÀøÃĪ«¡A¤w¦¨¬°«æ»Ýµ¥«Ý¸Ñ¨Mªº¤HÃþ°·±d¦M¾÷¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/12 ¤W¤È 10:15:39²Ä 1694 ½g¦^À³
|
ªYÄ£¤]À³¸Ó¦³±µÄ²ÁÉ¿Õµá¤~¬O?(11»õ¼Ú¤¸=12.54»õ¬ü¤¸) 2022.2.5 ªk°êÁɿյ᪺¬y·P¬Ì]©MDoliprane(¤AñQÓi×ô/´¶®³¯k) ¬OCovid ªº·N¥~Ĺ®a www.world-today-news.com/the-flu-vaccine-and-sanofis-doliprane-unexpected-winners-of-the-covid/ 2022.2.4¤é¬P´Á¤µo¥¬ªº¦~«×·~ÁZ³ø§iÅã¥Ü¡AÁɿյ᪺¨ä¥L²£«~¤w¶¡±µ¨ü¯q©ó Covid ¤j¬y¦æ¡C¦pªG±z¤w¸g±µºØ¹L«aª¬¯f¬r¬Ì]¡A±z¥i¯à¤w¸gªA¥Î¤F Doliprane¡CµM¦Ó¡A«áªÌ¤´µM¬OÁɿյᡧ®ø¶OªÌ°·±d¡¨¬¡°Ê¤¤ªº©ú¬PÃĪ«¤§¤@¡AÄݩ󡧤îµh¡¨Ãþ§O. ...2021 ¦~¡A¨ä¤îµh²£«~ªº¾P°âÃB¦]¦¹¼Wªø¤F 7.2%¡]«ö©T©w¶×²vpºâ¡^¡A¹F¨ì 11 »õ¼Ú¤¸¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/12 ¤W¤È 08:52:00²Ä 1693 ½g¦^À³
|
1. www.factmr.com/report/75/otc-analgesics-market ®Ú¾Ú Fact.MR µo¥¬ªº³Ì·s¦æ·~¤ÀªR¡A2020¦~¥þ²yOTC ÂíµhÃÄ¥«³õ»ùȬù¬°250»õ¬ü¤¸(¹ï¤A酰®ò°ò×ô¦û45¢H=112.5»õ¬ü¤¸) ¨ì2031 ¦~¡A¥þ²y«D³B¤èÂíµhÃÄ¥«³õ¹wp±NÂX¤j1.6 ¿¡A¦ôȱN¹F¨ì 400 »õ¬ü¤¸(¹ï¤A酰®ò°ò×ô¦û45¢H=180»õ¬ü¤¸)¡C ¥Ñ©ó±w¦³Ãö¸`µhµ¥µLªkªv¡ªº°·±d°ÝÃDªº¦Ñ¦~¤H¤f¤£Â_¼W¥[¡A¹ï«D³B¤èÃĹï¤A酰®ò°ò×ô©M«D³B¤èÃĤô·¨»ÄÆQªº»Ý¨D¼W¥[¡C ¬ü°êªºOTCÂíµhÃĻݨD«e´º¦p¦ó¡H ¨ì2031 ¦~¡A¬ü°ê«D³B¤è (OTC) ÂíµhÃÄ¥«³õ¹wp±N¼Wªø1.5¿¡C ¯gª¬¸û»´ªº COVID-19 ±wªÌ¥i¥H¨Ï¥Î«D³B¤èÃĪvÀø¡C¦]¦¹¡AOTC ÂíµhÃĤw¦¨¬°¤j¬y¦æºÞ²zªº¥DnµJÂI¡C¥Ñ©ó COVID-19 ¤j¬y¦æ¡A¦³®Äªº OTC Âíµh¾¯ªº¾P°âÃB¿E¼W¡A¹wp«D³B¤è (OTC) ÃĪ«¥«³õªº¾P°âÃB·|§ó°ª¡C 2.¬ü°êAPAP³B¤èÃĦ~«×¶}¥ß±i¼Æ: www.statista.com/statistics/781739/acetaminophen-prescriptions-number-in-the-us/ Number of acetaminophen prescriptions in the U.S. from 2004 to 2019(in millions) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/12 ¤W¤È 08:19:50²Ä 1692 ½g¦^À³
|
³o¬O¤§«e¶K¦aOTC¾P°âÃB¡A³B¤èÃľP°âÃB¨S¸ê®Æ? ............................................................................................... ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/19 ¤U¤È 01:02:07²Ä 1214 ½g¦^À³ J&J¦b2020¦~OTC¾P°âÃB¬°48.24»õ¬ü¤¸¡A48.24»õ¤¤Tylenolªº¼ÆÃB¬O¦h¤Ö? ³oÃ䪺¼Æ¾ÚÁô¬ù¥iºâ¥X MAT Q2 20202 nicholashallcompany.wordpress.com/tag/tylenol/ ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/5 ¤U¤È 12:30:36²Ä 902 ½g¦^À³ ±À¦ô2020¦~¬ü°êAcetaminophen(¤AñQÓi×ô)ÃÄ«~¾P°âÃB¦Ü¤Ö¼Wªø>10»õ¬ü¤¸¡A¤Ñ®É¦a§Q¤H©M(¾~¤ù¦M¾÷»P·s«a¬Ì±¡)¤U«¦^¦¨ªøÁͶÕ!!! ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/4 ¤U¤È 10:04:05²Ä 897 ½g¦^À³ 2021.2.22 J&J©u«×·~ÁZ³ø§i....Tylenol¾P°â¦¨ªø>3.8»õ¬ü¤¸¡A¦]¬°¦³¨Ç¶µ¥Ø¨ü·s«aªÍª¢¼vÅT¦Ó§e²{t¦¨ªø -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/4 ¤U¤È 10:04:05²Ä 897 ½g¦^À³ 2021.2.22 J&J©u«×·~ÁZ³ø§i johnsonandjohnson.gcs-web.com/static-files/e2a329b4-aeb6-438d-a449-f0e282cf8ee0 ²Ä21¶: J&J¦b2020¦~OTC¾P°âÃB¬°48.24»õ¬ü¤¸¡A¸û2019¦~ªº44.44»õ¬ü¤¸¼Wªø8.5¢H¡C¼Wªøªº¥Dnì¦]¬O¦]¬°·s«aªÍª¢ÅX°ÊTYLENOLªº¾P°â¦¨ªø! -------------------------------------------------------------------------------------------- 48.24-44.44 =3.8»õ¬ü¤¸µ¥©ó¼W¥[ªº¾P°âÃB¬O3.8*28=106.4»õ¥x¹ô(Tylenol¾P°â¦¨ªø>3.8»õ¬ü¤¸¡A¦]¬°¦³¨Ç¶µ¥Ø¨ü·s«aªÍª¢¼vÅT¦Ó§e²{t¦¨ªø) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/11 ¤U¤È 06:12:05²Ä 1691 ½g¦^À³
|
2021.7¤ëGSKpµe¤À©î®ø¶OªÌ°·±d³¡ªù(¬Ý¨Ó¬O·Q½æ680»õ¬ü¤¸¥H¤W) GSK Consumer Healthcare ªº¥D¾É²£«~¥]¬AµÎ¾A¹F¤ú»I¡B¤îµhÃÄ Panadol ©M·P«_ÃÄ Theraflu¡C www.bangkokpost.com/business/2250515/unilever-wont-up-%C2%A350bn-offer-for-gsk-pfizer-unit 2022.1.20 Áp¦X§QµØ...½T«O¦¬Áʬ°§Ú̪ºªÑªF³Ð³y»ùÈ¡A¨Ã¸É¥R»¡¥¦¤£·|±N³ø»ù´£°ª¨ì 500 »õ^Âé¡]680 »õ¬ü¤¸¡^¥H¤W¡C ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/7 ¤W¤È 07:09:08²Ä 1565 ½g¦^À³ ¸Ü»¡2021.11¤ëJ&J±N§â¨ä®ø¶OªÌ°·±d³¡ªù©î¤À¬°¤@®a·sªº¤W¥«¤½¥q¡A¶¢¨ÓµL¨Æ´N¦ôºâ¤@¤UTylenolªº¥«È? (¥x¿n¹q¥«È¬ù6000»õ¬üª÷¡A±Æ¦W¥@¬É¥«È«e¤Q¤j¡A¦p¤µ¥u¦³¤»®a¤½¥q¥«È¶W¹L1¸U»õ¬ü¤¸¡C) 1.J&J®ø¶OªÌ°·±d³¡ªù¥«È500»õ¬ü¤¸ |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/2/11 ¤U¤È 01:54:39²Ä 1690 ½g¦^À³
|
ªYÄ£±N¨Ó830©Î840¾Ü¤@¬O³B¤èÃÄ¡F810¬O«D³B¤èÃÄ87»õ¬ü¤¸¡A¦]¬°µL¬r¥«¥e·|§ó°ª¡A¨âÃÄ¥[Á`´N¬O±M®a»¡ªº100»õ¬ü¤¸±À¦ô¡A¤@¦¨¤À¼íª÷10»õ¬ü¤¸¢w¢w300»õ¥x¹ô¡A¤@ªÑÁÈ400¤¸¡C¥»¯q¤ñ25´N¬O10000¤¸ªÑ»ù¡CÁÙ¦³610©M§ó±jªº630¡A¤Ñ°Ú¡I¤£n¦Aºâ¤F¡A¤£µM·|³Q¤H»¡¬O§j¤û¡C¯¬ºÖ¤j®a¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/11 ¤W¤È 10:18:50²Ä 1689 ½g¦^À³
|
³o´X¦~J&J»PGSK°]³ø¤£¦A¦C¥XTylenol»PPanadol¾P°âÃB¡A2®a³£¦Xp¤J®ø¶OªÌ«O°·À禬¡C (¦]covid-19¬Ì±¡¡A2020»P2021¾P°âÃB¤@©w¤j¼W) ¦´Á1970¦~¥N¸ê®Æ¦p¤U: In the early 1970s, a series of highly publicized studies questioned consumers¡¦ uncritical dependence on aspirin. Tylenol was ideally positioned to take advantage of this turn of events. Sales of acetaminophen increased from 5% of a $550 million over-the-counter painkiller market in 1972 to 13% of a $680 million market in 1974. Tylenol accounted for approximately 90% of those sales.29 .................................................................................................. ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/5 ¤W¤È 08:35:18²Ä 464 ½g¦^À³ OTC(«D³B¤è)¤îµhÃÄ¥«³õ(NSAIDSªü´µ¤ÇÆF + APAP +§½³¡³Â¾KÃĵ¥ÃĪ«)±N¦b2019¦~¬ð¯}190»õ¬ü¤¸! (¤£§t»Ý¥ÑÂå¥Í¶}¥ßªº³B¤è¤îµh¾¯) FMI¬ã¨s³ø§i...¹ï¤A酰®ò°ò×ô(APAP)¬O³Ì±`¥ÎªºOTC¤îµhÃĤ§¤@¡A¸ÓÃþÃĪ«¦bOTC¤îµhÃÄ¥«³õªº¦¬¤J¤¤¦û45¢Hªº¥÷ÃB¡C ¨ì2019¦~¡A¹ï¤A酰®ò°ò×ôÃĪ«¦bOTC¤îµhÃÄ¥«³õ¤¤ªº³Ì¤j¥÷ÃB±N«O«ù¦b87»õ¬ü¤¸¥H¤W(¥þ²y«D³B¤è¥«³õ)... ................................................................................................. ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/14 ¤W¤È 09:59:01²Ä 133 ½g¦^À³ J&J(Tylenol)2016¦~¥þ²y¾P°âÃB20»õ¬ü¤¸.... |
|
|
·|û¡Gkim10134548 µoªí®É¶¡:2022/2/11 ¤W¤È 08:33:37²Ä 1688 ½g¦^À³
|
R¤j ±z¦n¡A¥i§_½Ð±Ð¡A¦bªYÄ£SNP-810¥¼¨Ó¥i¯àªº±ÂÅv¦X§@¤½¥q¤¤¡A J¤½¥q»PG¤½¥qÄÝ©ó±ÂÅvAPAP½d³òªºÀ禬¡A¦U¤j¬ù¬O¦h¤Ö¡H ¦³¿ìªk¬d±o¨ì¶Ü¡H¥ýÁÂÁ±z¤F¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/11 ¤W¤È 08:14:19²Ä 1687 ½g¦^À³
|
®õ¿Õ¼s§i¶O±q1976¦~400¸U¬ü¤¸.... in 1976, Tylenol took the offensive.Over $4 million was spent that year to advertise it as a safer alternative to aspirin. The following year the figure tripled to over $12 million. (Tylenol had an advertising budget of $142,000 in 1975 prior to the Datril offensive.) ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/10 ¤U¤È 09:21:52²Ä 1685 ½g¦^À³ Tylenol«~µP»ùȬO¨C¦~¯{¬ù1.5»õ¬ü¤¸ªº¯uª÷¥Õ»È¼s§i¶O´«¨Óªº¡ASNP-810±ÂÅvª÷§Oº|®ð¤F! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/11 ¤W¤È 07:59:50²Ä 1686 ½g¦^À³
|
2020«e10¤jÂåÃÄ[¼s§i¶O]±Æ¦æ www.biotechdistrict.com/post/top-pharmaceutical-ad-spenders-of-2020 1:Humira (¤£·\¬O¦~¾P°âÃB¯}200»õ¬ü¤¸ªºÃĤý¡A¼s§i¶O¤]«ÜÅå¤H) 2020¦~:4.9985»õ¬ü¤¸/2019¦~:5.773»õ¬ü¤¸ 2:Dupixent(ý³Ý»P¥Ö½§ª¢¡A³o¤ä¦b[¼s§i¶O¥Î]»P[¾P°âÃB]¼Wªø³t²v¦Pµ¥Åå¤H) 2020¦~:4.098»õ¬ü¤¸ /2019¦~:1.994»õ¬ü¤¸ 10:Otezla(2020¦~¾P°âÃB22»õ¬ü¤¸)2020¦~:1.504»õ¬ü¤¸ /2019¦~:1.559»õ¬ü¤¸ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/10 ¤U¤È 09:21:52²Ä 1685 ½g¦^À³
|
Tylenol«~µP»ùȬO¨C¦~¯{¬ù1.5»õ¬ü¤¸ªº¯uª÷¥Õ»È¼s§i¶O´«¨Óªº¡ASNP-810±ÂÅvª÷§Oº|®ð¤F! Tylenol ºaµn YouGov ¤µ¦~¥[®³¤j³Ì¨Î«~µPº]º(¬ü°ê®³²Ä6) mediaincanada.com/2021/11/23/tylenol-tops-yougovs-list-of-best-brands-in-canada-this-year/ .............................................................................................. ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/7 ¤W¤È 10:51:33²Ä 1568 ½g¦^À³ 2021¬ü°ê³Ì¨Î«~µP´£¤É±Æ¦æ YouGov BrandIndex ®ø¶OªÌ«~µP»{ª¾«×ªºÅv«Â«ü¼Ðwww.contagious.com/news-and-views/yougov-best-brand-improvers-of-2021-usa ±Æ¦W²Ä¤»ªº«D³B¤è¤îµh«~µP®õ¿Õ¡]Tylenol¡^ ²Ä¥|¤j§ï¶i«~µP¬O¨È°¨»¹ Prime Video ¤µ¦~¬ü°ê¶i¨B³Ì§Öªº«~µP²Ä¤@¬O½÷·ç(·s«a¬Ì]¤§½ç) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/10 ¤U¤È 07:34:07²Ä 1684 ½g¦^À³
|
¥_¼Ú°ê®a»â¥ý¥þ²y! ¤¦³Á2¤ë1¤é°_§¹¥þ¨ú®ø¨¾¬Ì¨î¡A¤£¦ý¤£±j¨îÀ¹¤f¸n¡A [¬Æ¦Ü³s½T¶E¤F¡A³£¤£»Ýn±j¨î¹jÂ÷]¡A¯u¥¿¶i¤J¡u»P¯f¬r¦@¦s¡vªº¥Í¬¡¤è¦¡ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/10 ¤U¤È 06:38:38²Ä 1683 ½g¦^À³
|
2022.2.10 ¥þ²y²Ä¤@¡I·ç¨å«Å§G·s«a¬Ì±¡µ²§ô ¥Í¬¡«ì´_±`ºA ·s«a¯f¬r¬Ì±¡¤´µM¦b¥þ²y¸vh¡A¤£¹L·ç¨å¤w¸g«Å§G¡A±N¤£¦A§â·s«a¯f¬rµø¬°¤½¦@½Ã¥Í«Â¯Ù¡C±q2¤ë9¤é¶}©l¡A«Å§G¹Ò¤º·s«a¬Ì±¡¤w¸gµ²§ô¡A¥þ·ç¨å¸Ñ°£©Ò¦³ªº¨¾¬Ì¨î¡A«ì´_¥¿±`¥Í¬¡¡C·ç¨å½Ã¥Í³¡ªø«¢Û®æÛ¥Nªí·ç¨å¬F©²«Å§G¡A·ç¨å±q2¤ë9¤é¶}©l¡A«Å§G·ç¨å¹Ò¤ºªº·s«a¬Ì±¡¡A¥¿¦¡µ²§ô¡C¥¼¨Ó¡A¥Á²³·P¬V·s«a¯f¬r¡A±N³Qµø¬°¤@¯ë¯e¯f¡A¤£¦A³QÂkÃþ¦¨¡u¦M®`ªÀ·|ªºÄY«¶Ç¬V©Ê¯e¯f¡v¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/10 ¤U¤È 12:50:15²Ä 1682 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/31 ¤U¤È 08:09:40²Ä 649 ½g¦^À³ ·í¥«³õ[µL]¨x¬rSNP-810¥i¥H¨ú¥N[¦³]¨x¬rAPAP«á...... .... 2008.02.26 FDAªº«Øij¤z¹w±¹¬I¥H´î¤Ö¹ï¤A酰®ò°ò×ô¨x¬r©Êªºµo¥Í Janet Woodcock (FDA¥N²z§½ªø) www.litigationandtrial.com/files/2011/12/2009-4429b1-02-FDA.pdf ¡K¡K§Ṳ́£§Æ±æFDA±Ä¨ú°®¹w±¹¬I¨Ó¸Ñ¨M¹ï¤A酰®ò°ò×ôªº¨x¬r©Ê·ÀI¡A[³Q»~»{¬°]¬ONSAIDSÃÄ(ªü´µ¤ÇÆF) ¤ñ (APAP)§ó¦w¥þ¡C NSAIDS¡]¤×¨ä¬Oªø´ÁªA¥Î¡^·|¾ÉP«nªºG¸z¹D¯e¯f©MµÇŦ¯e¯f¡C¤z¹w±¹¬Iªº¥Øªº¬O´î¤Ö¹ï¤A酰®ò°ò×ô¬ÛÃöªº¨x¬r©Ê¡A¦Ó¤£¬O [´î¤Ö ] ¹ï¤A酰®ò°ò×ôªº¨Ï¥Î©Î ÅX¨Ï ¤H̨ϥÎNSAID¡C -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/10 ¤U¤È 12:24:22²Ä 1681 ½g¦^À³ ¦ó¤£°®¯Ü¸T¤FAPAP? ¤Ï¥¿ÁÙ¦³ªü¥q¤ÇªL¡B¥¬¬¥ªâ©M³\¦h¨ä¥L±`¨£ªº«D³B¤è¤îµhÃÄ¥i¨ú¥N¡C ¦]¬°³o¼Ë°µ¦a«áªG§óºG¡C(§ó¥¿¤@¤U) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/10 ¤U¤È 12:24:22²Ä 1681 ½g¦^À³
|
¦ó¤£°®¯Ü¸T¤FAPAP? ¤Ï¥¿ÁÙ¦³ªü¥q¤ÇªL¡B¥¬¬¥ªâ©M³\¦h¨ä¥L±`¨£ªº«D³B¤è¤îµhÃÄ¥i¨ú¥N¡C ¦]¬°³o¼Ë°µ¦a«áªG¤ñ¸T¥ÎAPAP§óºG¡C sites.psu.edu/siowfa13/author/clr5450/ ¡¨ ¤@¶µ¬ã¨s¤ÀªR¤F 43 ¦W¨C¤ÑªA¥Î«DÍrÅé§Üª¢ÃÄ/ªü¥q¤ÇªLªvÀøÃö¸`ª¢ªº°·±d±wªÌ¡Aµo²{¡§71% ªº«DÍrÅé§Üª¢ÃļÉÅS¶W¹L 90 ¤Ñªº±wªÌªº¤p¸z¨ü¨ì©úÅã·l¶Ë¡C¡¨ ¨Ï¥Î«DÍrÅé§Üª¢ÃĪºªø´Á°Æ§@¥Î¨C¦~¾ÉPªñ 103,000 ¤H¦í°|©M 16,500 ¤H¦º¤`¡C¦¹¥~¡A¡§¦b¬ü°ê¡A¨C¦~¦º©ó«DÍrÅé§Üª¢ÃĬÛÃö¨Ãµo¯gªº¤H¼Æ¶W¹L¦º©ó¦ã´þ¯f©M®cÀVÀùªº¤H¼Æ¡C¡¨ §ÚµLªk§ä¨ì¬ã¨s©Î²Îp¼Æ¾Úªº¨ãÅéI´º¨Óµû¦ô¥¦Ìªº»ùÈ¡A¦ý¦pªG§Ú̯à¬Û«H¥LÌ©Ò»¡ªº¬O·Ç½Tªº¡A¨º»ò NSAIDS ªº¼vÅT¬O¬Û·íÄY«ªº¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/10 ¤W¤È 11:28:03²Ä 1680 ½g¦^À³
|
dk¤j±z§O¹ï¸¹¤J®y°Õ¡C ¤µ¤Ñ´N¬Ý3²Õ¼Æ¦r§a:¬ü°ê¦³¦h¤Ö¤H¦]¹ï¤A酰®ò°ò×ô¹L¶q¦Ó¦º¤`¡H ÁöµM3²Õì©l¼Æ¾ÚÁ`¼Æ¦³²§¡A¦ý3²Õ¼Æ¾Ú³£Åã¥Ü¦b¹L¥h¤Q¦~ªº¤j³¡¤À®É¶¡¸Ì¡A»P¹ï¤A酰®ò°ò×ô¬ÛÃöªº¦º¤`¤H¼Æ³£ [¦³©Ò¼W¥[] ¡A¥u¬O°¸º¸³v¦~¤U°¡C 1. FDA¼Æ¾ÚÅã¥Ü¡A¤@¦~¤¤¦³¦h¹F 980 ¤H¦º¤`»P§t¦³¹ï¤A酰®ò°ò×ôªºÃĪ«¦³Ãö¡C¦¹¥~¡AFDA »P¹ï¤A酰®ò°ò×ô¬ÛÃöªº¦º¤`³ø§i ªº¼Wªø³t«×¶W¹L¤Fªü¥q¤ÇªL¡B¥¬¬¥ªâ©M³\¦h¨ä¥L±`¨£ªº«D³B¤è¤îµhÃÄ¡C 2.¬ü°ê¯e¯f±±¨î©M¹w¨¾¤¤¤ß(CDC)ªº¼Æ¾ÚÅã¥Ü¡A¨C¦~¦³¶W¹L 300 ¤H¦º©ó¹ï¤A酰®ò°ò×ô¤¤¬r¡C ®Ú¾Ú¯e¯f¹w¨¾±±¨î¤¤¤ßªº¼Æ¾Ú¡A±q 2006 ¦~¶}©l¡A¦] [·N¥~ªA¥Î¹L¦h] ¹ï¤A酰®ò°ò×ô¦Ó¦º¤`ªº¤H¼Æ¶W¹L¤F¦] [¬G·N¹L¶q] ªA¥Î¦Û±þ¦Ó¦º¤`ªº¤H¼Æ¡C 3. ¬ü°ê¬rª«±±¨î¤¤¤ß¨ó·| (AAPCC) «DÀç§Q²Õ´¡A¥¦Åã¥Ü¨C¦~¬ù¦³ 113 ¤H¦]ªA¥Î¹ï¤A酰®ò°ò×ô ÃĪ«¹L¶q¦Ó¦º¤`¡C ¥u¬Ý¥H¤W¼Æ¾ÚÀ³¸Ó¤£¤Ó¦³¬Æ·Pı¡A¥[¤W¥H¤UCDC¼Æ¾Ú´N«Ü¦³·Pı¤F! CDC¼Æ¾Ú¡A±q 2001 ¦~¨ì 2010 ¦~¡A¨C¦~»P¹ï¤A酰®ò°ò×ô¬ÛÃöªº¦º¤`¤H¼Æ¬ù¬°©Ò¦³¨ä¥L«D³B¤è¤îµhÃĦº¤`¤H¼Æªº¨â¿¡C 2010 ¦~¡A¥]¬A¥¬¬¥ªâ¦b¤ºªº¾ãÓ¤îµhÃÄÃþ§O¡]¥]¬A³B¤èÃÄ©M«D³B¤èÃÄ¡^¶È³ø§i¤F 15 ¤H¦º¤`¡C ¦P¦~¡A¦³ 321 ¤H¦º©ó¹ï¤A酰®ò°ò×ô¤¤¬r¡C¶W¹L¤@¥b¡]166 ¤H¡^¦º©ó·N¥~¥ÎÃĹL¶q¡C¨ä¾lªº¤H¬G·N¹L¶qªA¥Î©Î¥L̪º·N¹Ï ¤£²M·¡¡C (®Ú¾Ú 2000 ¦~¥N¤¤´Áªº®ø¶OªÌ½Õ¬d¡AªA¥Î¥¬¬¥ªâªº¬ü°ê¤H»PªA¥Î¹ï¤A酰®ò°ò×ôªº¤H¼Æ®t¤£¦h¡C) |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/2/10 ¤W¤È 10:56:19²Ä 1679 ½g¦^À³
|
R¤j¤£¦n·N«ä¡A§Úı±o¤@¶}©l¬O§Ú¦b¹Ä®§·sÄ£©M°ê³»ªºªÑ»ù®t²§¡A³y¦¨±zªº¦^À³(¦Ü¤Ö§Úı±o¬O¦b¬ì¾Ç¤Wªº¤À¨É)¡A¦ý¤£¬OµLªº©ñ¥Ú¡C¦Ó¦³°ê³»ªÑªF¤£®®¡C§Æ±æ·sÄ£¬O¤U¤@Ó°ê³»(ªÑ»ù¤Wªºªí²{) |
|
|
·|û¡G¦N¦Ì¦Ï10000583 µoªí®É¶¡:2022/2/8 ¤U¤È 10:30:35²Ä 1678 ½g¦^À³
|
N¤j Å¥¨ä¨¥Æ[¨ä¦æ¡A¨CÓ¤H³£¦³¦Û¤vªº®É¶¡¦¨¥»¡A¿Ñ©w¦Ó«á°Ê |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/2/8 ¤U¤È 09:32:18²Ä 1677 ½g¦^À³
|
To ¦N¤j ½Ð°Ýn¦p¦óÃöª`©O¡HªÑªF·|¤]°Ñ¥[¤F¡A¤]¦V¤½¥q´£°Ý¤F¡A½Ð°Ý±zªº¬Ýªk¬O¡H |
|
|
·|û¡Gªü¤Ñ10149120 µoªí®É¶¡:2022/2/8 ¤U¤È 09:05:12²Ä 1676 ½g¦^À³
|
§ÚˬOı±oR¤j¶K¤å¤DÁͦNÁפ¿¡A¦³¨Ç¤H©Î³\¦¤w¤W¨®¡A¨º´N·íĵ¥@¤å¬Ý¬Ý§Y¥i¡C ÁͦNÁפ¿¦b§ë¸ê¨ÓÁ¿À³¸Ó³£¬O¾A¥Î¡K |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/8 ¤U¤È 08:37:25²Ä 1675 ½g¦^À³
|
ÁÂÁÂonly¤j»PNtumgk¤jªº±¡¸q¬Û®¼! ´N¦p¦N¦Ì¦Ï¤j»¡ªº¡A©Î³\¨º¤é¤ß¦å¨Ó¼é³o¨Ç¶K¤å´N¤j®¿²¾¨ì¦P¾Ç·|¡A¦b¤¤¸ÎªÅª©¦¬~½m¹L¡A¦ó¨¬惧«v¡C |
|
|
·|û¡G¦N¦Ì¦Ï10000583 µoªí®É¶¡:2022/2/8 ¤U¤È 08:02:21²Ä 1674 ½g¦^À³
|
To : Ntumgk¤j R¤j¦b2022/1/6»¡¡G Åý¥»ª©²M²b»P¥D¨¤¦^Âk¡A«¥¤£¦Aµoªí·s«aijÃD»P°Q½×! ÁÙµ¹ªYÄ£¤@Ó°®²bªºª©±¥i¬OR¤j¦Û¤v»¡ªº¡A¦ý¨S·Q¨ì¹L¨S´X¤Ñ¥L§Ô¤£¦í¤S¬GºA´_µÞ¡A ¨ä¥Lºô¤ÍÁö¤]¦³¥X±¨î¤î¡A¦ý¥L¤´§Ú¦æ§Ú¯ÀÄ~ÄòºZ©Ò±ý¨¥¡F §Úı±o¦bªYÄ£ª©±µo°ê¹©ÄU¥@¤å®Ú¥»¬O·d¿ù¾Ô³õ¤F¡A¥LÀ³¸Ón¥h¦P¾Ç·|¤O¾Ô¸s¶¯¤~¹ï¡A ¨º¸Ì¤~¦³¥Lµo´§ªºªÅ¶¡ ¦Ü©óªYÄ£¹À¡ãÁÙ¬OÃöª`¤@¤U°ê»Ú±ÂÅv»P¦X§@pµeªº¶i«×§a¡A¤j»æ³£µe¦h¤[¤F¡H |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/2/8 ¤U¤È 06:30:41²Ä 1673 ½g¦^À³
|
To¦N¤j ´«Ó¨¤«×·Q¡Ar¤j¤]¥i¯àÁקKª©¤Í°l¶i¥h®M¨c¡A¤@Åé¨â±¡C¦pªG±z¦³¤°»ò¹ï©óªYÄ£·Q°Q½×ªºÄ³ÃD¥i¥H´£¥X¨Ó°Q½×¡A¤£µM¦ponly¤j©Ò¨¥ª©±¤j¦h®É¶¡§N²M¡C¨Ã¨S¦³Ä±±or¤jµoªí¹ï°ê¹©ªº¬Ýªk¦³¤°»ò¤£¦n¡A±zY¤£³ßÅw¥i¥H¿ï¾Ü©¿²¤§Y¥i¡ã |
|
|
·|û¡G¦N¦Ì¦Ï10000583 µoªí®É¶¡:2022/2/8 ¤U¤È 05:09:48²Ä 1672 ½g¦^À³
|
To : Ntumgk ·Ó§A©Ò¿×§»Æ[ªº»¡ªk¡A·sÃĪѥþ³¡¶°¤¤¤@Óª©±¤jÂøÀí¨Ó°Q½×´N¦n¤F¡A ¦ó¥²¤ÀӪѡH ¥u¦]¥²´I³Q¸T¨¥°ê¹©¡A¥L´N¤@ª½¦b¦¹É´ßµo´§¡A¥u¦]¦Û¤v¨SÁȨì¡A¨£¤£±o§O¤H¦n¡H |
|
|
·|û¡Gonly10135877 µoªí®É¶¡:2022/2/8 ¤U¤È 05:02:36²Ä 1671 ½g¦^À³
|
R¤j¹ï³oª©ªº°Q½×¦³«Ü¤jªº°^Äm,¨S¦³R¤j ³oª©«Ü§N²Mªº,¤]¤Ö¦³±M·~ |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/2/8 ¤U¤È 04:51:54²Ä 1670 ½g¦^À³
|
To¦N¤j R¤jªø´Á¹ïªYÄ£µoªí¬Ýªk¡A¹ï°ê¹©¶i¦æµû½×¤]¯àÅý§ë¸ê¤H¥H§ó§»Æ[ªº¨¤«×¬Ý«Ý·sÃIJ£·~¡C ª©¤W°£¤FR¤j¤Ö¦³¤H·|µo±¸¨ìªYÄ£¬ÛÃöªº¸ê°T¡A¤£ª¾¹D¦N¤j»{¬°ªº°®²bªºª©±¬°¦ó¡H©ÎªÌ±z¤]¥i¥H¹Á¸Õµoªí¦Û¤vªº¬Ýªk¡AÅýª©¤Í¤¬¬Û°Q½×¡C |
|
|
·|û¡G¦N¦Ì¦Ï10000583 µoªí®É¶¡:2022/2/8 ¤U¤È 04:18:28²Ä 1669 ½g¦^À³
|
To:¥²´Iºôª©¥D POGER5889³o¦ìºô¤Í¡A¤@ª½¥Î¥L·¥²`ªº«è©À¦b°Q½×°ê¹©¡A ¥i¥H½Ð§A³B²z¤@¤U¡AÁÙµ¹ªYÄ£¤@Ó°®²bªºª©±¦n¶Ü¡HÁÂÁ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/8 ¤U¤È 03:27:45²Ä 1668 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤W¤È 08:24:14²Ä 1544 ½g¦^À³ ....°ê¹©¤G´Á¸Ñª¼«e¦³½Ö»¡±o·Ç? «ÂI¦b²Ä3´ÁÁ{§É!!! ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/16 ¤U¤È 05:21:57²Ä 1522 ½g¦^À³ 3¨¥2»y»¡¤£²M¡A²Ä6·Pn«¥¯à¸ú¦h»·°{¦h»·! -------------------------------------------------------------------------------------------- °ê¹©°ª¼h¦h°µ¨Æ¤Ö»¡¤j¸Ü¤~¬O! |
|
|
·|û¡G¶À±Ò½÷10152632 µoªí®É¶¡:2022/2/8 ¤U¤È 03:10:01²Ä 1667 ½g¦^À³
|
§dYÅv¡G¾Ö¦³®É¿n·¥§V¤O¡A¨S¦³®É±µ¨ü¥¢¥h¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/8 ¤U¤È 03:03:19²Ä 1666 ½g¦^À³
|
Âùª¼¸ÕÅ礣PK¡A©Ç«v! ¬Ý¬ÝNRxÃļtZyesami¦b2021.11.4³QFDA©Úµ´EUAì¦]:¼Æ¾Ú¤£¨¬¥H...FDAn¨D´£¨Ñ§ó¦hÃö©ó ZYESAMI »P¥]¬A·ç¼w¦è³¦b¤ºµ¥¥Ø«e§å㪺Àøªk¬Û¤ñªºÁ{§É¼Æ¾Úªºn¨D --------------------------------------------------------------------------------------------- NRxÃļt«áÄò°Ê§@... 2021.11.29 ir.nrxpharma.com/news-events/press-releases/detail/100/nrx-pharmaceuticals-identifies-significantly-higher ¤ÀªR¬O¬°¤F¦^À³FDAn¨D´£¨Ñ§ó¦hÃö©ó ZYESAMI »P¥]¬A·ç¼w¦è³¦b¤ºµ¥¥Ø«e§å㪺Àøªk¬Û¤ñªºÁ{§É¼Æ¾Úªºn¨D... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/8 ¤U¤È 02:43:31²Ä 1665 ½g¦^À³
|
¦pªG¤£n¤ÓµeªêÄê«ç·|©Û¤H°v? ¥h¦~6¤ëNRX¤½¥q°ª¼h¤½¥¬ZYESAMI¼Æ¾Ú¥¿¦Vn¥Ó½ÐEUA¡Aµ²ªG³QFDA¥´ºj¡A2022.1¤ë¾D¨ü·l¥¢ªº§ë¸êªÌ´£§i:¸ê®Æ¦s¦b«¤jµê°²©M»~¾É©Ê... ............................................................................................ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/21 ¤W¤È 07:50:58²Ä 1611 ½g¦^À³ ¸g¹L°ò¨È»P¯E¹©¨Æ¥ó«á¡A§ë¸ê¤H¹ï¥Í§ÞªÑ¯d¤U¤£¦nªº¦L¶H¡A¤£§Æ±æ¾ú¥v¨Æ¥ó«ºt! 1. FDA©Úµ´NRxÃļtZyesami¥Î©óªvÀø¦M«¯f±w¤§EUA ....... 2. 2022.1.20ÃÒ¨é´Û¶B«ß®v¨Æ°È©Ò¥Nªí§ë¸êªÌ«Å¥¬¹ï NRx ¶i¦æ½Õ¬d2021 ¦~ 6 ¤ë¡ANRx «Å¥¬¦V¬ü°êFDA´£¥æ¥Ó½Ð¡An¨DÀò ±oZYESAMIªººò«æ¨Ï¥Î±ÂÅvEUA¡A¥HªvÀø±w¦³©I§l°IºÜªº¦M« COVID-19 ±wªÌ. 2021 ¦~ 11 ¤ë 4 ¤é¡A NRx «Å¥¬ FDA ©Úµ´¬° ZYESAMI µo¥¬ EUA ¡A¡§¦]¬°Ãö©ó¸ÓÃĪ«ªº¤wª¾©M¼ç¦b¯q³B¥H¤Î ZYESAMI ¦b±w¦³ÄY« COVID-19©I§l¨t²Î¯e¯fªº±wªÌ¤¤ªº¤wª¾©M¼ç¦b·ÀIªº¼Æ¾Ú¤£¨¬¥¢±Ñ¡C¡¨ |
|
|
·|û¡G¶À±Ò½÷10152632 µoªí®É¶¡:2022/2/8 ¤U¤È 01:46:41²Ä 1664 ½g¦^À³
|
¥Í§Þ¤½¥q·sÃĪº¬ãµo¡A³£¬O³Æ·¥¨¯W¡A¦Ü¤Ö½Ð¯¸¦b¤ä«ùªº¨¤«×¡A®i²{¥]®eªº®ð«×¡C¥unÃĬO¦³®Äªº¡A«áÄòÁ`·|«ö·Ó¬J¦³ªº¶i«×¡A±ÂÅv¡B¸Ñª¼¡B¤T´Á¸ÕÅç¡AªÑ»ù¸Ó¤jº¦´N·|¤jº¦¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/8 ¤W¤È 06:25:02²Ä 1663 ½g¦^À³
|
¬°¤°»òn¬ÝPHE©µªø©Îµ²§ô? ©³¤U˹L¨Ó¡A¤@¥¹HHS«Å¥¬ºò«æª¬ºA(PHE)µ²§ô¡AFDA§Y¨S¦³EUAÅv¤O¡C ---------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 05:28:06²Ä 1657 ½g¦^À³ µo¥¬EUAªºµ{§Ç¯A¤Î¤Ó¨BÆJ¡G¤@¬O½T©w¬O§_¶i¤Jºò«æª¬ºA¡A¥Ñ°ê¨¾³¡¡B°ê¤g¦w¥þ³¡©Î½Ã¥Í©MºÖ§Q³¡¡]Health and Human Services¡AHHS¡^½T©w¡F¤G¬OHHS«Å¥¬¶i¤Jºò«æª¬ºA¡F¤T¬OFDA¹ïEUA½Ð¨D¶i¦æ¼fµû¡F¥|¬OHHSµo¥¬¡]©Î©e°UFDA¥Nµo¡^EUA©Î©Úµ´EUA½Ð¨D¡F¤¬OHHS²×¤îEUA¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/8 ¤W¤È 06:07:18²Ä 1662 ½g¦^À³
|
2022.1.21 ¦U¦{n¨D HHS ´N COVID-19 ºò«æ±¡ªp¦ó®Éµ²§ô´£¨Ñ§ó¦h«ü¾É (¨S·Q¨ì·R²üµØ¦{ªø¶}¥X²Ä1ºj:PHE©ó2¤ëµ²§ô!) States ask for more guidance from HHS on when COVID-19 emergency will end ¡K State officials want more time and predictability from the Biden administration before the end of the COVID-19 public health emergency and with it a massive undertaking to redetermine eligibility for Medicaid coverage. Several state officials and advocates discussed their current preparations for the end of the PHE during a Thursday meeting |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/8 ¤W¤È 05:53:57²Ä 1661 ½g¦^À³
|
¨S·Q¨ì·R²üµØ¦{ªø¶}¥X²Ä1ºj:PHE©ó2¤ëµ²§ô! 2022.2.3 ·R²üµØ¦{¦{ªøª÷¹p¿Õ¯÷(R) ¶g¥|«Å¥¬¡A¸Ó¦{°w¹ï COVID-19 ªº¤½¦@½Ã¥Íºò«æª¬ºA¤½§i(PHE)±N©ó 2 ¤ëµ²§ô¡C ¡§§Ṳ́£¯àÄ~Äò¼È°±¤w¥¿¦¡¹{¥¬ªºªk«ß¡A¨Ã±N COVID-19 µL´Á¦aµø¬°¤½¦@½Ã¥Íºò«æ¨Æ¥ó¡C¨â¦~«á¡A¥¦¤£¦A¥i¦æ©Î¨S¦³¥²n¡C¬y·P©M¨ä¥L¶Ç¬V¯f¬O§Ṳ́é±`¥Í¬¡ªº¤@³¡¤À¡A«aª¬¯f¬r¤]¥i¥HÃþ¦ü¦a¶i¦æºÞ²z¡A¡¨¹p¿Õ¯÷¦b¤@¥÷Án©ú¤¤»¡¡C thehill.com/homenews/state-watch/592777-iowa-announces-upcoming-end-to-covid-19-as-a-public-health-emergency ................................................................................................... ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 05:28:06²Ä 1657 ½g¦^À³ ¦Û2020.3¤ë¬ü°êHHSµo¥¬COVID-19ºò«æª¬ºA°_¤w³sÄò8©u§ó·s©µªø8¦¸(¨C¦¸©µªø90¤Ñ)¡A¤U¤@¦¸(2022.4¤ë)·|«Å¥¬©µªø©Î²×¤îEUA??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 11:04:17²Ä 1660 ½g¦^À³
|
ªYÄ£ºô¶: ²£«~¶i«×SNP-630:·sªvÀø¾AÀ³¯g±´°Q-°£¤F¹ï«D°sºë©Ê¯×ªÕ¨xª¢(NASH)¦³®Ä¡A¤]¦P®É¶i¦æ°Êª«¹êÅç¡A±´°QªvÀø°sºë©Ê¯×ªÕ¨xª¢(ASH)¤§Àø®Ä ................................................................................................ ¦³½ì¤F! µn¿ý¦b®×ªºASHÁ{§É©tªù¿W¥«´N1¥ó 1¥ó 1¥ó(ÁÙºM®ø¨S°õ¦æ)---³oªí¥ÜASHÀ³¸Ó¨S¥«³õ§a¡A¤£¸ÑªYÄ£·F¹À±´°Q??? clinicaltrials.gov/ct2/results?cond=ASH+alcoholic+Steatohepatitis&term=&cntry=&state=&city=&dist= |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 10:09:20²Ä 1659 ½g¦^À³
|
¥xÆW¥Ø«eÁö¦bÁקK·s«a¬Ì±¡ªºÂX´²¤W¨ú±o¦¨¥\¡A«o¤]·N¨ýµÛ¦³«D±`¤j¶qªº¤H¤f¼Æ¨S¦³§ÜÅé¡A¦]¬°Omicron¯f¬r¨ã¦³°ª¬ð¯}©Ê·P¬V²v¡A¸Õ¹Ïªý¾×Omicron¡A´N¹³¸Õ¹Ïªý¾×·¡C «ØijÁÙ¨S¥´¬Ì]ªÌ¶X¦(ªü¤¤«Å¥¬¥xÆW»P¯f¬r¦@¦s¶}©ñÃä¹Ò«e)¸É¦n¸Éº¡¾¯¼Æ! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 09:25:07²Ä 1658 ½g¦^À³
|
¤µ¤Ñ(2/7)¥þ²y¼Æ¤@¼Æ¤G¨¾¬Ì³ÌÄYV©M®É¶¡³Ì¤[ªº¿D¬w«Å¥¬«±Ò°ê¬É¡A2/21¤é°_¶}©ñ§¹¾ã±µºØ¬Ì]ªÌ¤J¹Ò¡AÀHµÛOmicron¯f¨Ò¿E¼W¡A¦Ó·í¤¤¦h¬°»´¯g¡A¿D¬w¤w¸g©ñ±ó¥ý«e°í¦uªº²M¹s¨¾¬Ì©M¯f¨Ò°lÂÜ°µªk¡C³o¦¸¨M©w§Î¦P§â©Ò¦³³Ñ¾lªº¨î¸Ñ°£¡C ¥xÆWÁÙ¯àÂê°ê¦h¤[?(¨S¥´¬Ì]ªÌ»°ºò¥´¦n¥´º¡§a) ................................................................................................. ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 04:50:42²Ä 1615 ½g¦^À³ µª®×˼Æ68¤Ñ´¦¾å!!! 2022.1.19 权«Â医学杂§Ó¡m¬húí¤MThe Lancet¡n«½S¡G·s«a¤j¬y¦æ§Y将结§ô (标§Ó时间点¬O2022¦~3¤ë) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 05:28:06²Ä 1657 ½g¦^À³
|
¦Û2020.3¤ë¬ü°êHHSµo¥¬COVID-19ºò«æª¬ºA°_¤w³sÄò8©u§ó·s©µªø8¦¸(¨C¦¸©µªø90¤Ñ)¡A¤U¤@¦¸(2022.4¤ë)·|«Å¥¬©µªø©Î²×¤îEUA??? 2022.1.14 ¬ü°ê½Ã¥Í»P¤½²³ªA°È³¡(HHS)±NCOVID-19ªº¤½¦@½Ã¥Íºò«æÁn©ú¦A©µªø 90 ¤Ñ¡A¦Û 1 ¤ë 16 ¤é°_¥Í®Ä¡C www.aha.org/news/headline/2022-01-14-hhs-renews-public-health-emergency µo¥¬EUAªºµ{§Ç¯A¤Î¤Ó¨BÆJ¡G¤@¬O½T©w¬O§_¶i¤Jºò«æª¬ºA¡A¥Ñ°ê¨¾³¡¡B°ê¤g¦w¥þ³¡©Î½Ã¥Í©MºÖ§Q³¡¡]Health and Human Services¡AHHS¡^½T©w¡F¤G¬OHHS«Å¥¬¶i¤Jºò«æª¬ºA¡F¤T¬OFDA¹ïEUA½Ð¨D¶i¦æ¼fµû¡F¥|¬OHHSµo¥¬¡]©Î©e°UFDA¥Nµo¡^EUA©Î©Úµ´EUA½Ð¨D¡F¤¬OHHS²×¤îEUA¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/4 ¤U¤È 09:50:55²Ä 1656 ½g¦^À³
|
¬ü°ê´Nn¨¾¬Ì¡uÃP¸j¡v¤F¡AFDAÁÙ«ùÄò±ÂÅvEUA (ºò«æ¨Ï¥Î±ÂÅv)? ·Q¨úÃÒ¥u¦³°µ¤T´ÁÁ{§É¤@³~! 1.2022.02.04 ½T¶EÆJ´î35% ¬ü°êCDC¡G¨¾¬Ì¡uÃP¸j¡vnµ¥¦í°|¡B¦º¤`²vÂù´î udn.com/news/story/121707/6076068 ^°ê¤½½Ã©xû«ü¥X¡A¥Ñ©ó¹w´Á¬Ì±¡±NÀò±±¨î¡A·P¬V¤Î¦º¤`¤H¼Æ±N°¦Ü¡u·¥§C¼ÆÃB¡v¡A¦]¦¹¹wp¤£¤[ªº±N¨Ó±N°±¤î»`¶°¬Ì±¡¼Æ¾Ú¡C 2.2022.02.04 ¬K©uªï¨Ó¼Ú¬w¬Ì±¡¡u°±¤õ¡v¡H¥@½Ã¡G¦³±æ¶i¤J [ªø´Á¥ÀR´Á] udn.com/news/story/6809/6075829 §J¾|®æ«ü¥X¡A¥]¬A^°ê¦b¤ºªº53Ó¼Ú¬w°ê®a©M¦a°Ï¤W©P¥X²{1200¸U¨Ò·s½T¶E¡A³o¬O¬Ì±¡Ãzµo¥H¨Ó³æ©P [³Ì°ª] ªº¼Æ¦r¡C µM¦Ó¦í°|¤H¼Æ©M«¯gºÊÅ@±wªÌªº¼Æ¶q¨Ã [¨S¦³ÅãµÛ¼W¥[]¡A¦P®É¦º¤`¤H¼Æ¤]¶}©lÁÍ©ó¥Ã¡C |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/1/31 ¤W¤È 09:31:34²Ä 1655 ½g¦^À³
|
¯¬ºÖ¦U¦ì¤j¤j ·sªº¤@¦~ ¥¦w¡B°·±d¡B§Ö¼Ö¡I ªYÄ£¡Aªê¦~¦æ¤j¹B¡I |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/1/28 ¤U¤È 02:25:37²Ä 1654 ½g¦^À³
|
«e°}¤lŪ¨ì¤@Ó¬ã¨s¡Aµ¹¤j®a°Ñ¦Ò¡C¥¦°w¹ï¹L¥h´¿¬OªÑ¤ýªÑ²¼¬y¦V¬ã¨s¡Aµo²{ªÑ»ù¦b3¡B400¤¸®É¡A´²¤áÁ`«ùªÑ¼Æ½æ¨ì³Ñ¤@¦¨¡A¦b5¡B600¤¸®É§ó¼µ¤£¦í¤£½æ¡A¶È³Ñ¤£¨ì5¦Ê¤À¤ñ¡A¹L´X¦~¦¨¬°ªÑ¤ý®É¡AÁÙ¦³ªÑ²¼ªº«Ü¤Ö¤F¡C ·|¤£·|¦¨¬°ªÑ¤ý¨S¦³¤H´±»¡¡A¯à»¡ªº¬OªYÄ£²{¦b¤~è¶}©lnµoöt¦Ó¤w¡A¯¬¤j®aµo°]¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2022/1/26 ¤U¤È 05:25:12²Ä 1653 ½g¦^À³
|
kim¤j¡A¦³ªk«ß³d¥ôªº¡A¤£¥i¯à°äÀs°Ú¡A ¤p§Ì§ë¸ê¹L6598Âà¤W¥«¡A107¦~¤Q¤ë¤@¤é¨ú±oFDA¸zª¢¸Õ¾¯¡A©ó¦¸¦~¤G¤ë¤½§i¨ú±o¬ì§Þ¨Æ·~¨ç¡A°e¥ó¥Ó½Ð¤é¥i¥H¤£¥Î¤½§i¡A¥æ©ö©Òªº¤@°ï«°T¤½¥¬¿ìªk·Ðº¾¡A ¥u¯à®³«e¨Ò¤ñ¸û¡A ©Ò¥H±j¯P±À´úªYÄ£¬O®³¬ü°ê«D³B¤èÃĦX§@¥h¥Ó½Ðªº¡A²{¦b«ù¦³¦Üµ¥Âà¤WÂd²z½×¤W³£¦³¾÷·|Àò§Q¡A¨Ñ参¦Ò¡ã¯¬«ù¦³ªÌ³£Àò§Q¡A·s¦~§Ö¼Ö¡I¡I |
|
|
·|û¡GAYuan10148816 µoªí®É¶¡:2022/1/26 ¤U¤È 05:13:40²Ä 1652 ½g¦^À³
|
¥Ø«e·sÃĬãµo¤½¥q¥Ñ©ó»Ý§ë¸ê¤j¶q¸êª÷¬ãµo¡A¥B¬ãµo´Á¶¡ªø¡A¥i¯à²£¥Í¹dÃBÁ«·l©Î¤´µLªk²£¥ÍÀò§Q¡A¦]¦¹¤j³¡¤À¥H¬ì§Þ¨Æ·~¥Ó½ÐªÑ²¼¤W¥«©Î¤WÂd¡F¦ýY¥H¬ì§Þ¨Æ·~¥Ó½ÐªÑ²¼¤W¥«©Î¤WÂd¡A»Ý¥ý¨ú¨ã¤u·~§½®Öã¨ç¡A±©²{¤µ¸gÀÙ³¡¤u·~§½¼f®Ö¤éÁÍÄY®æ¡A°w¹ï²£«~¤§§Þ³N¤Î¥«³õ¥¼¨Ó©Ê¥ç§ó¬°ª`«¡A¬G²{¤µ¦]¤u·~§½¼f®Ö¥¼¹L¦Ó¼vÅT¤W¥«Âd®Éµ{ªÌ¡A¥ç¤£¦b¤Ö¼Æ¡C¦¹¥~¡A¨Ì¹L©¹¸gÅç¡A¥Ø«e¥Ó½Ð¤u·~§½®Öã¨ç¬ù¯Ó®É<<¦Ü¤Ö¤G¦Ü¤TÓ¤ë¥H¤W>>¡A¬Æ¦Ü»Ý¹FÁ{§É¤T´Á¡A¤è¥i¨ú¨ã¬ì§Þ¨Æ·~®Öã¨ç¡C¥t¬ì§Þ¨Æ·~®Öã¨ç¤§<<®Ä´ÁÁö¬°¤@¦~>>¡A¦ý¤½¥qÀ³ÁקK¬ì§Þ¨Æ·~®Öã¨ç§Y±N¨ì´Á¤è°e¥ó¡A¥H§K²£«~¥¼¨Ó©Ê¾D¨ü½èºÃ¡C¦]¦¹¡A¤½¥q³W¹ºªÑ²¼¤W¥«©Î¤WÂd®É¡A¶·¼f·V¦Ò¶q¦V¤u·~§½¥Ó½Ð¬ì§Þ¨Æ·~®Öã¨ç¤§®ÉÂI¡A¨Ã©ó§¹³Æ²£«~§Þ³N¤§®t²§»P²£«~¥¼¨Ó³W¹º«á¡A¦A¦æ¥Ó½Ð¤u·~§½®Öã¨ç¡A¨ú¨ã¤u·~§½®Öã¨ç¤è¯à¸û¬°¶¶§Q¡AÚ«K©ó³W¹ºªÑ²¼¤W¥«©Î¤WÂd®Éµ{¡C |
|
|
·|û¡Gkim10134548 µoªí®É¶¡:2022/1/26 ¤U¤È 04:38:01²Ä 1651 ½g¦^À³
|
¦h¦h¤j¤Î¦U¦ì¥ý¶i¡G ½Ð°Ý¡AÃö©ó¡u¤u·~§½¤w°e¥ó¡v¤@¨Æ¡A·|¤£·|¬O¤½¥q¤è±ÀH«K©ñÓ·Án¡A ©IÄV¤@¤U§Ú̳o¨Ç¤pªÑªF¡H¦³§_¥i¥H¦b¤u·~§½©Î¬ÛÃöªººô¯¸¬d¸ß±o¨ì©O¡H ½Ñ¦p¡G°e¥ó¤é´Á¡B¤½¥q¦WºÙ¡B©Î¬ÛÃö®×¸¹¡K¡Kµ¥µ¥¡C |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/1/26 ¤U¤È 02:28:22²Ä 1650 ½g¦^À³
|
·PÁÂN¤j§ó·sªÑªF·|®ø®§; ¦^À³¦h¦h¤j:§Ú¤]»{¬°¬O810¦X§@®×®³¥h¥Ó½Ðªº! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/1/26 ¤U¤È 02:00:17²Ä 1649 ½g¦^À³
|
¤p§Ì¦n©_¡A ¦pªG¨S§Q¦h¡A¤µ¤Ñ©Ô³o¤@¤p¬õ¬Onµ¹½Ö¶]ªº?? |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2022/1/26 ¤U¤È 01:15:01²Ä 1648 ½g¦^À³
|
¹ï©ó¤w°e¤u·~§½¤@¨Æ¡A¤p§Ì¤]²`·P¬ðµM¡A¦ý¤£ª¾¬O´X®É°e¥óªº¡A¤]³\¥¼¨Ó¤K¶g¤º³£·|¦³Ãz¬µ®ø®§¡A ÁÙ¬O¦³ÂI©Ç²§¡AÀ³¸Ó¬O¦X§@±ÂÅv®×¥Í®Ä¦A°e¤u·~§½¤ñ¸û¦X²z¡A§_«h¬O¥Îþ¤@±ø¥ó»¡ªA¤u·~§½¡A¬O¬ü°ê«D³B¤èÃĤw¨úÃÒ¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/26 ¤U¤È 01:13:21²Ä 1647 ½g¦^À³
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2022/1/26 ¤U¤È 12:49:34²Ä 1644 ½g¦^À³ ..¥t¥~¨Ì·|«á¸³¨Æªø©Ò»¡¶i«×¡AÓ¤H±À´ú810¦X§@®×¤~¬O¤u·~§½³q¹L¤§¥D¦]¡A ------------------------------------------------------------------------------------------------ ¦¶¸³¥i¬O±ý¨¥¤S¤î¤@¤ÁºÉ¦b¤£¨¥¤¤? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/26 ¤U¤È 12:58:43²Ä 1646 ½g¦^À³
|
¤u·~§½¤w°e¥ó¡A³Ì±ß¤K¶g¥iª¾³q¹L§_? ------------------------------------------------------------------------- ¥ý±Ù«á«µ¡A¤Ï¥¿¤pªÑªF¦³½Ö·|¤Ï¹ï?¦Ó¤ñ¨Ò¤]±À½¤£¤F¸³¨Æ·|¨Mij |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/1/26 ¤U¤È 12:53:05²Ä 1645 ½g¦^À³
|
ªÑªF·|¶i¦æ®ÉªÑ¥«ÁÙ¦b¥æ©ö¡A·íµM¤£¯à¦b½L¤¤³zÅS«n°T®§¡C ¬Ý¬Ý½L«á¦³µL«¤j°T®§¤½§i¡A·PÁ§i¤§¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2022/1/26 ¤U¤È 12:49:34²Ä 1644 ½g¦^À³
|
¦p¦P¤§«e·s»D©Ò¨¥¡A§ó§ï½á«¬¾¯¡A¤£¥Î§ó´«ÃÄÃÒ¡A¤u·~§½¤w°e¥ó¡A³Ì±ß¤K¶g¥iª¾³q¹L§_¡A ¥t¥~¨Ì·|«á¸³¨Æªø©Ò»¡¶i«×¡AÓ¤H±À´ú810¦X§@®×¤~¬O¤u·~§½³q¹L¤§¥D¦]¡A¤WÂd¹wp¬ù¤@¦~¦Ü¤@¦~¥bªº®É¶¡¡A¤p§Ì»{¬°n©Ô¤@ªiªº®É¶¡ÁÙ¨S¨ì¡A¦]¬°¤WÂd®Éµ{ÁÙ¤[¡AªÑ»ù´NºCºC¨ÓÅo¡A¤Ï¥¿´NÄò©êµ¥§Q¦h¤F¡ã |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/1/26 ¤U¤È 12:43:29²Ä 1643 ½g¦^À³
|
¦³¤H°Ý¡A¦ý¦L¶H¤¤¦¶¸³»¡¨S¿ìªk³zÅS¡AY¦³®ø®§·|§Y¨è¤½¥¬¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/1/26 ¤U¤È 12:40:04²Ä 1642 ½g¦^À³
|
ÁÂÁ°ѥ[ªºªÑ¤ÍÌ´£¨Ñ¸ê°T ¬Ý¨ÓÁÙ¬OÃÓªá¤@²{ ¬õ¥]nµ¥¦~«á¤F |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/1/26 ¤U¤È 12:28:55²Ä 1641 ½g¦^À³
|
¹ï°Ú¡I 810ªºÃĮĸÕÅç¡A¥i»¡¬O«¤¤¤§«¡C Ãø¹D¨S¦³ªÑªF°w¹ï¦¹ÂI´£°Ý¡H ³£¤w¸g¶W¹L1¦~¤F¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/26 ¤W¤È 11:44:46²Ä 1640 ½g¦^À³
|
ºÃ? J&J»PGSKªº½T®Ä¹êÅç¨S¸É¥R»¡©ú¶iµ{? |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/1/26 ¤W¤È 11:32:52²Ä 1639 ½g¦^À³
|
To R¤j ¤p¨k¤H¤j ¤µ¤ÑªÑªF·|¤¤ÀÄÁ´Nµ²§ô¤F¡A·|«á¦¶¸³¨Æªø¦³±µ¨üªÑªF´£°Ý¡A¨S¦³Å¥¨ì¤°»ò·sªº¤º®e¡C 1. 810¼Ï¯Ã¸ÕÅ礣¬O³æ¤@¸ÕÅç¡A¥Ø«e¶i¦æ³\¦h°Êª«¸ÕÅ礤¡C 2. 810±ÂÅv»P¼Ï¯Ã¸ÕÅçµLÃö¡A¦ý¼Ï¯Ã¸ÕÅç¥i¯à·|¥[¤À¡C 3. 630¤@´Á±µªñ§ÀÁn¡A·Ç³Æ¶i¦æ¤G´Á¸ÕÅç¡C 4. ¤WÂd¥Ó½Ð¬yµ{¤w¸g±Ò°Ê ¤j·§¬O³o¼Ë¡ã |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/1/26 ¤W¤È 11:32:37²Ä 1638 ½g¦^À³
|
¬Ý¨Ó¦³®ø®§¤F®@~~¬ðµM©Ô¤@®Ú¤p¬õ¡A¬Ý¦³¨S¦³«ùÄòÅܤj¬õ¡Aµ¹Ó¬õ¥]¦n¹L¦~ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/26 ¤W¤È 11:29:14²Ä 1637 ½g¦^À³
|
°ê»Ú§½¶Õ¦³·ÀI¡A«X¯QÀH®É¥i¯à¶}¾Ô! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/26 ¤W¤È 11:11:09²Ä 1636 ½g¦^À³
|
Á{®É·|¦³¬Æ®ø®§? ÁÂÁÂ~ |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/1/25 ¤U¤È 06:37:48²Ä 1635 ½g¦^À³
|
¤p§Ì§ÚÀ³¸Ó·|¥h |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/1/25 ¤U¤È 03:31:32²Ä 1634 ½g¦^À³
|
½Ð°Ý¦³¤H©ú¤Ñ1/26·|¥h°Ñ¥[Á{®ÉªÑªF·|¶Ü? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/24 ¤U¤È 04:57:40²Ä 1633 ½g¦^À³
|
«sªo «¥®a¦Û¼u¦Û°Û¦±°ª©M¹èªº¤]³Q©À Orz. FDA¤ñNSA(°ê®a¦w¥þ§½)ÁÙÁV¿| (¦w¥þ©Ê¤jPK?) Tylenol Can Kill You: Why the FDA is Worse Than the NSA www.youtube.com/watch?v=z6s3Bay04M0 |
|
|
·|û¡G°ê¤§¤jªÌ10143132 µoªí®É¶¡:2022/1/24 ¤U¤È 03:21:48²Ä 1632 ½g¦^À³
|
°ê¹©ªº¥¥x¦´N³Q©Ò¿×ªº¬ì¾Ç¥¿¸q¡A°Q½×¨ìÃö³¬¤F¡I «Øij¥u°Q½×ªYÄ£¡A¦³¨Ì¾Ú¡A§O·dˤ½²³ªºµo¨¥¥¥x |
|
|
·|û¡G¤ý¥ý¥Í10149972 µoªí®É¶¡:2022/1/24 ¤U¤È 02:54:56²Ä 1631 ½g¦^À³
|
¦¹±MÄæ¬O°Q½×ªYÄ£¡A¦pªGn°Q½×°ê¹©¡AÁ¿¨ì°ê¹©¨ºÃä¥h°Q½×¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/24 ¤U¤È 01:20:18²Ä 1630 ½g¦^À³
|
¿W¥ß«ä¦Ò¸Á»eÁ{§É¬O¦p¦óÀòã¶i¤J¤T´ÁÁ{§É....¡A³oÓ3´Á´Á¤¤¼Æ¾Ú¥Ó½Ð¤£¤FEUA ¡C °ê¹©³]p³æÁu¦¬12¤H¡AÓ¤HÁr´ú¬O¦æ±´¯Á©Ê¤ÀªR¡A¥Î¥H¹ï¸ÕÅçµ²ªG´£¥X¸ÑÄÀ©Î¤ä«ù¡A¨Ã¬°«áÄò¬ã¨s´£¥X¶i¤@¨Bªº°²³]¡C (Àù¯gÁ{§É¡A¬O¬Û·íªá¿ú¦a¡A¬Ý¹L¤@½g¨ÅÀùÁ{§É¸ê®Æ¡A©Û¶Ò1¦ì¯f±w±oªá¶O120¸U¬ü¤¸) .............................................................................................. ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/17 ¤W¤È 07:50:32²Ä 1523 ½g¦^À³ ..¸Á»e¤]¯àªv·s«aªÍª¢¡AÁÙ¬O3´ÁÁ{§É³á! ¤£¬Û«H? Honey & Nigella Sativa Trial Against COVID-19 (HNS-COVID-PK) Phase 3 clinicaltrials.gov/ct2/show/NCT04347382?term=Honey+%26+Nigella+Sativa&draw=2&rank=1 |
|
|
·|û¡G°ê¤§¤jªÌ10143132 µoªí®É¶¡:2022/1/24 ¤U¤È 01:09:49²Ä 1629 ½g¦^À³
|
¦Y¹¡¤Ó¼µ¤F ³o¬OªYÄ£¡A¤£¬O°ê¹©¡I »¡¤F¤@°ï¡A´N¬O¦³¨S¦³¶R¨ìªÑªº°ÝÃD §Ú¦b³o¸Ì¤w¸g10¦~¡A«È¤H¤£´± ¦ý½Ð°O±o³o¬O¤½¦@ºô¶¡A¤£¬O¨p¤H¥¥x |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/24 ¤U¤È 01:05:34²Ä 1628 ½g¦^À³
|
¤W¶gFDA©Ó»{¨S¦³±µªñ§åãEUAªº±ß´ÁªvÀøÃĪ«¡¨¡]°Ñijû»y®ð±j½ÕNo¡^.....¡C FDA©w¸qªº[±ß´Á]ªvÀø¬OÁ{§É¨ºÓ¶¥¬q¦Û¤v§ä¡A¦Û¤v¿W¥ß«ä¦Ò¤@¤U? 2022.1.20 ²³Ä³°|¦@©MÄÒ»â¾É¤HÁ|¦æ¨C¶g·s»Dµo¥¬·| www.youtube.com/watch?app=desktop&v=wtyNdmqm6BM&feature=youtu.be 5:20 Senator Andy Harris ¡§LAST WEEK FDA admitted there are NO late stage therapeutics that near EUA approval¡¨ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/1/24 ¤U¤È 12:56:07²Ä 1627 ½g¦^À³
|
R¤j½Ð±Ð¤@¨Æ Á{§É¤G´Á¤£¬On¥ý¹êÅç³]p«á¤~§ë¤J¡A¥i¥H¦Û¦æ³]p¤@µL¹ï·Ó²Õ¤§¤G´Á??FDA¤]¤£ºÞ¡A¤Ï¥¿µ¥¼Æ¾Ú¥X¨Ó«á¦A¼f¬d?? °ê¹©°©Åè©Ê¥Õ¦å¯f·sÃĤG´Á¡A¦pªGÁ{§É³]p»P²{¦³ªvÀøÃĪ«ÀY¹ïÀY¸ÕÅç¡AµM«áÁ{§Éµ²ªG¦P¤Wz¡A§Ú«OÃÒ¨úÃÒ¬O©ö¦p¤Ï´x¡C ¬°¦ó³æÁu? +++++++++++++++++++++++++++++++ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/23 ¤U¤È 08:56:44²Ä 1626 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/19 ¤W¤È 09:37:35²Ä 1602 ½g¦^À³ 2020.11.16ªº°©Åè©Ê¥Õ¦å¯f·sÃĤG´Á¡A´N¬O [¨S] ¹ï·Ó²Õ¼Æ¾Ú¡AÀø®Ä[¬Ý°_¨Ó]¦n´Î´Î! (¦pªG³o¬O»P¤W¥«ªvÀøÃĪ«ÀY¹ïÀY¸ÕÅç¡A¥Dn»P¦¸n«ü¼Ð¥þ³¡¹F¼Ð¡A¥Ó½ÐÃÄÃÒ³Q§_¨M¾÷²vÀ³¸Ó¬O~0%) 2020.11.16 °ê¹©°©Åè©Ê¥Õ¦å¯f·sÃħ¹¦¨Á{§É¤G´Á ±N¥Ó½Ð¤W¥«³\¥iÃÒ news.cnyes.com/news/id/4543080 ¾ÚÁ{§É¸ÕÅçµ²ªGÅã¥Ü¡A¥Dn¸ÕÅçÀø®Ä«ü¼Ð¡AÀu©ó¥Ø«e¥«³õ¤W¤w¨ú±oÃÄÃÒªºªvÀøÃĪ«¤G´Á¸ÕÅçµ²ªG¡F¦¸n¸ÕÅçÀø®Ä«ü¼Ð¡B¦w¥þ ©Ê¤è±¡A¦s¬¡²v¸û²{¦æÃĪ«ªø¡B°§C¯f±w¿é¦åªvÀø¡A¥H¤ÎµLÅãµÛ°Æ§@¥Î¡C ............................................................................................. °ê¹©°©Åè©Ê¥Õ¦å¯f·sÃĤG´Á¡A¦pªGÁ{§É³]p»P²{¦³ªvÀøÃĪ«ÀY¹ïÀY¸ÕÅç¡AµM«áÁ{§Éµ²ªG¦P¤Wz¡A§Ú«OÃÒ¨úÃÒ¬O©ö¦p¤Ï´x¡C ¬°¦ó³æÁu? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/23 ¤U¤È 08:44:10²Ä 1625 ½g¦^À³
|
·|û¡GªY½à¼Æ¦r¬ü10147157 µoªí®É¶¡:2022/1/9 ¤U¤È 10:55:51²Ä 1571 ½g¦^À³ ..§Úı±o¬O¦³¾÷·|¥i¥H¥Îµ¥®Ä©Ê¥H¤Î«D¦H®Ä©Ê©MFDA½Í§P ................................................................................................ [FDA³W½d¥²¶·¬O³]¦³¹ï·Ó²ÕªºÁ{§É¸ÕÅç¡A¤è¥i¾Ú¨äÁ{§Éµ²ªG¥Ó½Ðºò«æ±ÂÅv¨Ï¥Î¡]EUA¡^©Î¥¿¦¡®Öã¡C] ±z»¡µ¥®Ä©Ê¥H¤Î«D¦H®Ä©Ê--¨S»P¹ï·Ó²ÕPK«çª¾Àu¦H©Ê? °ÝÃD¨Ó¤F¡A¥i¬O°ê¹©¼B¸³»P°]°Èªø´¿¤ì¼W»¡¤£»P¹ï·Ó²ÕPK°Ú! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/23 ¤U¤È 08:31:49²Ä 1624 ½g¦^À³
|
¬Ý±zªì¨Ó¥E¨ì¬O«È¡A¦A¦^¤@¦¸! «¥®a¬O°v°ê¹©»¡¤j¸Ü2´Á®³¨ìEUA¡A¤ß®®»PÃĵصØ...À³¸Ó¨Sµo2´Á®³¨ìEUA·s»D§a? Gºô¥i¬O¯uª¾¨ô¨£¦b2021.11.8 ¥Z½g¬ü°êNRxÃļt¥Ó½ÐEUAªºÄµ§i¤å¡A±z¬Ý¤F¶Ü? ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/21 ¤W¤È 07:50:58²Ä 1611 ½g¦^À³ ¸g¹L°ò¨È»P¯E¹©¨Æ¥ó«á¡A§ë¸ê¤H¹ï¥Í§ÞªÑ¯d¤U¤£¦nªº¦L¶H¡A¤£§Æ±æ¾ú¥v¨Æ¥ó«ºt! 1. FDA©Úµ´NRxÃļtZyesami¥Î©óªvÀø¦M«¯f±w¤§EUA 2021.11.8 www.genetinfo.com/trend/item/53794.html ¥xÆW§ë¸ê¤Hª`·N¤F!±o¨ì«n¬ã¨s¾÷ºcNIH©ÎWHOµ¥ªºÃÙ§U¡A¬Æ¦Ü¨ú±o¬ü°êFDA§Ö³t¼f®Öªº¸ê®æ¡A³£µLªk«OÃÒ¤@©w·|±o¨ìFDA ªº®Öã??!!....... 2. 2022.1.20ÃÒ¨é´Û¶B«ß®v¨Æ°È©Ò¥Nªí§ë¸êªÌ«Å¥¬¹ï NRx ¶i¦æ½Õ¬d2021 ¦~ 6 ¤ë¡ANRx «Å¥¬¦V¬ü°êFDA´£¥æ¥Ó½Ð¡An¨DÀò ±oZYESAMIªººò«æ¨Ï¥Î±ÂÅvEUA¡A¥HªvÀø±w¦³©I§l°IºÜªº¦M« COVID-19 ±wªÌ. 2021 ¦~ 11 ¤ë 4 ¤é¡A NRx «Å¥¬ FDA ©Úµ´¬° ZYESAMI µo¥¬ EUA ¡A¡§¦]¬°Ãö©ó¸ÓÃĪ«ªº¤wª¾©M¼ç¦b¯q³B¥H¤Î ZYESAMI ¦b±w¦³ÄY« COVID-19©I§l¨t²Î¯e¯fªº±wªÌ¤¤ªº¤wª¾©M¼ç¦b·ÀIªº¼Æ¾Ú¤£¨¬¥¢±Ñ¡C¡¨ 3. ³ÌªñNRX¤S«·s¥Ó½ÐEUA... .................................................................................................. ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/19 ¤U¤È 12:51:39²Ä 1606 ½g¦^À³ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/10 ¤W¤È 09:51:38²Ä 1574 ½g¦^À³ ¼Æ¾Ú¨S§¹¾ã¤½¥¬¡A¨S¤Hª¾¾å¡A¦ý¶ø¦a§Q°ÓSanova¤@©wª¾¹D! (¤@ñ´N®¼°ê¹©) ----------------------------------------------------------------------------------------------- «¥®a¬O°v°ê¹©»¡¤j¸Ü2´Á®³¨ìEUA¡A¥i¨S½èºÃ¹LMOU¡C |
|
|
·|û¡G°ê¤§¤jªÌ10143132 µoªí®É¶¡:2022/1/23 ¤U¤È 02:40:13²Ä 1623 ½g¦^À³
|
½Ð¤ñ¹ï°ê¹©»P¨ä¥L¨â®a·s«a¡A¤£µM¤@ª½¼g¬O¬°¤°»ò¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/23 ¤W¤È 10:13:01²Ä 1622 ½g¦^À³
|
°ê¹©·s«a·sÃĸÕÅç¼Æ¾ÚÅã¥Ü¡A¥Dnµû¦ô«ü¼Ð¡]®É¶¡14¤Ñ¡^ªº±d´_²v(recover ratio)¡A²Ä14¤Ñ¥ÎÃIJձwªÌªº±d´_²v¬O97.9%¡A¥ÎÃIJզb²Ä28¤Ñ©Ò¦³¯f¤H³£¨S¦³¦º¤`¡B¤]¨S¦³©I§l°IºÜ¡A±d´_²v¬O100%¡F¦¸nµû¦ô«ü¼Ð ¡]®É¶¡½d³ò¬°28¤Ñ¡^³¡¥÷¡A¥[Å@¯f©Ð«¯g¥ÎÃIJկf¤H¤¤¦ì¼ÆªvÀø¤Ñ¼Æ©M¦w¼¢¾¯²Õ¤¤¦ì¼ÆªvÀø¤Ñ¼Æ¬Û¤ñ¡A¥ÎÃIJժºªvÀø®É¶¡ÁYµu¤F9.5¤Ñ¡A¥t¥~¥ÎÃIJժº¯f¤H¤¤¦ì¼Æ¦í°|®É¶¡¬°¥|¤Ñ¡A²M°£¯f¬r®É¶¡¤¤¦ì¼Æ¤Ñ¼Æ¬°14¤Ñ¡C --------------------------------------------------------------------------------------------------- ¬ü°ê CDC ¹ï©ó 7 ¸U ¦h¦W(52297¦W·P¬V Omicron¡A16982¦W·P¬V Delta)¨ü·P¬Vªº¥[¦{¤H¶i¦æªºµû¦ôµo²{... Omicron¦í°|±wªÌªº¦í°|®É¶¡¤¤¦ìªvÀø®É¶¡¬° 1.5 ¤Ñ¡C(PK °ê¹©¥ÎÃIJÕn4¤Ñ) 52297¦W·P¬V Omicron ªº±wªÌ¤¤¶È¦³ 1 ¤H¦º¤`¡A16982¦W·P¬V Delta ªº±wªÌ¤¤¶È¦³ 14 ¦º¤`( PK °ê¹©¦¬®×124¦W¡A¥ÎÃIJզb²Ä28¤Ñ©Ò¦³¯f¤H³£¨S¦³¦º¤`¡A¬Û¸û´N¤£¨¬¬°©_§a!) PS:¥H¤W¤ñ¸û§¹¥þ¤£¬ì¾Ç¨S·N¸q¡C¥u¬On¥YÅã¨S¦³¹ï·Ó²Õ¡AÁ{§É®ÄªG¬Ý°_¨Ó´N«Ü®e©öº}«G! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/23 ¤W¤È 09:54:50²Ä 1621 ½g¦^À³
|
¦º¤`²v»P¦í°|®É¶¡¤j´îµ¥¦M«æª¬ªp±µªñ¸Ñ°£ ¡AFDA¦³¥²n«ùÄòµo EUA? 1. ¬ü°ê CDC ¬ã¨sOmicronP¦º²v¸û Delta §C 91%(¥¼±µºØ¬Ì]ªÌ¤]¬O!) nypost.com/2022/01/13/omicron-91-percent-less-likely-to-be-fatal-compared-to-delta-cdc-study/ ¬ü°ê CDC ¹ï©ó 7 ¸U ¦h¦W(52297¦W·P¬V Omicron¡A16982¦W·P¬V Delta)¨ü·P¬Vªº¥[¦{¤H¶i¦æªºµû¦ôµo²{¡A±w¦³ Omicron ªº¤H»Ýn¦í°|ªº¤H¼Æ¤£¨ì Delta ªº¤@¥b¡A»Ýn«¯gºÊÅ@ªº¥i¯à©Ê¤]°§C¤F¬ù 75%¡COmicron¦í°|±wªÌªº¦í°|®É¶¡¤]´î¤Ö¤F¬ù 70%¡A¤¤¦ìªvÀø®É¶¡¬° 1.5 ¤Ñ¡C ¦¹¥~¡A52297¦W·P¬V Omicron ªº±wªÌ¤¤¶È¦³ 1 ¤H¦º¤`¡A16982¦W·P¬V Delta ªº±wªÌ¤¤¶È¦³ 14 ¦º¤`¡A¬ã¨s¤Hû Walensky ªí¥Ü¡A¡uÁöµMÁÙ¬O¦³¬Ý¨ì Omicron ¦º¤`ӮסA¤£¹L§Ú»{¬°¥Ø«eÁÙ¬O¥H Delta ¦º¤`Ӯש~¦h¡C¡v 2. 2003¦~SARS¯f¬rP¦º²v¥§¡¦º¤`²v¬ù10%¡A65·³¥H¤W°ª¹F55%(¬Û·íÅå¤H)¡A¦ý±J¥D¤HÃþ¦º¤`¡A¯f¬r¤]µLªk¦s¬¡¡C 3.¬ü°ê´¶³q·P«_¥§¡¦º¤`²v¬ù 0.13%¡C www.cdc.gov/flu/images/about/burden/influenza-burden-chart2-960px.jpg (®Ú¾Ú¬ü°êCDC²Îp¹Ïªí¡A2017-18¦³4500¸U¤H±o¨ì·P«_(14% of 3.4»õ¤H)¡A81¸U¤H¦í°|ªvÀø¡A6¸U1¤d¤H(0.13%)¯f¦º ¡C) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 10:55:07²Ä 1620 ½g¦^À³
|
ÁÙÂ_±ËÂ÷¤£¤F¡AºÎı«e¦A¨Ó¤@°Oª@Às®±KO! 2022.1.22 ¬ü°ê¥Õ®cº®u¨¾¬ÌÂåÀøÅU°Ý¦ò©_¡GOmicron¼Æ¤ë¤º¡u·¥¤£¥i¯à¡v¤G«×·P¬V¡@¬ü¦´Á¬Ì°Ï¯f¨ÒÆJ° ............................................................................................ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 04:50:42²Ä 1615 ½g¦^À³ µª®×˼Æ68¤Ñ´¦¾å!!! 2022.1.19 权«Â医学杂§Ó¡m¬húí¤MThe Lancet¡n«½S¡G·s«a¤j¬y¦æ§Y将结§ô (标§Ó时间点¬O2022¦~3¤ë) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 08:41:06²Ä 1619 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/19 ¤U¤È 12:51:39²Ä 1606 ½g¦^À³ ¼Æ¾Ú¨S§¹¾ã¤½¥¬¡A¨S¤Hª¾¾å¡A¦ý¶ø¦a§Q°ÓSanova¤@©wª¾¹D! (¤@ñ´N®¼°ê¹©) ----------------------------------------------------------------------------------------------- Â_±ËÂ÷ªºÃöÁä¦b¶ø¦a§Q°ÓSanova(1¤ë31¤é)¡A°®¯Ü§O»{½ßµ¥Â½µP¡C ................................................................................................. «ö¤µ¤Ñ5½g·s¶K¸ê®Æ¡A§Oµ¥Â½µP¥i¥HÂ_±ËÂ÷¤F! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 06:41:27²Ä 1618 ½g¦^À³
|
¯f¬rºt¤Æ¥H¬r§ð¬r¡A¦b¬ü°ê¶È¶È51¤Ñ¡AOmicron§Y±N·Àµ´Delta!? ¬ü国¯e¯f±±¨îÉO预¨¾¤¤¤ß¡]CDC¡^当¦a时间1¤ë18¤é发¥¬ªº³Ì·s数Õu显¥Ü¡AºI¦Ü1¤ë17¤éªº¤@©P内¡A¬ü国·s¼W奥±K§J¦¥¬r®è·P¬V¯f¨Ò数¶q¤w经¥eÕu该国·s¼W·s«aªÍª¢ÚÌ诊¯f¨Ò总数ªº99.5%¡A¨ä§E0.5%ªº¯f¨Ò·P¬Vªº¬O¼wûضð¬r®è¡C -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 02:22:40²Ä 1614 ½g¦^À³ ¶K´X«h°T®§¡A§ë¸ê¤H[¿W¥ß«ä¦Ò]²´¤UFDA±ÂÅvEUA¦a±ø¥ó??? 1.°ê¹©¤G´ÁÁ{§ÉOmicron¯f¨Ò¤H¼Æ? 2. ¬ü°ê¦b2021.11.27«eOmicron¯f¨Ò 0¡A ¬ü°êÁp¨¹¯e¯f¨¾ªv¤¤¤ß(CDC)ºI¦Ü2022.1.1¤é°ê¤º95.4%ªº·s¯f¨Ò¡ADeltaÅܺدf¬r«h³QÀ£ÁY³Ñ¤U4.6% |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 05:29:03²Ä 1617 ½g¦^À³
|
¤µ¥V«Ü¦h国®aªº·P¬V数¶q¬O¥h¦~¦P´Áªº10¿¡A¦ý¦í°|¤H数¦}没¦³¼W¥[ ¤µ¥V«Ü¦h国®aªº·P¬V数¶q¬O¥h¦~¦P´Áªº10¿¡A¦ý¦í°|¤H数¦}没¦³¼W¥[ ¤µ¥V«Ü¦h国®aªº·P¬V数¶q¬O¥h¦~¦P´Áªº10¿¡A¦ý¦í°|¤H数¦}没¦³¼W¥[ ¦b¥_¥b²y¡A¤µ¥V [Omicron¤Þ发ªº¤H¤f¦º¤`²v] ©M [严«¬y·P]±µªñ ¦b¥_¥b²y¡A¤µ¥V [Omicron¤Þ发ªº¤H¤f¦º¤`²v] ©M [严«¬y·P]±µªñ ¦b¥_¥b²y¡A¤µ¥V [Omicron¤Þ发ªº¤H¤f¦º¤`²v] ©M [严«¬y·P]±µªñ Chris Murray®ÚÕu«n«D©M^国©x¤è数Õu计ºâ±o¥XOmicronªºÆÓ¯g状·P¬V¤ñ¨Ò¥i¯à°ª达80-90%¡C §@ªÌ¥H医疗条¥ó为¥þ²y¤¤¦ì¤ô¥ªº§ÆÛK为¨Ò¡A«ü¥X¤µ¥V«Ü¦h国®aªº·P¬V数¶q¬O¥h¦~¦P´Áªº10¿¡A¦ý¦í°|¤H数¦}没¦³¼W¥[¡F¦Ó¦b¥_¥b²y¡A¤µ¥VOmicron¤Þ发ªº¤H¤f¦º¤`²v©M严«¬y·P±µªñ¡]2017-2018¥V©u¡A¬ü国52000¤H¦º¤_¬y·P¡A¥§¡1500¤H/¤Ñ¡^¡C ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/21 ¤W¤È 10:05:07²Ä 1613 ½g¦^À³ ¤@¥¹¯àÂç²M½T»{¬OOmicron¯f¬r¥»¨´N§ó·Å©M¡A¥H«á´N¬O¬y·P¤Æ¤F¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 05:14:05²Ä 1616 ½g¦^À³
|
¤@¥¹·s«a¤j¬y¦æ¦pChris Murray¹w´ú¦b3¤ë©³µ²§ô¡AFDAÁÙÄ~Äò±ÂÅvEUA? ³Ì·s¬ã¨s«ü¥X¡AOmicron ¯f¬r¥i¥H¶Ç¬Vµ¹´¿¸g½T¶E¹L Delta ¯f¬rªº¤H¡A¦ý Delta ¯f¬r«oµLªk¤Ï¹L¨Ó¶Ç¬Vµ¹ Omicron ½T¶EªÌ¡C 2022.1.21 ¯Ã¬ù¦{Ú̶E³Ð·s§C [¤J°|]¤H¼Æ¤j´T¤U° (1/21©P¤·s¼W¯f¨Ò爲28296¨Ò¡A¸û1¤ë7¤é³Ð¤Uªº90132¨Òªº¾ú¥v³Ì°ª¤U°¤F69%) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 04:50:42²Ä 1615 ½g¦^À³
|
µª®×˼Æ68¤Ñ´¦¾å!!! 2022.1.19 权«Â医学杂§Ó¡m¬húí¤MThe Lancet¡n«½S¡G·s«a¤j¬y¦æ§Y将结§ô (标§Ó时间点¬O2022¦~3¤ë) news.bioon.com/article/6795119.html 这½g«½S评论¤å³¹ªº§@ªÌ¬O°·±d«ü标ÉO评¦ô¬ã¨s©Ò¡]IHME¡^ªº¥D¥ôChris Murray¡A¥L´N职¤_¦è¶®图华²±顿¤j学¡C¦b过¥h两¦~¤¤¡AMurray团队«ù续为¥Õ宫´£¨Ñ·s«a¬Ì±¡«Ø¼Ò¡A对¯f¦º²vªº预测¤@ª½¤Q¤ÀãÚÌ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 02:22:40²Ä 1614 ½g¦^À³
|
¶K´X«h°T®§¡A§ë¸ê¤H[¿W¥ß«ä¦Ò]²´¤UFDA±ÂÅvEUA¦a±ø¥ó??? 1.°ê¹©¤G´ÁÁ{§ÉOmicron¯f¨Ò¤H¼Æ? 2. ¬ü°ê¦b2021.11.27«eOmicron¯f¨Ò 0¡A ¬ü°êÁp¨¹¯e¯f¨¾ªv¤¤¤ß(CDC)ºI¦Ü2022.1.1¤é·í©Pªº·s¼Æ¾Ú«ü¥X¡AOmicronÅܺدf¬r¤w¥e°ê¤º95.4%ªº·s¯f¨Ò¡ADeltaÅÜºØ ¯f¬r«h³QÀ£ÁY³Ñ¤U4.6% www.statista.com/chart/26437/covid-19-variants-in-the-us/ 3. 2021.12.1 FDA ªí¥ÜÄ@·N»P¦æ·~§Ö³t¦X§@¥HÀ³¹ï Omicron www.fdanews.com/articles/205598-fda-signals-willingness-to-quickly-collaborate-with- industry-to-tackle-omicron Woodcock (FDA¥N²z§½ªø)»¡¡A¨ì¥Ø«e¬°¤î FDA ¤w¸g±Ä¨ú¤F³\¦h±¹¬I¨Ó¾AÀ³·s¥X²{ªºÅÜÅé¡A¨Ò¦pn¨D¤½¥q¿n·¥ºÊ´ú©Mµû¦ôÅÜÅé¹ï¨ä²£«~ªº¼vÅT¡A§@¬°±ÂÅvªº±ø¥ó¡C FDA ¤w¸g±Ä¨ú¤F³\¦h±¹¬I¨Ó¾AÀ³·s¥X²{ªºÅÜÅé¡A¨Ò¦pn¨D¤½¥q¿n·¥ºÊ´ú©Mµû¦ôÅÜÅé¹ï¨ä²£«~ªº¼vÅT¡A§@¬°±ÂÅvªº±ø¥ó¡C FDA ¤w¸g±Ä¨ú¤F³\¦h±¹¬I¨Ó¾AÀ³·s¥X²{ªºÅÜÅé¡A¨Ò¦pn¨D¤½¥q¿n·¥ºÊ´ú©Mµû¦ôÅÜÅé¹ï¨ä²£«~ªº¼vÅT¡A§@¬°±ÂÅvªº±ø¥ó¡C ................................................................................................... ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/21 ¤W¤È 08:33:30²Ä 1612 ½g¦^À³ ¥H¬r§ð¬r¦³¥Î¡AFDA¤£¸Ó×¥¿EUA? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/21 ¤W¤È 10:05:07²Ä 1613 ½g¦^À³
|
¨S¦³±µºØ·s«aªÍª¢¬Ì]«o·P¬VOmicron¯f¬rªº¤H¡A¤]¤£¤Ó®e©ö¥X²{«¯g¡B¦í°|¬Æ¦Ü¦º¤`? ¤@¥¹¯àÂç²M½T»{¬OOmicron¯f¬r¥»¨´N§ó·Å©M¡A¥H«á´N¬O¬y·P¤Æ¤F¡C 2022.1.15 www.chinatimes.com/realtimenews/20220115002224-260408?chdtv ®Ú¾Ú«n«D14¤é¤½¥¬ªº¤@¶µ³Ì·s¬ã¨sÅã¥Ü¡A»P«e¤Tªi·P¬VDeltaµ¥Åܺدf¬rªº¤H¬Û¤ñ¡A¨S¦³±µºØ·s«aªÍª¢¬Ì]«o·P¬VOmicron¯f¬rªº¤H¡A¤]¤£¤Ó®e©ö¥X²{«¯g¡B¦í°|¬Æ¦Ü¦º¤`¡C¤£¹L¡A³o¶µ¬ã¨sÁÙ¨S¸g¹L¦P¹±¼f¬d¡C ...¥Ø«e¾Ç¬É¸Õ¹ÏÂç²M¡A¯gª¬¸û»´¨ì©³¬O¦]¬°¤HÌ´¶¹M¬I¥´¬Ì]¡AÁÙ¬O¤w¸g·P¬V·s«aªÍª¢¦Ó¦³¤F§ÜÅé¡AÁÙ¬OOmicron¯f¬r¥»¨´N§ó·Å©M¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/21 ¤W¤È 08:33:30²Ä 1612 ½g¦^À³
|
¥H¬r§ð¬r¦³¥Î¡AFDA¤£¸Ó×¥¿EUA? 2022.01.19 ¬Ì±¡¦³±æ¥[§Öµ²§ô¡H¬ã¨s¡GDelta ¯f¬rµLªk¶Ç¬Vµ¹ Omicron ½T¶EªÌ technews.tw/2022/01/19/omicron-delta-coronavirus/ ³Ì·s¬ã¨s«ü¥X¡AOmicron ¯f¬r¥i¥H¶Ç¬Vµ¹´¿¸g½T¶E¹L Delta ¯f¬rªº¤H¡A¦ý Delta ¯f¬r«oµLªk¤Ï¹L¨Ó¶Ç¬Vµ¹ Omicron ½T¶EªÌ¡C¬ã¨s¤Hû«ü¥X¡A³oªi Omicron ·P¬V¦³±æ¥[§Ö¤j¬y¦æµ²§ô¡A¥B½T¶EªÌ¤j³£»´¯g¡A´£¨Ñ¹ï Delta Åܺدf¬rªº«OÅ@¤O¡C 2. 2022.1.20 WHO¡G«n«DOmicron¬Ì±¡¨«¦Vµ²§ô ¯f¦º²v¬°´Xªi¬Ì±¡¤¤³Ì§C 3. 2022.01.20 ¬ü¬ã§POmicron¬Ì±¡¶}©l®ø°h ^°ê1¤ë27¤é°_¦b¤½¦@³õ¦X¤£¥Î±j¨î°tÀ¹¤f¸n¡B¤]¤£¥Î±j¨î¥X¥Ü¬Ì]±µºØ©Î¿z À˳±©ÊÃÒ©ú¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/21 ¤W¤È 07:50:58²Ä 1611 ½g¦^À³
|
¸g¹L°ò¨È»P¯E¹©¨Æ¥ó«á¡A§ë¸ê¤H¹ï¥Í§ÞªÑ¯d¤U¤£¦nªº¦L¶H¡A¤£§Æ±æ¾ú¥v¨Æ¥ó«ºt! 1. FDA©Úµ´NRxÃļtZyesami¥Î©óªvÀø¦M«¯f±w¤§EUA 2021.11.8 www.genetinfo.com/trend/item/53794.html ¥xÆW§ë¸ê¤Hª`·N¤F!±o¨ì«n¬ã¨s¾÷ºcNIH©ÎWHOµ¥ªºÃÙ§U¡A¬Æ¦Ü¨ú±o¬ü°êFDA§Ö³t¼f®Öªº¸ê®æ¡A³£µLªk«OÃÒ¤@©w·|±o¨ìFDA ªº®Öã??!!....... 2. 2022.1.20ÃÒ¨é´Û¶B«ß®v¨Æ°È©Ò¥Nªí§ë¸êªÌ«Å¥¬¹ï NRx ¶i¦æ½Õ¬d2021 ¦~ 6 ¤ë¡ANRx «Å¥¬¦V¬ü°êFDA´£¥æ¥Ó½Ð¡An¨DÀò ±oZYESAMIªººò«æ¨Ï¥Î±ÂÅvEUA¡A¥HªvÀø±w¦³©I§l°IºÜªº¦M« COVID-19 ±wªÌ. 2021 ¦~ 11 ¤ë 4 ¤é¡A NRx «Å¥¬ FDA ©Úµ´¬° ZYESAMI µo¥¬ EUA ¡A¡§¦]¬°Ãö©ó¸ÓÃĪ«ªº¤wª¾©M¼ç¦b¯q³B¥H¤Î ZYESAMI ¦b±w¦³ÄY« COVID-19©I§l¨t²Î¯e¯fªº±wªÌ¤¤ªº¤wª¾©M¼ç¦b·ÀIªº¼Æ¾Ú¤£¨¬¥¢±Ñ¡C¡¨ 3. ³ÌªñNRX¤S«·s¥Ó½ÐEUA... .................................................................................................. ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/19 ¤U¤È 12:51:39²Ä 1606 ½g¦^À³ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/10 ¤W¤È 09:51:38²Ä 1574 ½g¦^À³ ¼Æ¾Ú¨S§¹¾ã¤½¥¬¡A¨S¤Hª¾¾å¡A¦ý¶ø¦a§Q°ÓSanova¤@©wª¾¹D! (¤@ñ´N®¼°ê¹©) ----------------------------------------------------------------------------------------------- «¥®a¬O°v°ê¹©»¡¤j¸Ü2´Á®³¨ìEUA¡A¥i¨S½èºÃ¹LMOU¡C .................................................................................................... |
|
|
·|û¡G¬d²z¤ý10150572 µoªí®É¶¡:2022/1/21 ¤W¤È 07:36:20²Ä 1610 ½g¦^À³
|
½Ð°ÝR¤j¤]¶}©lª±·s«a¬ÛÃöÃþªÑ¤F¶Ü? ªYÄ£ªºªÑ»ùÅý¤HµL¨¥.. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/21 ¤W¤È 06:45:37²Ä 1609 ½g¦^À³
|
2022.1.6 According to the latest EUA, the proposed indication is for treating Covid-19 patients who have no other therapy options available. ®Ú¾Ú³Ì·sªº EUA¡AÀÀijªº¾AÀ³¯g¬O¥Î©óªvÀø¨S¦³¨ä¥LªvÀø¿ï¾Üªº Covid-19 ±wªÌ¡C ®Ú¾Ú³Ì·sªº EUA¡AÀÀijªº¾AÀ³¯g¬O¥Î©óªvÀø¨S¦³¨ä¥LªvÀø¿ï¾Üªº Covid-19 ±wªÌ¡C ®Ú¾Ú³Ì·sªº EUA¡AÀÀijªº¾AÀ³¯g¬O¥Î©óªvÀø¨S¦³¨ä¥LªvÀø¿ï¾Üªº Covid-19 ±wªÌ¡C www.pharmaceutical-technology.com/news/nrx-fda-eua-zyesami/ .................................................................................................. ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/19 ¤U¤È 12:38:04²Ä 1605 ½g¦^À³ www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#coviddrugs FDA±ÂÅv14¶µÃĪ«EUA¡A»´¤¤«¯g¦í°|±wªÌ³£¦³ªvÀøÃĪ«¡A°ê¹©ªºÃĪ«Àø®Ä¾Ö¦³¤£¥i¨ú¥N©Ê? |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/1/20 ¤U¤È 04:23:09²Ä 1608 ½g¦^À³
|
³Ñ¤U´X¤Ñ«ÊÃö¤F¡A·sÄ£§ÖµoÓ¤j¬õ¥]¦n¹L¦~ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/20 ¤W¤È 07:18:35²Ä 1607 ½g¦^À³
|
¤£¹L124¤Hªº¸Ñª¼¡A[ªì¨B]¼Æ¾Ú¦nÃø! ¤U±³o2¤äª§Ä³©Ê¤jªº¸Ñª¼¡A[ªì¨B]¼Æ¾Ú1®a3¤Ñ¡A1®a12¤Ñ¡C 1.¯E¹©OBI-822¸Ñª¼pµe°õ¦æ¹Lµ{¸ÔªR (349¤H) (2/17®Ê¥[¤½¥q³qª¾¯E¹©... 2/19®Ê¥[¥Hemail³qª¾Âå°Èªø¤w§¹¦¨¼Æ¾Ú¤ÀªR...) chunwenyu.wixsite.com/biotechnology/post/obi-822%E8%A7%A3%E7%9B%B2%E8%A8%88%E7%95%AB%E5%9F%B7%E8%A1%8C%E4%BD%9C%E6%A5%AD%E9%81%8E%E7%A8%8B%E8%A9%B3%E6%9E%90 2.°ªºÝ·s«a¬Ì]¸Ñª¼µ²ªG¡@¤½¥qÁn©ú¥þ¤å¬Ý³oÃä¡I(4000¤H¼Æ¾Ú) finance.ettoday.net/news/2004107 [¤¤ë©³] ±N´Á¶¡¤ÀªR¤§©Ò¦³¬ÛÃöì©l¸ê®Æ¡A¦bª¼©Êª¬ºA¤U¡A¤W¶Ç¦Ü²Ä¤T¤èÁ{§É¸ÕÅç¨ü°U¾÷ºc¡G¬ü°ÓCRO¤½¥qClinipace¡A ¶i¦æ¼Æ¾Ú·JÁ`¾ã²z»P¤ÀªR¡C©ó [6¤ë10¤é ]¤U¤È1ÂI¥l¶}¥Ñ¿W¥ß¬ì¾Ç±M®a²Õ¦¨ªºIDMC¿W¥ß¼Æ¾ÚºÊ´ú©eû·|ij¡A¶i¦æ´Á¶¡¤À ªR¸Ñª¼¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/19 ¤U¤È 12:51:39²Ä 1606 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/10 ¤W¤È 09:51:38²Ä 1574 ½g¦^À³ ¼Æ¾Ú¨S§¹¾ã¤½¥¬¡A¨S¤Hª¾¾å¡A¦ý¶ø¦a§Q°ÓSanova¤@©wª¾¹D! (¤@ñ´N®¼°ê¹©) ----------------------------------------------------------------------------------------------- Â_±ËÂ÷ªºÃöÁä¦b¶ø¦a§Q°ÓSanova(1¤ë31¤é)¡A°®¯Ü§O»{½ßµ¥Â½µP¡C «¥®a¬O°v°ê¹©»¡¤j¸Ü2´Á®³¨ìEUA¡A¥i¨S½èºÃ¹LMOU¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/19 ¤U¤È 12:38:04²Ä 1605 ½g¦^À³
|
www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#coviddrugs FDA±ÂÅv14¶µÃĪ«EUA¡A»´¤¤«¯g¦í°|±wªÌ³£¦³ªvÀøÃĪ«¡A°ê¹©ªºÃĪ«Àø®Ä¾Ö¦³¤£¥i¨ú¥N©Ê? |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/1/19 ¤U¤È 12:33:34²Ä 1604 ½g¦^À³
|
°ê³»¤x¸g½ä¿é¤F~~§Æ±æªYÃÄ¥i¥H¥ý¤ñªÓ°ê³»¦A¶WÅD3xx!!!¤µ¦~¥Ø¼Ð¦R¤@¤f³¾®ð otc³£¹L¤F¡Aµ¥©ó§@¹ô¤xª¾µª®×¡C¹³¤@¶}©lªºÄ_¹s¤@¼Ë¡A°½°½¥X³f |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/19 ¤U¤È 12:12:50²Ä 1603 ½g¦^À³
|
·Q[½ä]°ê¹©4¤ë¥Ó½Ð¯à®³¨ìFDA±ÂÅvEUA? ¤Uª`«e¬Ý¬Ý2021.08.26µø°T³ø¾É! www.fool.com/investing/2021/08/26/why-did-the-fda-reject-rigels-eua-application-for/ ¬°¤°»ò FDA ©Úµ´ Rigel ªº COVID-19ªvÀø EUA ¥Ó½Ð¡H (¼Æ¾Ú¥¿¦V:ªvÀø²Õ30¦W«¯g±wªÌ¦b²Ä29 ¤Ñ¦º¤`¤H¼Æ¬°0¡A¦Ó¦w¼¢¾¯²Õ29 ¤H¦º¤`¤H¼Æ¬°3 ¤H¡C) ... ¦pªG¥L̬O [²Ä¤@Ó] ¹Á¸ÕÀò±oºò«æ¨Ï¥Î±ÂÅvªºÃĪ«¡A¨º»ò¤]³\(59¤H¦a¼Æ¾Ú)³o´N¨¬°÷¤F¡C ¦pªG¥L̬O [²Ä¤@Ó] ¹Á¸ÕÀò±oºò«æ¨Ï¥Î±ÂÅvªºÃĪ«¡A¨º»ò¤]³\(59¤H¦a¼Æ¾Ú)³o´N¨¬°÷¤F¡C ¦ý¦b¤j¬y¦æªº±ß´Á¡A¹ï©ó FDA ¨Ó»¡¡An¨D§ó¦h¦a¼Æ¾Ú¡C ¦ý¦b¤j¬y¦æªº±ß´Á¡A¹ï©ó FDA ¨Ó»¡¡An¨D§ó¦h¦a¼Æ¾Ú¡C ¦ý¦b¤j¬y¦æªº±ß´Á¡A¹ï©ó FDA ¨Ó»¡¡An¨D§ó¦h¦a¼Æ¾Ú¡C ¦Ó¥B¥«³õ¤W¤w¸g¦³¤FªvÀø¤èªk¡A§Ú»{¬°³oµ¹«á¨ÓªÌ±a¨Ó¤FÀ£¤O¡An¨D¥L̤ñ¦´ÁªÌ²£¥Í§ó¦hªº¼Æ¾Ú¡C ¦Ó¥B¥«³õ¤W¤w¸g¦³¤FªvÀø¤èªk¡A§Ú»{¬°³oµ¹«á¨ÓªÌ±a¨Ó¤FÀ£¤O¡An¨D¥L̤ñ¦´ÁªÌ²£¥Í§ó¦hªº¼Æ¾Ú¡C ¦Ó¥B¥«³õ¤W¤w¸g¦³¤FªvÀø¤èªk¡A§Ú»{¬°³oµ¹«á¨ÓªÌ±a¨Ó¤FÀ£¤O¡An¨D¥L̤ñ¦´ÁªÌ²£¥Í§ó¦hªº¼Æ¾Ú¡C .............................................................................................. ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/6 ¤U¤È 02:38:54²Ä 1562 ½g¦^À³ 2021.8.13 ¥ÑNIH¬ü°ê½Ã¥Í°|»P°ê®a¤ßªÍ¦å²G©ÒÃÙ§UªºÁ{§ÉÃĪ«Tavalisse¤]³Q©Úµ´EUA. FDA§i¶D Rigel¡ATavalisse¤£·|Àò±oºò«æ¨Ï¥Î±ÂÅv (EUA)¡CFDA¦b2018.4.17®Öã¤W¥«ªº³B¤èÃÄ¡AªvÀø¦]ºC©Ê§K¬Ì©Ê¦å¤pªO´î¤Ö¯g (ITP) ¦Ó¾ÉP¦å¤pªOp¼Æ§Cªº¦¨¤H¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/19 ¤W¤È 09:37:35²Ä 1602 ½g¦^À³
|
¡u¨S¦³¹ï·Ó²Õ´N¶}¸Ñª¼«°T¡A¹êÄݨu¨£¡C¡v ¥»¥H¬°¼B¸³¥u¬O¤f»~¥Îµü¤£¨Î¡A¬Ý¨Ó¬O¯u¨SPK¡C(¨S¹ï·Ó²Õ¡A¼Æ¾Ú[¬Ý°_¨Ó]´N¬Oº}«G!) 2020.11.16ªº°©Åè©Ê¥Õ¦å¯f·sÃĤG´Á¡A´N¬O [¨S] ¹ï·Ó²Õ¼Æ¾Ú¡AÀø®Ä[¬Ý°_¨Ó]¦n´Î´Î! (¦pªG³o¬O»P¤W¥«ªvÀøÃĪ«ÀY¹ïÀY¸ÕÅç¡A¥Dn»P¦¸n«ü¼Ð¥þ³¡¹F¼Ð¡A¥Ó½ÐÃÄÃÒ³Q§_¨M¾÷²vÀ³¸Ó¬O~0%) 2020.11.16 °ê¹©°©Åè©Ê¥Õ¦å¯f·sÃħ¹¦¨Á{§É¤G´Á ±N¥Ó½Ð¤W¥«³\¥iÃÒ news.cnyes.com/news/id/4543080 ¾ÚÁ{§É¸ÕÅçµ²ªGÅã¥Ü¡A¥Dn¸ÕÅçÀø®Ä«ü¼Ð¡AÀu©ó¥Ø«e¥«³õ¤W¤w¨ú±oÃÄÃÒªºªvÀøÃĪ«¤G´Á¸ÕÅçµ²ªG¡F¦¸n¸ÕÅçÀø®Ä«ü¼Ð¡B¦w¥þ ©Ê¤è±¡A¦s¬¡²v¸û²{¦æÃĪ«ªø¡B°§C¯f±w¿é¦åªvÀø¡A¥H¤ÎµLÅãµÛ°Æ§@¥Î¡C ------------------------------------------------------------------------------------------------- ·|û¡G°]°È¦Û¥Ñ¤H10132540 µoªí®É¶¡:2022/1/9 ¤U¤È 02:09:53²Ä 1570 ½g¦^À³ °ê¹©ªº«°Tµø°T¡C11¤À40¬í¡A¼B¸³»¡²Ä14¤Ñ»P²Ä28¤Ñªº¥DnÀø®Ä ¡y§Ų́èS¦³n¸ò¹ï·Ó²Õ°µ©Ò¿×ªºPK ¡z¡C ¤£ª¾¹D¬O§_¤f»~¡AY¼Æ¾Ú¤£ PK ¡A¯à»¡ªA FDA ¡H --------------------------------------------------------------------------------------------------- ºÃ°Ý¤@¡G«çµL¹ï·Ó²Õ¡H ¤@¦ì¦P¦b¬ãµo·s«a¸ÑÃĪº¤W¥«¤½¥q°ªºÞ¤]´£¨ì¡A¡u¦b«Å¥¬¸Ñª¼®É¡A©~µM¨S¦³¹ï·Ó²Õ¸ê®Æ¡A¥O¤H¤£¸Ñ¡C¡v¥L»¡¡A³q±`©e°U¬ã¨s¾÷ºc´£¨Ñªº³ø§i¡Aºn´N¬O¦C¥X¨ü¸ÕªÌ»P¹ï·Ó²Õ¼Æ¾Ú¡A¦b²Îp¤ÀªR¤W¦³µLÅãµÛ®t²§¡A¡u¨S¦³¹ï·Ó²Õ´N¶}¸Ñª¼«°T¡A¹êÄݨu¨£¡C¡v µM¦Ó¦b°ê¹©²´¤¤¡A¤G´ÁÁ{§É¸ÕÅ窺¸Ñª¼¤wÃÒ©ú·sÃĦ³®Ä©Ê¡A°ê¹©¥Í§Þ°]°Èªø´¿¤ì¼W»¡©ú¡A¦bFDA³\¥iªº¸ÕÅçpµe¡A¥Dn«ü¼Ð³]©w¬°¡u¤Q¥|¤Ñ¤º¦s¬¡¥BµL©I§l°IºÜªº±wªÌ¤ñ²v¡v¡A¦b¥Dn«ü¼Ð¤W¡u¨S¦³¼g»¡n¸ò¦w¼¢¾¯¤ñ¸û¡C¡v °w¹ï³oÂI¡Aù±Óµ×»{¬°n±q¸Ó¸ÕÅçpµeªºI´º²z¸Ñ¡A¦b¤G¡³¤G¡³¦~·í®É¬Ì±¡Ãø¥H±±¨îªºª¬ºA¤U¡AFDA¹ï·s«aÃĪ«¬ãµoµ¹¤©·¥¤jªºµo®iªÅ¶¡¡A¡uFDA¥Dn¬Ýªº¬O¤£¥i¥H¦³±wªÌ¦º¤`¡A¨ä¥L«ü¼Ðªº³]©w¡A¥¦¤£·|·N¨£¤Ó¦h¡C¡v |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/18 ¤W¤È 10:24:03²Ä 1601 ½g¦^À³
|
¶i¤F½ä³õ¡A§A´N¬O½a°¡A°£¤F100%Ĺ¡A¥ô¦ó®ÉÔ³£¤£À³¤Uª`¡A·Qnűo³Ó§Q¡A°ß¤@ªºªk«h¬O¡G¤£½ä¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/18 ¤W¤È 07:49:34²Ä 1600 ½g¦^À³
|
·Q[½ä]¤@©]P´I?³o®aIntercept pharmaceuticalsªº[²×§½¤§¾Ô]¦³¼Éº¦10~20¿ªº¹ê¤O»P¾÷·|?! ì¦]: 1.ªÑ»ù¾ú¥v°ª 2014.1.6 $497¡A¾ú¥v§C:2021.8.16 $11.6 (FDA©Úµ´¥[³t§åãOcaliva«á¤½¥q°ª¼h¨«¤H¤jµôû...) 2.¬Q¤é¦¬½Lº¦7.96% ¦¬$17.76----¬ü°ê§ë¸êªÌ¶}©l©ãª`Ocalivaªº[²×§½¤§¾Ô] 2022.1.7---2022 ¦~¤£¥i¿ù¹Lªº 3¶µ....¹ï©ó³o¨Ç»sÃÄ°Ó¨Ó»¡¡A³o¥i¯à¬O«D±`¿E°Ê¤H¤ßªº¤@¦~¡C www.fool.com/investing/2022/01/07/3-cant-miss-biotech-events-coming-up-in-2022/? source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article 3.¤@¾Ô¨M¥Í¦º®É¶¡:2022¦~¤W¥b¦~ 2021.12.20 Intercept ¥i¯à·|¦b 2022 ¦~¤W¥b¦~»P FDA «·s´£¥æ·|ij¡C www.globenewswire.com/news-release/2021/12/20/2355190/23024/en/Intercept-Pharmaceuticals-Provides-Update-on-Phase-3-REVERSE-Trial-in-Compensated-Cirrhosis-Due-to-NASH.html 4.Ó¤H¤£·|©ãª`³o³õ½ä§½¡A°lÂÜFDA§å㪺²Ä1¤äNASHÃĪ«¥Î¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/11/20 ¤W¤È 11:34:58²Ä 1477 ½g¦^À³ ²×§½¤§¾Ô! 2021.8.2 Intercept ø»sOcalivaÀò±oNASH §å㪺·s³~®|:¥un«O«ù¦w¥þ©Ê www.fiercepharma.com/pharma/intercept-still-sees-fda-approval-pathway-for-nash-hopeful-ocaliva-as-long-as-safety-holds ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/21 ¤U¤È 12:54:38²Ä 807 ½g¦^À³ ¦b³Ì¦³¾÷·|¹Ü±o²Ä1¤äNASH¤W¥«ÃÄÃÒªºOcaliva¡]Intercept¡^¦]¬°[¨x¬r©Ê]°Æ§@¥Î³Q§_¨M«á¡A ------------------------------------------------------------------------------------------- |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/16 ¤U¤È 08:08:06²Ä 1599 ½g¦^À³
|
°ê¹©¼B³Ó«i:¦ý¬O¤W¬ü°ê°ê®a½Ã¥Í¬ã¨s°|NIHºô¯¸¥h¬d¡A°ê¹©³Q®Öã¶i¦æªº·sÃÄAntroquinonol¤G´Á¸ÕÅç´N¦b¤W±¡C¡v ±¹ï¥~¬Éªº¤@¨Ç§åµû¡A¼B³Ó«iªí¥Ü¡A¥L»Ýn¹ï¥~»¡©ú¡A¸ÕÅç¤H¼Æ¯à¤£¯à¦³¥Nªí©Ê¡A´N¬ÝFDA¬O§_³q¹L®ÖãÅý°ê¹©¶i¦æ¤G´Á¸ÕÅç¡AÃĪ«¦³¨S¦³®Ä¡A´N¬ÝFDA¬O§_¦P·NÅý°ê¹©¨ú±oEUA¡C ---------------------------------------------------------------------------------------------------- ¯º¸Ü! ¦bÄY«¯f¨Ò¤¤,¸Á»e¥ÎÃIJկf¨Ò¦b²Ä10¤Ñ¥X°| PK °ê¹©¥ÎÃIJժºªvÀø®É¶¡ÁYµu¤F9.5¤Ñ¡C §Ú¤]¥i¥H»¡¸Á»eÀø®Ä¹F¼Ð¡A°ê¹©¨S¦³¤½¥¬§¹¾ã¼Æ¾Ú¡A´N¬O¤½»¡¤½¦³²z¡A±C»¡±C¦³²zªºª§°õ¤£¤U¡C (¸Á»eÁ{§É¥Ó½Ð¤£¤FEUA) ¸Á»e³Q®Öã¶i¦æªvÀø·s«aªÍª¢Á{§É¤]¦bNIHºô¯¸¡A¤£¶È¬O¤T´Á¡A¹ï·Ó²Õ¼Æ¾Ú³£¦³! ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤U¤È 04:14:55²Ä 1548 ½g¦^À³ °ê¹©«ç¤£´£¨Ñ¹ï·Ó²Õ¼Æ¾Ú? ©³¤U¸Á»e©M¶ÂºØ¯ó¡]¤]ºÙ¬°¶Â§¶µM¡^3´ÁÁ{§É¸ê®Æ(µLªk½Æ»s¶K¤W«¥¤j·§¼g¤@¤U): »P¹ï·Ó²Õªº7¤Ñ»P13¤Ñ¬Û¤ñ,µo²{¥ÎÃIJզb¤¤¦Ü«¯g¯f¨Ò¤¤¤À§O¦b4¤Ñ»P6¤Ñ¤º½w¸Ñ·s«a¯gª¬(P<0.0001)¡C »P¹ï·Ó²Õ¬Û¤ñ,¥ÎÃIJզb¤¤¦Ü«¯g¯f¨Ò¤¤ªº¯f¬r²M°£¤]´£¦4¤Ñ¡C ¥ÎÃIJÕÁÙ°§C¤F«¯g¯f¨Òªº¦º¤`²v(P=0.029) ¦b¤¤«×¯f¨Ò¤¤,96.26%ªº¤¤«×¯f¨Ò±wªÌ¦b²Ä10¤é«ì´_¤é±`¬¡°Ê,¦Ó¹ï·Ó²Õ¬°68.93%¡C ¦bÄY«¯f¨Ò¤¤,¥ÎÃIJկf¨Ò¦b²Ä10¤Ñ¥X°|,¦ÓÆ[¹î¨ì¹ï·Ó²Õ¤´»Ý¦í°|ªvÀø»P»Ýn®ñ®ð¡C ¹ï·Ó²Õªº30¤Ñ¦º¤`²v¬°18.87%, ¦Ó¥ÎÃIJլ°4%¡C ............................................................................................... ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/17 ¤W¤È 07:50:32²Ä 1523 ½g¦^À³ ..¸Á»e¤]¯àªv·s«aªÍª¢¡AÁÙ¬O3´ÁÁ{§É³á! ¤£¬Û«H? Honey & Nigella Sativa Trial Against COVID-19 (HNS-COVID-PK) Phase 3 clinicaltrials.gov/ct2/show/NCT04347382?term=Honey+%26+Nigella+Sativa&draw=2&rank=1 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/16 ¤U¤È 07:37:00²Ä 1598 ½g¦^À³
|
»~¸Ñ±zì·N¡A±z¬O»¡°ê¹©°©Åè©Ê¥Õ¦å¯f¤G´Á¥Ó½Ð¤W¥«³\¥i? A:Àù¯gÃĪ«¦bÁ{§É¹êÅçYµo²{«D±`ÅãµÛÀø®Ä¬O¥i¥H´£«e²×¤î...¥_·¥¬PªºADI-PEG20´N¬O¦b¤T´Á´£«e§¹¦¨¦¬®×¡A °ê¹©¬JµM»¡¤G´ÁÁ{§É[Àø®ÄÀu²§] n´£¥X¥Ó½Ð¤W¥«¡A«ç¹L¤F1¦~2Ó¤ë¨S¦³¤U¤å?(°ê¹©¤£»¡¡A¤Ñ¾å±o¬O¥Ó½Ð¤¤?¸É¸ê®Æ?Äò°µ ¤T´Á? ) ............................................................................................... ·|û¡Gªü¤Ñ10149120 µoªí®É¶¡:2022/1/16 ¤U¤È 01:20:27²Ä 1597 ½g¦^À³ ½Ð°Ý¤@¤UR¤j¡F¬°¦ó¥i¥H¤G´Á¥Ó½Ð¤W¥«³\¥i¡H¡]°©ÅèÃÄ¡^ ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/16 ¤W¤È 11:15:23²Ä 1596 ½g¦^À³ ...2.¨S±ÂÅvñ¬ù ¤j·§¤S¦P¨xÀù»PªÍÀù(2010¦~Á{§É~¨´¤µ)»P ¦åÀù(¤£¨£¤W¥«³\¥iÃÒ?)»Pªü¯÷®üÀq¯g¤@¼Ë´ùµLµ°T! 2020.11.16 °ê¹©°©Åè©Ê¥Õ¦å¯f·sÃħ¹¦¨Á{§É¤G´Á ±N¥Ó½Ð¤W¥«³\¥iÃÒ news.cnyes.com/news/id/4543080 ................................................................. ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/29 ¤U¤È 01:47:04²Ä 1534 ½g¦^À³ 1¤äÃĪ«ªºÁ{§É¹êÅç«ç»ò¸ÑŪ? 1.¦pªG©úÅãÀu©ó(«D±`ÅãµÛ)¹ï·Ó²Õ---FDA·|´£«e²×¤î 2021.07.28¥_·¥¬P - KY(6550-TE) ¤µ (28) ¤éªí¥Ü¡A¦¬¨ì¬ü°ê FDA ¨Ó¨ç³qª¾¡AªvÀø´c½èªÍ¶¡¥ÖÀù·sÃÄ ADI-PEG20 ¤T ´ÁÁ{§É¸ÕÅç¡A¥i°±¤î¦¬¨ú¯f±w¡B´£¦µ²§ô¸ÕÅç¨Ã¶i¦æ¸Ñª¼¡A«Ý§¹¦¨Á{§É¸Ñª¼«á¡A±N¥Ó½ÐÃÄÃÒ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/16 ¤U¤È 05:47:19²Ä 1597 ½g¦^À³
|
1.®É¶¡«æ¢©Ê ³Ì«æ¢»Ýnªº²Ä1¤ä·ç¼w¦è³¬O¥Î[¤T´Á]´Á¤¤¼Æ¾Ú®³¨ìEUA (°ê¹©antroquinonol PK ·ç¼w¦è³) 2.¥i¹w¨£[ªvÀøÃĪ«]EUAÃöªù®É¶¡¤wªñ ¨´¤µ¤w¦³[7¤ä] [7¤ä] [7¤ä] ªvÀøÃĪ«®³¨ìFDA EUA + [1¤ä] ·ç¼w¦è³(¥¢¥hEUA¡A¦]¬°¦b2021.10.23¥¿¦¡®³¨ìÃÄÃÒ¤W ¥«¡A¦¨¬°²Ä¤@Ó FDA®Ö㪺·s«aªÍª¢Àøªk) FDA¬°¤°»ò¤£¦A¨ü²z[¬Ì]]EUA ? ¬°¤°»òªñ´Á¤]¹w¥ÜÃö³¬[ÂåÀø¾¹§÷³]³Æ]EUA? 3.¬ü°êªº±M®a¾ÇªÌ¶}©l§åµûFDAn¨D¦¬ºò EUA(©IÆ~§ó°ª¼Ð·ÇªºÃÒ¾Ú).... fortune.com/2021/06/07/covid-emergency-use-authorizations-fda-euas-therapies-drugs- medicines-pandemic/ 2021.12.21 www.cidrap.umn.edu/news-perspective/2021/12/most-covid-related-euas-backed-low-quality- data-review-finds ¼f¬dµo²{¡A¤j¦h¼ÆCOVID19ªºEUA¥Ñ§C½è¶q¼Æ¾Ú¤ä«ù...¬ã¨sµ²ªG¥i¥HÅýºÊºÞ¾÷ºc¤F¸Ñ EUA ªº²{ª¬¡A¨ÃÀ°§U«ü¾É§ï¶i¤u§@ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/16 ¤U¤È 04:35:07²Ä 1596 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/8 ¤W¤È 06:27:58²Ä 10270 ½g¦^À³ §Ú¤£¬OÃį«-©_Âݯ몺ÃĪ«(2´ÁÁ{§É¸ÕÅç«á¡A´NÀòFDA¥[³t§åã¤W¥«) kknews.cc/zh-tw/health/m625m56.html 1998¦~6¤ë¡A¥ì°¨´À¥§ªï¨Ó¤F¾ú¥v©Êªº¤@¤Ñ¡X¡X¥¦²×©ó¶i¤J¤F¤HÅé¸ÕÅ綥¬q¡C¦b³o¶µ1´ÁÁ{§É¸ÕÅ礤¡A¬ã¨s¤Hû̪º¥Dn¥Øªº¡A¬O´M§ä³Ì¤j@¨ü¾¯¶q¡A±´¯Á³o´ÚÃĪ«ªº¦w¥þ©Ê¡C¬ã¨s©Û¶Ò¤F¤@¸s¸g¹LªvÀø¡A¦ý¯f±¡¨ÌÂÂÄY«ªº±wªÌ¡A¨ÃÅý¥Ḻµ¨ü¨C¤é¥ì°¨´À¥§ªº¤fªAÀøªk¡C¬ã¨sªí©ú¸ÓÃĪ«¤£¦ý@¨ü¨}¦n¡A¦Ó¥B¦³µÛ³ôºÙ©_Âݯ몺Àø®Ä¡G±µ¨ü300mg¾¯¶qªº54¦W±wªÌ¤¤¡A¦³53¦W¥X²{¤F¦å²G¾Ç¤Wªº§¹¥þ½w¸Ñ¡]complete hematologic responses ¡ACHR¡^¡C ³o¤@¥i³ßªºµ²ªG¡A¨³³t±N¥ì°¨´À¥§±a©¹¤F2´ÁÁ{§É¸ÕÅç¡C1999¦~±Ò°Êªº2´ÁÁ{§É¸ÕÅç¦A¦¸ÅçÃÒ¤F1´Á¸ÕÅ礤Æ[¹î¨ìªº¿n·¥Àø®Ä¡C§ó¬°¥i³ßªº¬O¡A³o¨ÇÀø®Ä¬Ý¨Ó¬Û·í«ù¤[¡G¦bªvÀøªº¤@¦~¥b«á¡A±wªÌªºµL¶i®i¥Í¦s²v¨ÌµM¹F¨ì¤F89.2%¡C°ò©ó¨ä¥X¦âªºªvÀø®ÄªG¡A¬ü°êFDA¦b2´ÁÁ{§É¸ÕÅç«á¡A´N¥[³t§åã³o´Ú·sÃÄ°Ý¥@¡AªvÀøºC©Ê°©Åè©Ê¥Õ¦å¯f¡C¦Ó³o´ÚÃĪ«ªº²£«~¦W¡A´N¬O§ÚÌ©Ò¼ôª¾ªº®æ¦C½Ã¡C Àò§å¤§«á¡A¬ã¨s¤Hû̧¹¦¨¤F3´ÁÁ{§É¸ÕÅ窺¤u§@¡C¬Û¤ñ¼Ð·ÇÀøªk¡A¥¦¦b©Ò¦³«ü¼Ð¤W³£¹üÅã¥X¤FÅãµÛªºÀø®Ä¡C¦b®æ¦C½Ã½Ï¥Í«e¡A¥u¦³30%ªººC©Ê°©Åè©Ê¥Õ¦å¯f±wªÌ¯à¦b½T¶E«á¬¡¹L5¦~¡C®æ¦C½Ã±N³o¤@¼Æ¦r±q30%´£°ª¨ì¤F89%¡A¥B¦b5¦~«á¡A¨Ì¦³98%ªº±wªÌ¨ú±o¤F¦å²G¾Ç¤Wªº§¹¥þ½w¸Ñ¡C¬°¦¹¡A¥¦¤]³Q¦C¤J¤F¥@¬É½Ã¥Í²Õ´ªº°ò¥»ÃĪ«¼Ð·Ç²M³æ¡A³Q»{¬°¬OÂåÀø¨t²Î¤¤¡u³Ì¬°¦³®Ä¡B³Ì¬°¦w¥þ¡Aº¡¨¬³Ì«¤j»Ý¨D¡vªº°ò¥»ÃĪ«¤§¤@¡C -------------------------------------------------------------------------------------------------- ¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1¶ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/8 ¤W¤È 06:13:10²Ä 10269 ½g¦^À³ ©ú¦~¥¿¦¡¤W¥«---¤£µL¥i¯à!!! 1.[§Ú¤£¬OÃį«]¹q¼v¤¤¨º¤ä¯«ÃÄ. ¥ì°¨´À¥§¡]®æ¦C½Ã¡A¿ÕµØ¡^ªº¾ú¥vÃÒ©ú¤F FDA ·í«eÃĪ«§åãµ{§Çªº®Ä²v....¦]¬°¥¦³Q¸m©ó¨ã¦³©t¨àÃľAÀ³¯gªº¥[³t§åã³~®|¡C¦¹¥~¡A¥ì°¨´À¥§ªº NDA ÀH«á¦b 2.5 Ӥ뤺Àò±o§åã¡A³o¬O¥ô¦ó§ÜÀùÃĪ«Àò±o§å㪺³Ìµu®É¶¡¡C ---------------------------------------------------------------------------------------------------- ³o¤ä¯«ÃÄ¡A±z¦A¬d¤@¤U´Nª¾¹D¬°¦óFDA¦b¤G´Á´N¯«³t¯}¬ö¿ýµ¹Ãįg¡C |
|
|
·|û¡Gªü¤Ñ10149120 µoªí®É¶¡:2022/1/16 ¤U¤È 01:20:27²Ä 1595 ½g¦^À³
|
½Ð°Ý¤@¤UR¤j¡F ¬°¦ó¥i¥H¤G´Á¥Ó½Ð¤W¥«³\¥i¡H¡]°©ÅèÃÄ¡^ ·PÁ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/16 ¤W¤È 11:15:23²Ä 1594 ½g¦^À³
|
·|û¡G¨}¥²«L10147410 µoªí®É¶¡:2022/1/6 ¤W¤È 08:51:47²Ä 1560 ½g¦^À³ R ¤j ¤Hªº¯S©Ê¡A´N¬O¨º¸Ì·´º¬ü¤H¦h¤]·Q¥h ¬Ý·s»D¨º¨Ç°}§ú¡A§½³£¥¬¦n¤F¡A¬Ý½Ö¬O³Ì±ß¤U¤s ---------------------------------------------------------------------------------------------- 7000¦h¤H¤J¤s! ¤s±Yµo¥Í¾÷²vÆ[¹î«ü¼Ð¶ø¦a§QSanova(2022.1.31«e): 1.¦³±ÂÅvñ¬ù ¤G´Á¼Æ¾Ú¥¿¦V¡A¤£¹L¥H124¤Hªº¤G´Á¼Æ¾Ún®³¨ìEUA¾÷²v§C·L¡C (¤¤°ê§ÜÅéÃĪ«Á{§É¤G´Á©Û¶Ò1631¦W,¹ï·Ó²Õ:·ç¼w¦è³Remdesivir®³¨ìFDA EUA) 2.¨S±ÂÅvñ¬ù ¤j·§¤S¦P¨xÀù»PªÍÀù(2010¦~Á{§É~¨´¤µ)»P ¦åÀù(¤£¨£¤W¥«³\¥iÃÒ?)»Pªü¯÷®üÀq¯g¤@¼Ë´ùµLµ°T! 2020.11.16 °ê¹©°©Åè©Ê¥Õ¦å¯f·sÃħ¹¦¨Á{§É¤G´Á ±N¥Ó½Ð¤W¥«³\¥iÃÒ news.cnyes.com/news/id/4543080 ¾ÚÁ{§É¸ÕÅçµ²ªGÅã¥Ü¡A¥Dn¸ÕÅçÀø®Ä«ü¼Ð¡AÀu©ó¥Ø«e¥«³õ¤W¤w¨ú±oÃÄÃÒªºªvÀøÃĪ«¤G´Á¸ÕÅçµ²ªG¡F¦¸n¸ÕÅçÀø®Ä«ü¼Ð¡B¦w¥þ ©Ê¤è±¡A¦s¬¡²v¸û²{¦æÃĪ«ªø¡B°§C¯f±w¿é¦åªvÀø¡A¥H¤ÎµLÅãµÛ°Æ§@¥Î¡C ¡u¤½µL´çªe¡A¤½³º´çªe¡C¼Zªe¦Ó¦º¡A·í©`¤½¦ó¡I¡v |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/1/15 ¤U¤È 03:49:43²Ä 1593 ½g¦^À³
|
810ÃÄÅç³q¹L¡A±ÂÅv¤½¥¬¡BªÑ»ù¼Q¥X«á¡A¤~¦³¡m¤º®e¡n¥Ó½Ð¤WÂd¡B©Ó¾P»ùq©w¡A³o¬O¤@¯ë¹w´Á¡F¦pªG¯àÂX¤j¦X§@830©Î¬O610¡B630¶¯¶¯±ÂÅv½Í¦¨¡A¨ºªÑ»ù´N·|¼Q¨ì¶³ºÝ¤F¡I¤]¬O¤j®a¸û¨S¦³®Æ·Q¨ìªº¥i¯à¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2022/1/15 ¤U¤È 12:35:13²Ä 1592 ½g¦^À³
|
¦¬¨ìÁ{®ÉªÑªF·|³qª¾¤F¡AÀ³¸Ó¥¼¨Ó´XÓÓ¤ë·|¦³Âà¤WÂd§Q¦hºCºCµo®Ä¡A ´Á«Ý¦³¤@¤Ñ¤]¨ÓÓ°±µP¤j§Q¦h¤½¥¬ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/15 ¤W¤È 11:45:21²Ä 1591 ½g¦^À³
|
¤é¥»¬ã¨sÅã¥ÜOmicron ¶Ç¬V¤O¬°Delta ªº4.2 ¿¡AAPAP¾P°â¶q§ó³Ó¥H©¹ = ªA¥ÎAPAP¹L¶q¤¤¬r®×¨Ò¶Õ¥²¼W¥[! 1. 2022.1.15 ^°ê Omicron®ö¼é¾ÉP¼³¼ö®§µh(APAP)©M¥¬¬¥ªâµu¯Ê www.independent.co.uk/news/health/covid-omicron-paracetamol-ibuprofen-shortage-b1993185.html 2. 2021.12.24 Âå¥Í¶g¤ªí¥Ü¡A¨´¤µ¬°¤î¡A¦b¼w¨½ªº Lok Nayak Âå°|¡A¬° Omicron ±wªÌ´£¨Ñªº°ß¤@ªvÀø¤èªk¬O½Æ¦Xºû¥Í¯À©M¼³¼ö®§µh¡C ¸ÓÂå°|ªº¤@¦W°ª¯ÅÂå¥Íªí¥Ü¡A¤j¬ù 90% ªº±wªÌ¡§µL¯gª¬¡¨¡A¨ä¾l±wªÌ«h¥X²{¡§³ïÄVµh¡B§C¿N©M¨Åé¯kµh¡¨µ¥»´·L¯gª¬¡C www.outlookindia.com/website/story/india-news-omicron-patients-are-being-treated-using-paracetamol-and-multivitamin-delhi-doctors/406536 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/14 ¤U¤È 11:28:48²Ä 1590 ½g¦^À³
|
µL¤H¯à¥X¨ä¥k¤F!? »´¤¤¯g¤fªAÃļƾں}«G¡AFDAn¨DRevive¤½¥q¸õ¹LP1»PP2¡A¯Sã±qP3Á{§É¹êÅç¡C¦A¥HP3ªº´Á¤¤¼Æ¾Ú¥Ó½ÐEUA. www.clinicalleader.com/doc/can-revive-overcome-long-odds-with-a-small-molecule-covid-treatment-0001 ...In June 2020, we approached the FDA with an IND for COVID. We hoped to move into a Phase 2 study and were surprised when the FDA looked at the data and fast-tracked our request to a Phase 3 study. Being able to skip the Phase 1 and Phase 2 studies was a huge win for our small company.¡¨ --------------------------------------------------------------------------------------------------- Benjamin A. Smith¡G¦b±z¬Ý¨Ó¡ARevive ¬O§_¦³¾÷·|Àò±o EUA¡A±z»{¬°³oºØ¾÷·|¦³¦h¤j¡H Biomedical_trader¡G¶â¡A¦b¤U¤@¦¸¤¤´Á¤ÀªR¤¤¡]600 ¦W±wªÌ¡A¹wp±N«Ü§Ö´£¥æ¡^¡A§Ú»{¬°¾÷·|¤£¤j¡C¦ý¬O¡A§Aª¾¹D¡A§Ú³Ì¦nªº²q´ú¬O¡A¤j¬ù»Ýn 700 ¨ì 900 ¦W±wªÌ¤~¯àÃÒ©ú¥L̪ºÃĪ«¦³©Ò¤£¦P¡C¦Ó¥B¡A±zª¾¹D¡A§Ú̪¾¹D¥¬¦è©Ô©úªº¬Y¨Ç¾÷¨î¥i¥H¸Ñ¨M¬Y¨Ç°ÝÃD¡A³o¨Ç°ÝÃD¨Ï¬Y¨Ç±wªÌ¡]¨Ò¦p¿}§¿¯f±wªÌ©M¦Ñ¦~¤H¡^¥X²{ COVID ÄY«¯gª¬ªº·ÀI§ó°ª¡C©Ò¥H§Ú½T¹ê»{¬°¥L̦³¤j¬ù 60% ªº¾÷·|¦b 800¡]±wªÌ¡^¼Ð°O³Bªí²{¥X®t²§¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/14 ¤U¤È 10:25:33²Ä 1589 ½g¦^À³
|
®É¶¡ªº«æ¢©Ê´N¬O[ÃĪ«]EUA¤jªù¦ó®É·|Ãöªù!!! 2021.6¤ë FDA Ãö³¬[¬Ì]]EUA¤jªù 2022.01.07 ¤w¶}©l·t¥Ü[ÂåÀø¾¹±ñ³]³Æ]EUA±N¦b¤£¤[¤§«á¤]Ãöªù www.mpo-mag.com/contents/view_online-exclusives/2022-01-07/the-end-of-eua-is-coming-soon/ -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/8 ¤W¤È 05:56:27²Ä 1571 ½g¦^À³ ¦³·P¦Óµo¡A¯u¤ßÀ°°ê¹©³o¦¸²æL´«°©ªº«_ÀI¿n·¥ºë¯««öÆg! °ê¹©¾ú¨Ó´N1©Û»f¸»ÂI¤ôµê®Ì¤@¤U¡A³o¤]°µ¨º¤]°µ¡A¨Æ¨Æ°µ¤£¤F¡A³o¦^·Q¥Î¤G´Á¼Æ¾Ú³q¹LEUA³o¹D¯¶ªù¡A¤£¬O¦³¦Û«H¦Ó¦b2©Û[§L¶Q¯«³t]»P[¼C¨«°¾¾W]¡C 1. [§L¶Q¯«³t]:¸Ñª¼·|´£¨ì±wªÌ·U¨Ó·U¤£¦n¦¬¡A¦ý¯}100¤H¥i¸Ñª¼¡A¨º¬°¦ó¦¬®×124¤H´N«æµÛn¸Ñª¼? (¼B¸³·íµM¤£·|³o»ò»¡)¦]¬° ¡§®É¶¡ªº«æ¢©Ê FDA¦b³q¹L´X¤ä·s«a¬Ì]EUA«á¡A¦b2021¦~6¤ë Ãö³¬ ¡¨¬Ì]¡¨ EUA¤jªù¤£¦A¨ü ²z¡A¦Ó³o¹D ¡§ÃĪ«¡¨ EUA¤jªù¤]¤w¸g¦³ ¡¨7Ó¡¨ (¤£¬O´CÅé¼gªº¥u¦³Àq§J»P½÷·ç³o2Ó)¶i¥h¡A§Y±NÃöªù! ................................................................................... ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/4 ¤W¤È 09:02:32²Ä 1538 ½g¦^À³ ¦P²z¥iÃÒ¡A¦bÀq¨FªF»P½÷·çªº·s«aªÍª¢¤fªAÃĨú±oÃÄÃÒ«á¡A¤]±NÃö³¬·s«aÃĪ«EUA¤jªù!!! ................................................................................... 2.[¼C¨«°¾¾W]:µL©`®É¤£§Ú»Pµ¥¨ì3´Á´Á¤¤¼Æ¾Ú¥X¨Ó¡A©úª¾®³¤G´Á¼Æ¾Ú³q¹L¾÷²v«Ü§C¡A¥u¯à¥XÀI©Û®³124¤Hªº¼Æ¾Ú¤@·i±qªùÁ_À½ ¬Ý¬Ý?¤Ï¥¿¦³EUA,Á{§É¤T´Á±o°µ ,¨S¦³EUA,Á{§É¤T´ÁÁÙ¬O±o°µ ,ªp¥B¶O¥Î»P®É¶¡¤GªÌ®t«Ü¤j¡C (¤p´²¤á¤j¡A«¥ÁÙ¦³°w¹ï©Ê¶Ü?) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/14 ¤W¤È 06:06:59²Ä 1588 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/13 ¤U¤È 09:07:29²Ä 1586 ½g¦^À³ SNP-810Ävª§¹ï¤â-1¡C Kalyra KP-1199(¹ï¤A酰®ò°ò×ôÃþ¦üª«)¦bP1´£«e²×¤î ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/16 ¤U¤È 04:13:56²Ä 790 ½g¦^À³ SNP-810Ävª§¹ï¤â¦A+1¡A¬ü°ê¶¤¤w¦³3®a(¦³2®a®³¨ì¬ü°ê°ê¥ß½Ã¥Í¬ã¨s°|¡]NIH¡^ÃÙ§U)!!! ----------------------------------------------------------------------------------------------- ¬ü°ê¶¤§R¥h²Ä1®aKalyra KP-1199«á¡A²Ä2®a»¡n¦b2020.Q3¶i¤JP1¡Aµ²ªG©µº¢¨ì2022.1¤ë¶}©lP1¸ÕÅç¡A²Ä3®a«hÁÙ¦bÁ{§É«e.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/13 ¤U¤È 10:28:07²Ä 1587 ½g¦^À³
|
¥X²{µL¨x¬rªºSNP-810¡A¦³¨x¬rªºAPAP¸Ó¤£¸Ó±q¥«³õ®ø¥¢? ´£¨Ñ¤@¬q2005¦~ Dr.Woodcock(«ôµn¤W¥ô«áªºFDA¥N²z§½ªø)¦b°ê·|³Æ¸ßªºµª´_ www.govinfo.gov/content/pkg/CHRG-109shrg20047/html/CHRG-109shrg20047.htm ...But in general, in my professional opinion, it is very important to have people involved in decisionmaking who actually treat patients with that condition, because if you only look at risk we would not have any drugs. It would not be sensible to have any drugs because they all cause harm. Even acetaminophen very common drug, over-the-counter, number one cause of drug-induced liver failure in the United States. If you took that fact in isolation what you would say is that should not be on the market. So you have to have the benefit side right in front of you when you are evaluating the safety problems of drugs. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/13 ¤U¤È 10:05:03²Ä 1586 ½g¦^À³
|
SNP-630§¹¦¨P1Á{§Éµ²ªG¥¿¦V? ¤¤°ê¥«³õ±ÂÅvÃÄ©ú±d¼w? ........................................................................................ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/9/20 ¤W¤È 10:19:33²Ä 1411 ½g¦^À³ 乔¤¥ »´ä®a±Ú办¤½«Ç 风险§ë资 ¬ì§Þ¤½¥q独¥ß¸³¨Æ ----------------------------------------------------------------- 发¥¬¤_ 2020-02-06 ·s药¤½¥q¹v¦V¦ó¤è zhuanlan.zhihu.com/p/105323292 ³Ìªñ协§U¤@®aªC¦{ªº·s药¤½¥q©w°Ó业µ¦²¤, 这®a¬ã发¤p¤À¤l¹v¦V药ªº¤½¥q·Q´Â¦VNASH.... µù:¤å³¹¤§©Ò¥H§l¤Þ«¥ª`·Nªº¬O©ñ¦b³Ì³»ºÝªºSNP-630§@¥Î¾÷¨î¹Ï¤ù¡C¤å³¹¶}ÀY[³Ìªñ协§U¤@®aªC¦{ªº·s药¤½¥q©w°Ó业µ¦²¤]»P[¦X¥þ]¦³ÃöÁp??? -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/7/9 ¤U¤È 04:59:24²Ä 1306 ½g¦^À³ 2021¦~«×¼W¸êpµe ...First in classªº·s¦¨¤À·sÃÄ SNP-630...¥Ø«e¤]»P°ê»Ú»sÃļt¦X§@¡AÂX¤jì®ÆÃĥͲ£¡C---«üÃÄ©ú±d¼w? --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/11 ¤U¤È 04:04:01²Ä 958 ½g¦^À³ 2020.12¤ëÀ禬46¸U¤¸¬O»P¦X¥þÃÄ·~»´ä¦³¤½¥q©e°UÃÄ«~¦X¦¨¬ÛÃö¨Æ©y ¦X¥þÃÄ·~»´ä¦³¤½¥q¬OÃÄ©ú±d¼w(¤¤°ê±Æ¦W«e¤T¤jÃļt)ªº¤l¤½¥q¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/13 ¤U¤È 09:23:10²Ä 1585 ½g¦^À³
|
onlinelibrary.wiley.com/doi/full/10.1111/trf.16497 ...¥»¬ã¨sªí©úKP-1199¡A¤@ºØ·s«¬ APAP Ãþ¦üª«¡A¥Ø«e³B©ó 1 ´ÁÁ{§É¬ã¨s¤¤¡A¨S¦³¨x¬r©Ê... --------------------------------------------------------------------------------------------------- P1ì©w©Û¶Ò97¦W°·±d¨ü¸ÕªÌ¡A³Ì²×¥u©Û26¦W¡A©ó2021.9.9´£«e²×¤î... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/13 ¤U¤È 09:07:29²Ä 1584 ½g¦^À³
|
SNP-810Ävª§¹ï¤â-1¡C Kalyra KP-1199(¹ï¤A酰®ò°ò×ôÃþ¦üª«)¦bP1´£«e²×¤î www.clinicaltrialsarena.com/analysis/novartis-rare-disease-regulatory-roundup/ ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/16 ¤U¤È 04:13:56²Ä 790 ½g¦^À³ SNP-810Ävª§¹ï¤â¦A+1¡A¬ü°ê¶¤¤w¦³3®a(¦³2®a®³¨ì¬ü°ê°ê¥ß½Ã¥Í¬ã¨s°|¡]NIH¡^ÃÙ§U)!!! 3®a¬ü°ê¶¤¥þ¬OAPAPµ²ºcÃþ¦üª«¡A»PªYÄ£SNP-810(¨Ï¥Îì¨Ó¦³®Ä¦¨¤À¡A¤S¤£¦A¦³¥ô¦ó¨x¬r©Ê)§@¥Î¾÷¨îºIµM¤£¦P¡C [»P¹ï¤A酰®ò°ò×ô¬Û¤ñ¡A¦w¥þ©Ê¬Û¦P©Î§ïµ½ªº¦w¥þµL¨x¬r©ÊÃĪ«±N¦¨¬°ªvÀø¯kµhªº¬ð¯}©Ê·s²£«~¡C] ...Kalyra Pharmaceuticals...¦X¦¨¤F³\¦h»P [µ²ºc] ¬ÛÃöªº¹ï¤A酰®ò°ò×ô [Ãþ¦üª«] |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2022/1/13 ¤U¤È 03:43:52²Ä 1583 ½g¦^À³
|
§Y±N¥l¶}ªÑªF·|¡A½Ð°Ý¦³¤j¤j参¥[¡H¦ü¥GÁÙ¨S¦¬¨ìªÑªF·|³qª¾®Ñ¡A¶}·|«e·|¦³«½S®ø®§¡H¶}©l´Á«Ý¤F¡I¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/11 ¤W¤È 08:29:46²Ä 1582 ½g¦^À³
|
Q:½Ð°Ý¶Q¤½¥q¦³¥Ó½Ð¤W¥«Âdªº®Éµ{ªí¶Ü? A:§Ú̦³³W¹º2021¦~©³´£¥X¤WÂd¥Ó½Ð¡A±©¸gÀÙÁ`Å骬ªp¡B°ê»Ú¬Ì±¡¡B±ÂÅv¶i«×µ¥½Ñ¦h¦]¯À·|¼vÅT¤WÂdªº°e¥ó®É¶¡¡C -------------------------------------------------------------------------------------------------- ©¹¼ÖÆ[¤è±Áp·Q·í¬O±ÂÅv.... |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/1/10 ¤U¤È 10:55:04²Ä 1581 ½g¦^À³
|
ROGER¤j µL¨x¬r¤îµhÃĦb¥xÆW³o¤p¥«³õ¡A¤jÃļt·íµM¤£·|¦³¿³½ì¡C ¦pªG·Q¨ú±ÂÅv¡A¤]¬O¥H¥þ²yªº¥«³õ¬°±ÂÅv¹ï¹³¡C ¤½¥q¥Ø«e¦n¹³¤]ÁÙ¨S¦³¤½§i¶}©l¼Ï¶s¸ÕÅç¡A¦³¥i¯à·|¥H¼Ï¶s¸ÕÅç¥Ó½Ð¤WÂd¡H ÃĮĸÕÅç¦ô¤]¸Óµ²§ô¤F¡A±ÂÅvª÷¤]¦³¥i¯à©Ê¡H n¤£µM¡A«æ©ó¤ë©³Á|¦æÁ{®É·|¡A°Q½×¤WÂd®×¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/10 ¤U¤È 04:58:40²Ä 1580 ½g¦^À³
|
¤HÅéÁ{§É¸ÕÅ窺³Ì«áÅçÃÒ¶¥¬q¡A¤]´N¬O²Ä¤T´ÁÁ{§É¸ÕÅç¡A´NºÙ¬°¼Ï¯Ã¸ÕÅçpivotal studies¡C ¥u¬O¥xÆW³o¶ôµL¨x¬r¥«³õ¹¤§µL¨ý! ´Á±æȶV¤j¡A¥¢±æ·P´N¶V¤j¡A¥±`¤ß´N¦n¡I -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/12/23 ¤W¤È 09:09:55²Ä 413 ½g¦^À³ ±ÂÅvª÷«¥¤ß¸Ì¤]¨S©³!±ÂÅvª÷«¥¤ß¸Ì¤]¨S©³!±ÂÅvª÷«¥¤ß¸Ì¤]¨S©³! ------------------------------------------------------------------------------------------ °ª¤£¥ÎÁ§ڡA§C¤]§O«è§Ú¡C |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/1/10 ¤U¤È 03:28:52²Ä 1579 ½g¦^À³
|
ROGER¤j ÃÙ¦P±zªº¬Ýªk¡A¬°¤°»òn«æ©ó1¤ë©³¶}Á{®É·|¡C ¨º¥Î¤°»ò¡u±ø¥ó¡v¥Ó½Ð¤WÂd¡H «D³B¤èÃÄ¡B¾Ç¦WÃÄÃÒ¡H¨S¦³À禬¡A¹êÃø¦ôºâ¥«³õ©Ê¡A©Ò¥H¦n¹³¤£¤Ó¥i¯à¡C 810¥xÆW®Ö㪺¼Ï¶s¸ÕÅç¡A¯àµø¬°·sÃĪº¡u²Ä¤T´Á¡v¸ÕÅç¶Ü¡H¦n¹³¤]»¡¤£¹L¥h¡I ¨º³Ñ¤Uªº¬O¤°»ò±ø¥ó¡H¥i¥H²Å¦X¤WÂd¡H ¦n¹³¥u¦³¡u°ªÃB±ÂÅvª÷¡vªº¦X¬ù¡B¨½µ{ª÷µ¥¡C ½Ð±Ð±zªº¬Ýªk¦p¦ó¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/10 ¤U¤È 02:25:27²Ä 1578 ½g¦^À³
|
¥h¦~110.7.29ªÑªF·|´N¥i¥H°Q½×ªí¨Mªº¥Ó½ÐªÑ²¼¤WÂd! ¦ó¥²³Ò®v°Ê²³¦b¤µ¦~1/26¥[¶}Á{®É·|? 2022.1.9µá«ß»«¨¾¬Ì¸T¥O¤Þ®£·W °h¿N¤îµhÃľDºÆ·m¯Ê³f ¸û¬°ª¾¦W¡B§t¦³¤AñQÓi×ô¡]Paracetamol¡^¦¨¤Àªº°h¿N¤îµhÃĦpBiogesic¡BTempra©M·P«_ÃĪ«Bioflu¡BNeozepµ¥¡A³£³Q¤@±½¦ÓªÅ¡C tw.news.yahoo.com/%E8%8F%B2%E5%BE%8B%E8%B3%93%E9%98%B2%E7%96%AB%E7%A6%81%E4%BB%A4%E5%BC%95%E6%81%90%E6%85%8C-%E9%80%80%E7%87%92%E6%AD%A2%E7%97%9B%E8%97%A5%E9%81%AD%E7%98%8B%E6%90%B6%E7%BC%BA%E8%B2%A8-152638874.html |
|
|
·|û¡Gonly10135877 µoªí®É¶¡:2022/1/10 ¤U¤È 01:32:52²Ä 1577 ½g¦^À³
|
ªYÄ£¤]ºâ¨¾¬Ì·§©ÀªÑ ¬°¥´¬ÌÐt«á¤ÞµoÀYµhµo¿N«á,¨Ï¥Î¦w¥þµL¸·ªº¨îµhÃĪ« |
|
|
·|û¡Gonly10135877 µoªí®É¶¡:2022/1/10 ¤U¤È 01:20:25²Ä 1576 ½g¦^À³
|
«á¬q¯Zªº¥xºÍ¤ß®®³£§Ö¶W¨®¤F ªYÄ£n¥[ªo°Ú!§Æ±æ³Ìªñ¯à¦³¾÷·|°±µP¤½¥¬¤j¼tÀË´úµ²ªG |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/10 ¤W¤È 11:15:06²Ä 1575 ½g¦^À³
|
ºÃ? ªYÄ£12¤ëÀ禬«ç»ò¤µ¤Ñ10¸¹¤FÁÙ¨S¤½¥¬? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/10 ¤W¤È 09:51:38²Ä 1574 ½g¦^À³
|
¼Æ¾Ú¨S§¹¾ã¤½¥¬¡A¨S¤Hª¾¾å¡A¦ý¶ø¦a§Q°ÓSanova¤@©wª¾¹D! (¤@ñ´N®¼°ê¹©) ª`·N1/31¤é´Á¤]¬O¯àÅÜ°Ê£x. --------------------------------------------------------------------------------------------- ¤½§i¥»¤½¥q»P¶ø¦a§Q°ÓSanova Pharma GesmbHñ¸p¦X§@³Æ§Ñ¿ý(MOU) 1.¨Æ¹êµo¥Í¤é:110/08/24 2.«´¬ù©Î©Ó¿Õ¬Û¹ï¤H:¶ø¦a§Q°ÓSanova Pharma GesmbH 3.»P¤½¥qÃö«Y:µL¡C 4.«´¬ù©Î©Ó¿Õ°_¨´¤é´Á(©Î¸Ñ°£¤é´Á):110/08/19~111/01/31 |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2022/1/10 ¤W¤È 09:40:19²Ä 1573 ½g¦^À³
|
¶Ã¤J¦¹°Q½×°Ï¦^ªY½à¤j. ¹êÅç¥ÎÃÄn¯à¸ò²{¦æ¥ÎÃÄ°µHead to Head ¹ï¤ñ,¤@©w¬O¦¹ÃĤw³QÃÒ©ú¦³¬Û·í¦nªºÃÄ®Ä. ¥H°ê¹©ªº¨Ò¤l¨Ó¬Ý,¦b¤G´Á§¹¦¨«eÂå¥Í®Ú¥»¤£ª¾¹D¦¹ÃĦn¤£¦n. Y¹êÅç²Õ¨S¦³¥ÎSOC, ¨º¤@¥¹¹êÅç¥ÎÃĮĪG¤£¦n,¤£´N·l¶Ë¤F¨ü¸ÕªÌªº°·±d? ³o¬O¤£³Q¤¹³\ªº. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/10 ¤W¤È 09:31:12²Ä 1572 ½g¦^À³
|
§Ú°¸º¸¤]·|°µ¿ù¨ÆÁ¿¿ù¸Ü£x!(¼B¸³À³¸Ó¥u¬O¤f»~¥Îµü¤£¨Î!?) 1.²Ä1¤ä·s«a¤fªAÃĦb2020.11.29ÀòFDA EUA (¤£¬O½÷·ç»PÀq§J) ¤Ú·ç´À¥§¡]Olumiant-Baricitinib¡^¬O获±oFDA紧«æ¨Ï¥Î±Â权ªº¥t¤@个针对·s«aªÍª¢ªº§K¬Ì调节药ª«¡A为¤fªA¤ù剂 m.yunnan.cn/system/2021/12/24/031836534.shtml 2.¤¤°ê§ÜÅéÃĪ«¥HÁ{§É¤G´Á(©Û¶Ò1631¦W,¹ï·Ó²Õ:·ç¼w¦è³Remdesivir)¦b2021.2¤ë®³¨ìFDA EUA clinicaltrials.gov/ct2/show/NCT04634409?term=LY-CoV555&draw=2&rank=8 ¡mCOVID-19ªvÀø¡n§¨Ó(Eli Lilly)°§C»´¤¤«×¯f±w¦í°|²v·sÃÄLY ... www.genetinfo.com/international-news/item/42155.html (¤~¹L´X¤Ñ´N¦Û®a¥´¦Û®aªºÁyOrz.) |
|
|
·|û¡GªY½à¼Æ¦r¬ü10147157 µoªí®É¶¡:2022/1/9 ¤U¤È 10:55:51²Ä 1571 ½g¦^À³
|
°ê¹©¤G´Áªº¦¬®×±ø¥ó¹ï·Ó²Õ¥ÎÃĦ³¨S¦³¥]¬A¤w¨ú±oEUAªºÃĪ«? ¤@°ï·sÃĤT´ÁÁ{§É³]p¤]¬O¥Î©M²{¦³ÃĪ«°µµ¥®Ä©Ê©M«D¦H®Ä©Ê¸ÕÅ箳ÃÄÃÒ ®³ÃÄÃÒªº¤T´Á¹êÅç¨S¦³¤@©w»Ýnµ´¹ïÀu©ó¹ï·Ó²Õ ÃĵØÃĪºÃÄÃÒ¤]¬O¥Î«D¦H©Ê ¬Ì±¡ªì´Á¹êÅç¤@©w¬O¨Ï¥Î¤ä«ùÀøªk¡A·|±Æ°£¨ä¥LÁ{§É¤¤ÃĪ«¨Ï¥Î¡A¼Æ¾Ú¤@©w¬O¥ÎÀu¶V©Ê finance.ettoday.net/news/2162209 ·s»D¸Ì»¡¹ï·Ó²Õ»Ýn¤°»òÃÄ¡A¬O¥H·í¤UªºÂåÀø±¡¹Ò¯à°÷¨ú±oªº·í¦a¢á¢Ý¢Ñ¨Ó§@¬°¹ï·Ó ª©¤W´£¨Ñªº¸ê®Æ»¡°ê¹©¨S¦³±Æ°£¤w¬I¥´¬Ì]ªº¯f±w¡A¦pªG¹ï·Ó²Õ¹êÅç¦A¥[¤W¤w¨ú±oEUAªºÃĪ« §Úı±o¬O¦³¾÷·|¥i¥H¥Îµ¥®Ä©Ê¥H¤Î«D¦H®Ä©Ê©MFDA½Í§P |
|
|
·|û¡G°]°È¦Û¥Ñ¤H10132540 µoªí®É¶¡:2022/1/9 ¤U¤È 02:09:53²Ä 1570 ½g¦^À³
|
www.youtube.com/watch?v=R1Xs-SLfu8Q °ê¹©ªº«°Tµø°T¡C11¤À40¬í¡A¼B¸³»¡²Ä14¤Ñ»P²Ä28¤Ñªº¥DnÀø®Ä ¡y§Ų́èS¦³n¸ò¹ï·Ó²Õ°µ©Ò¿×ªºPK ¡z¡C ¤£ª¾¹D¬O§_¤f»~¡AY¼Æ¾Ú¤£ PK ¡A¯à»¡ªA FDA ¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/8 ¤W¤È 05:56:27²Ä 1569 ½g¦^À³
|
¦³·P¦Óµo¡A¯u¤ßÀ°°ê¹©³o¦¸²æL´«°©ªº«_ÀI¿n·¥ºë¯««öÆg! °ê¹©¾ú¨Ó´N1©Û»f¸»ÂI¤ôµê®Ì¤@¤U¡A³o¤]°µ¨º¤]°µ¡A¨Æ¨Æ°µ¤£¤F¡A³o¦^·Q¥Î¤G´Á¼Æ¾Ú³q¹LEUA³o¹D¯¶ªù¡A¤£¬O¦³¦Û«H¦Ó¦b2©Û[§L¶Q¯«³t]»P[¼C¨«°¾¾W]¡C 1. [§L¶Q¯«³t]:¸Ñª¼·|´£¨ì±wªÌ·U¨Ó·U¤£¦n¦¬¡A¦ý¯}100¤H¥i¸Ñª¼¡A¨º¬°¦ó¦¬®×124¤H´N«æµÛn¸Ñª¼? (¼B¸³·íµM¤£·|³o»ò»¡)¦]¬° ¡§®É¶¡ªº«æ¢©Ê FDA¦b³q¹L´X¤ä·s«a¬Ì]EUA«á¡A¦b2021¦~6¤ë Ãö³¬ ¡¨¬Ì]¡¨ EUA¤jªù¤£¦A¨ü ²z¡A¦Ó³o¹D ¡§ÃĪ«¡¨ EUA¤jªù¤]¤w¸g¦³ ¡¨7Ó¡¨ (¤£¬O´CÅé¼gªº¥u¦³Àq§J»P½÷·ç³o2Ó)¶i¥h¡A§Y±NÃöªù! ................................................................................... ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/4 ¤W¤È 09:02:32²Ä 1538 ½g¦^À³ ¦P²z¥iÃÒ¡A¦bÀq¨FªF»P½÷·çªº·s«aªÍª¢¤fªAÃĨú±oÃÄÃÒ«á¡A¤]±NÃö³¬·s«aÃĪ«EUA¤jªù!!! ................................................................................... 2.[¼C¨«°¾¾W]:µL©`®É¤£§Ú»Pµ¥¨ì3´Á´Á¤¤¼Æ¾Ú¥X¨Ó¡A©úª¾®³¤G´Á¼Æ¾Ú³q¹L¾÷²v«Ü§C¡A¥u¯à¥XÀI©Û®³124¤Hªº¼Æ¾Ú¤@·i±qªùÁ_À½ ¬Ý¬Ý?¤Ï¥¿¦³EUA,Á{§É¤T´Á±o°µ ,¨S¦³EUA,Á{§É¤T´ÁÁÙ¬O±o°µ ,ªp¥B¶O¥Î»P®É¶¡¤GªÌ®t«Ü¤j¡C (¤p´²¤á¤j¡A«¥ÁÙ¦³°w¹ï©Ê¶Ü?) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/7 ¤W¤È 10:51:33²Ä 1568 ½g¦^À³
|
2021¬ü°ê³Ì¨Î«~µP´£¤É±Æ¦æ YouGov BrandIndex ®ø¶OªÌ«~µP»{ª¾«×ªºÅv«Â«ü¼Ðwww.contagious.com/news-and-views/yougov-best-brand-improvers-of-2021-usa ±Æ¦W²Ä¤»ªº«D³B¤è¤îµh«~µP®õ¿Õ¡]Tylenol¡^ ²Ä¥|¤j§ï¶i«~µP¬O¨È°¨»¹ Prime Video ¤µ¦~¬ü°ê¶i¨B³Ì§Öªº«~µP²Ä¤@¬O½÷·ç(·s«a¬Ì]¤§½ç) ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/7 ¤W¤È 07:09:08²Ä 1567 ½g¦^À³ ¸Ü»¡2021.11¤ëJ&J±N§â¨ä®ø¶OªÌ°·±d³¡ªù©î¤À¬°¤@®a·sªº¤W¥«¤½¥q¡A¶¢¨ÓµL¨Æ´N¦ôºâ¤@¤UTylenolªº¥«È? (¥x¿n¹q¥«È¬ù6000»õ¬üª÷¡A±Æ¦W¥@¬É¥«È«e¤Q¤j¡A¦p¤µ¥u¦³¤»®a¤½¥q¥«È¶W¹L1¸U»õ¬ü¤¸¡C) 1.J&J®ø¶OªÌ°·±d³¡ªù¥«È500»õ¬ü¤¸ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/7 ¤W¤È 10:14:20²Ä 1567 ½g¦^À³
|
¦Û¤vªº¬ö¿ý¦Û¤v¯}¡A¦X¤@ON101¤¤°êÃÄÃÒ»P¥þ²y±ÂÅv(°ª©óFB825ªº5.3»õ¬ü¤¸)ÀH®É¥i¯à³sÀôÃz¥iª`·N ªYÄ£ÂàÂd³Ì§Ö¤]n¤]n¦~©³ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/1/7 ¤W¤È 09:46:13²Ä 1566 ½g¦^À³
|
¬Û«H¤j®a³£¬Ý¦n «¥·sÃÄ¡A¦ý¤£¯d¦b¿³Âd ´N¨S¥i¯à¦³®eÂ_ªº¾÷·|¤F n©M¦X¤@¤@¼ËºCºCº¦¨ì300!¦pªG¦b¤WÂd«e¤½¥¬¤@¤U§Q¦h¤]¨Ó®eÂ_¤@¤U¡A¥X¤f®ð |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/7 ¤W¤È 07:09:08²Ä 1565 ½g¦^À³
|
¸Ü»¡2021.11¤ëJ&J±N§â¨ä®ø¶OªÌ°·±d³¡ªù©î¤À¬°¤@®a·sªº¤W¥«¤½¥q¡A¶¢¨ÓµL¨Æ´N¦ôºâ¤@¤UTylenolªº¥«È? (¥x¿n¹q¥«È¬ù6000»õ¬üª÷¡A±Æ¦W¥@¬É¥«È«e¤Q¤j¡A¦p¤µ¥u¦³¤»®a¤½¥q¥«È¶W¹L1¸U»õ¬ü¤¸¡C) 1.J&J®ø¶OªÌ°·±d³¡ªù¥«È500»õ¬ü¤¸ 2.J&J®ø¶OªÌ°·±d³¡ªùªºª¾¦W²£«~:®õ¿Õ¡B¬üªL¡B¥P¯S©ú¡A¦p¨¹}¡B§õ¬I¼wªL¡BÅS±o²M¡BNeosporin¡B¦ã±©¿Õ¡B¥i§D¥i«W¡B¸¨°· -------------------------------------------------------------------------------------------------- 2021.12.10 ¨ì2035¦~¡A³o4¥uªÑ²¼¥«È±N¬ð¯}1¸U»õ(1¥ü)¬ü¤¸(±j¥Í¡BÁp¦X°·±d¡B¸U¨Æ¹F¥d©M³Õ³q) nai500.com/zh-hant/blog/coverage/%E5%88%B0-2035-%E5%B9%B4%EF%BC%8C%E9%80%994%E5%8F%AA%E8%82%A1%E7%A5%A8%E5%B8%82%E5%80%BC%E5%B0%87%E7%AA%81%E7%A0%B41%E8%90%AC%E5%84%84%E7%BE%8E%E5%85%83/ ±j¥Í¤½¥q¡G¥«È3800»õ¬ü¤¸ §@¬°¥«È³Ì¤jªºÂåÃĪѡA±j¥Í¤½¥q¡]JNJ¡^¥i¯à¤£»Ýn¤¶²Ð¡CÁöµM¥H®õ¿Õ(Tylenol)©M²ö¯SªL(Motrin)µ¥®ø¶O«~µP»D¦W¡A ¨Æ¹ê¤W¡A±j¥Í±N§â¨ä®ø¶OªÌ°·±d³¡ªù©î¤À¬°¤@®a·sªº¤W¥«¤½¥q¡C³o¬O¤@¶µ§Q¼í²v¸û§C¡B¼Wªø¸û§Cªº·~°È¡X¡X¶È¥e±j¥ÍÁ`¦¬¤Jªº 16%¡C¦pªG§Ú̱N±j¥Í¤½¥q¥Ø«e4300»õ¬ü¤¸ªº¥«È´î¥h500»õ¬ü¤¸¡]¬°§Y±N¨ì¨Óªº©î¤À¶i¦æ¤jP½Õ¾ã¡^¡A¨º»ò³Ñ¤Uªº·~°Èªº¦ôȱN¹F¨ì3800»õ¬ü¤¸¡C¦b¥¼¨Ó13¦~¸Ì¡A±j¥Í¤½¥qªºªÑ»ù»Ýn¨C¦~¼Wªø¬ù8%¤~¯à¹F¨ì1¸U»õ¬ü¤¸ªº¥«È¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2022/1/6 ¤U¤È 05:35:26²Ä 1564 ½g¦^À³
|
§Ú¬Ý¦n ½²¤j 3¦~«á¥²¦³©Ò¦^³ø |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/6 ¤U¤È 02:54:22²Ä 1563 ½g¦^À³
|
Tavalisse (fostamatinib) ·s«a«¯g¤G´ÁÁ{§É: ªvÀø²Õ30¦W±wªÌ¦b²Ä29 ¤Ñ¦º¤`¤H¼Æ¬°¹s¡A¦Ó¦w¼¢¾¯²Õ29 ¤H¦º¤`¤H¼Æ¬°3 ¤H¡C ------------------------------------------------------------------------------------------- ¦A¶K¤U¥hXX¥i¯à¨Ó¨çn¨D¡A¬°¤FÁקK»~¾É§ë¸ê¤H¡A¨Ã´L«¥ø·~¸gÀç¡An¨D«ÊÂꥻª©¡C Åý¥»ª©²M²b»P¥D¨¤¦^Âk¡A«¥¤£¦Aµoªí·s«aijÃD»P°Q½×! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/6 ¤U¤È 02:38:54²Ä 1562 ½g¦^À³
|
2021.8.13 ¥ÑNIH¬ü°ê½Ã¥Í°|»P°ê®a¤ßªÍ¦å²G©ÒÃÙ§UªºÁ{§ÉÃĪ«Tavalisse¤]³Q©Úµ´EUA. FDA§i¶D Rigel¡ATavalisse¤£·|Àò±oºò«æ¨Ï¥Î±ÂÅv (EUA)¡C ì¦]¡H¸ÓÃĪ«²{¦³ªº COVID-19 ¼Æ¾Ú¨Ó¦Û¶È¹ï 59 ¦W±wªÌ¶i¦æªº 2 ´Á¸ÕÅç¡AÁÙ¤£°÷¡CFDAn¨D´£¨Ñ²Ä3´Á¼Æ¾Ú! TAVALISSE¬OFDA¦b2018.4.17®Öã¤W¥«ªº³B¤èÃÄ¡AªvÀø¦]ºC©Ê§K¬Ì©Ê¦å¤pªO´î¤Ö¯g (ITP) ¦Ó¾ÉP¦å¤pªOp¼Æ§Cªº¦¨¤H¡C www.fiercepharma.com/pharma/fda-denies-rigel-s-autoimmune-drug-early-covid-19-emergency-use-for-hospitalized-patients |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/1/6 ¤U¤È 02:06:01²Ä 1561 ½g¦^À³
|
·sªº¤@¦~¦V¦U¦ì¤j¤j«ôÓ¦¦~¡A·s¬K§Ö¼Ö¡B¨Æ¨Æ¦p·N¡I ¥h¦~ªYÄ£¤w¶}ªá¡A¥¼¨Ó¤T¦~·|½AÀéµ²ªG¡I ¤WÂdÃD§÷¡B810¤À°Ï±ÂÅv¡B830ÃÄÃÒ»P±ÂÅv¡B610¡B630¶i®i»P±ÂÅv¡A²Ê¦ô¤T¦~¤º¹ê²{¡C ¸Õ·Q¥þ³¡§¹¦¨«á¡AªÑ»ù·|¦h¤Ö¡H¤j®aªº¡m¹Ú¤ÛªÑ¤ý¡n¤£n§Ñ¤F¡I«¥ªYÄ£¤]³\´N¬O¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/6 ¤W¤È 09:38:11²Ä 1560 ½g¦^À³
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/1/5 ¤U¤È 04:48:53²Ä 1551 ½g¦^À³ ªÑ»ù·|»¡¸Ü¡A¤F¸Ñ¤Ó¦h¤£ÁÈ¿ú¡A§Ú¹çÄ@·ísb¡C ------------------------------------------------------------------------------------------- ¤µ¤Ñ¬O¶Ì¤H¦³¶ÌºÖ! ©ú¤Ñ¶ë¯Î¥¢°¨²jª¾«DºÖ! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/1/6 ¤W¤È 09:29:23²Ä 1559 ½g¦^À³
|
§Ú¥uª¾¹D¤µ¤Ñ¤Ö¤F¦Ê¨Ów¡Ashit |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/6 ¤W¤È 07:17:26²Ä 1558 ½g¦^À³
|
·|û¡G¨}¥²«L10147410 µoªí®É¶¡:2022/1/5 ¤U¤È 05:22:59²Ä 1554 ½g¦^À³ ...¦³ªº¥h¦~Á{§É¸ÕÅç¤T´Á´Á¤¤¼Æ¾Ú«Ü¦n¡A¤H¼Æ¦¬ªº¤ñÁ繩¦h¤]¬O³Q¥´¦^¡AÁ繩 124¤H¥Ó½ÐEUA,¥u¯à説¤Ó¦³¦Û«H -------------------------------------------------------------------------------------------------- Lenzilumab (520¦W¯f±w) ¦b2021.9.9³QFDAÀ»¸¨ endpts.com/humanigen-crashes-as-fda-shoots-down-its-covid-19-drug-eua/ ..FDA ©Úµ´ EUA ªº½T¤Áì¦]¦b«Ü¤jµ{«×¤W¤´µM¥¼ª¾¡A¦]¬°¸Ó¤½¥q´£¨Ñªº²Ó¸`«Ü¤Ö¡C ¸Ó¤½¥q¦b¤@¥÷Án©ú¤¤ªí¥Ü¡G¡§¦b«H¤¤¡AFDA ªí¥ÜµLªk±o¥Xµ²½×¡Alenzilumab ªº¤wª¾©M¼ç¦b¯q³B¶W¹L¨ä¥Î§@ COVID-19 ªvÀøªº¤wª¾©M¼ç¦b·ÀI¡C --------------------------------------- Lenzilumab¤T´Á´Á¤¤¼Æ¾ÚPȳ£<0.05¹F¼Ð³á! (°ê¹©¤G´ÁPȵS¥¼ª¾?) www.contagionlive.com/view/lenzilumab-significantly-improves-covid-19-survival-without-invasive-ventilation-for-newly-hospitalized-patients |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤U¤È 06:53:11²Ä 1557 ½g¦^À³
|
¨}¤j, 2021.8.29 °ê¹©¤G´Á´Á¤¤:finance.ettoday.net/news/2067132 ²Ä¤G¶¥¬q²Öp¦¬ªv¤§80¦ì¯f±wªºÁ{§É¼Æ¾Ú¡A..¼f¬d§¹¦¨¡A¥BDMC«Øij¼W¥[¦¬ªv»Ýn®ñ®ð¤ä«ù¤§«¯g¦í°|¯f±w¡C ------------------------------------------------------------- ©Ò¥H8/29«á¦A¦¬124¤H-80¤H(»´¤¤¯g)=44¤H(«¯g¤H¼Æ?) ¦Ó»´¤¤¯gªÌ¦b®a¥ð®§¡A´N¬O¨S¦YÃĤ]¥i¯à·|²¬Â¡!!! ¨ºÓºô¯¸¸ê®Æ¬OÀH®É¥i§ó·s£x. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤U¤È 06:35:59²Ä 1556 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/27 ¤W¤È 08:50:32²Ä 9913 ½g¦^À³ «¥¤ÞÃzAOP¼Ú¬wºM¦^©t¨àÃĨƥó.... --------------------------------------------------------------------------------------------- «¥²Ä1¤â¶K¥XAOP¼Ú¬wºM¦^©t¨àÃÄ°T®§¤Þ°_·¼É(¨º®ÉÁ٤ⴤÃĵØ)¡C ¥i¥hÃĵتŪ©À˵ø«¥¦³¤f¥X´c¨¥¬Û¦V§_! ¤H¤§«ä¼{¦³¡A¤@¤H¤£¥iÝÁ`¼Æ¾¡C ¥un¦³¾Ì¦³¾Ú«¥¬O¤@·§Åwªï! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤U¤È 06:22:31²Ä 1555 ½g¦^À³
|
2019/11/28 23:20°ê¹©ªÍÀùº§å54¸UÁû·sÃÄ Àòã¶i¤f¬ü°ê °ê¹©¥Í§Þ (4132-TW) ¤µ (28) ¤é«Å¥¬¡A¥Î©ó«D¤p²ÓMªÍÀù¥½´Á·sÃÄ Antroquinonol¡Aº§å 54 ¸UÁû·sÃÄ¥i¶i¤f¦Ü¬ü°ê¡Aªì¦ô¨CÁûÃÄ«~¶O¥Î¬° 65 ¬ü¤¸¡Aªk¤H¬Ý¦n¡AY·sÃıҰʳc°â«á¡A±N²KÀç¹B·s¬¡¤ô¡C Á`¸g²zĬ¸g¤Ñªí¥Ü¡AAntroquinonol ¤w§¹¦¨ªÍÀù¤G´ÁÁ{§É¦¬®×¡Aµ²ªGÅã¥Ü¡A¹ï©ó±µ¨ü¶W¹L 2 ¦¸¤ÆÀøªº¯f±w¡A¤¤¦ì¼ÆÁ`Åé¥Í¦s´Á (mOS) ¬° 47.3 ¶g¡AÀu©ó¨ä¥LÃĪ«¡C °ê¹©ªí¥Ü¡A¾Ú¬ü°ê¡uRight to Try Act¡v(RTT, ¹Á¸ÕÅvªk®×) ³W©w¡A·í¯f¤H³Q¶EÂ_¥X¦M¤Î¥Í©R¡A¥BµL®ÖãÃĪ«¥iªvÀø®É¡AÃļt¥iª½±µ´£¨Ñµ¹²Å¦X±ø¥óªº¯f±w¥Ó½Ð¸ÕÅç¡C -------------------------------------------------------------------------------------------- 54¸UÁû*65¬ü¤¸*¶×²v30=¥x¹ô10.5»õ¦³§I²{??? ²{¦b¤@¨Ç´CÅé¤S©ß¥X2´ÁÁ{§É¼Æ¾Úª½±µ¥Ó½ÐEUA¤W¥«¡C Orz. |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/1/5 ¤U¤È 06:13:44²Ä 1554 ½g¦^À³
|
´N¬O¤Ó¬ì¾Ç¤Ó²z©Ê ¤~ÁȤ£¨ì¿ú¡A¨S¦³P VLAUE¤]¦bµo¡A´N¬Oª£ªÑ¡C©ú¤Ñ·|³Q¤£²z©ÊªºªB¤Í¬~Áy¨ì½¡C¤Q´X±i¤]¬O¤Ö¤F¦Ê¨ÓW |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤U¤È 05:04:51²Ä 1553 ½g¦^À³
|
¾À¥ß¤d¥Q¡A µL±ý«hè¡C ®ü¯Ç¦Ê¤t¡A ¦³®e¤D¤j¡C |
|
|
·|û¡G¤p´²¤á10148935 µoªí®É¶¡:2022/1/5 ¤U¤È 04:52:30²Ä 1552 ½g¦^À³
|
¨S©È°Ú ¥uı±o¦³¨Ç¤å³¹«Ü°w¹ï |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/1/5 ¤U¤È 04:48:53²Ä 1551 ½g¦^À³
|
ªÑ»ù·|»¡¸Ü¡A¤F¸Ñ¤Ó¦h¤£ÁÈ¿ú¡A§Ú¹çÄ@·ísb¡CÁÈ¿ú¤~¬O¤ý¹D¡C°ªºÝ¤£¬O¤]³o¼Ë¡C¤@¥y¸Ü ¬Ý¿ù¤F¡A§Ú¦Û¤wt³d¡A©ú¤Ñ¤£ª¾¨ì¼Q¨ì¦ó³B¥h ¯uªº·|ú¦º |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤U¤È 04:48:09²Ä 1550 ½g¦^À³
|
ec.ltn.com.tw/article/breakingnews/3790951 ¤£¹LÂd¶R¤¤¤ß°w¹ï¤µ¤Ñ¸Ñª¼¤]´£¥X¦hÓ°ÝÃD¡A¥]¬A쥻Á{§É¸ÕÅç³]p¹wp¦¬®×174¤H¡A³Ì²×¬°¦ó¶È¦¬124¤H¡H¥H¤Î124¦ì¦¬®×¯f±w¤¤¡A»´¡B¤¤¡B«¯g¯f±w¦U¬°¦h¤Ö¡HÁ{§Éµ²ªG¬°¦ó¨S¦³PÈ¡]§PÂ_²Îp¤W¬O§_ÅãµÛªº¤@Ó«n«ü¼Ð¡^¡H ¼B³Ó«iµªÂЪí¥Ü¡Aè¥XÁ{§É³]p´N¬O³W¹º¦¬®×¶W¹L100¤H´N¥i¥H¸Ñª¼¡A¥B¥Ø«e¦¬®×³t«×ÅܺC¡A¦]¦¹¥ý°±¤U¨Ó¡F¦Ü©ó¦¬®×¯f±w¤À¥¬¡A¹ê»Ú¼Æ¨Ã¤£½T©w¡FPȥثeÁÙ¥¼®³¨ì¡A¬O¦]¬°Á{§É¤ÀªR³ø§i¥Ø«eÁÙ¥¼®³¨ì¡A©Ò¥HµLªk¤½¥¬¡C --------------------------------------------------------------------------------------------------- ¬O¯uª÷´N¤£©È¤õ·Ò¡A¤p´²¤á¤j©È¬Æ? ©ú¤ÑÃöt£x. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤U¤È 04:29:34²Ä 1549 ½g¦^À³
|
n¥Ó½Ð¬ü°êEUA¡A½Ð«ö¬ü°êªº³W©w¨«¡C ¬ü°êFDAªºEUA¾÷¨î¦³¥|¶µ¹ê¦æì«h: ²Ä¤@¡B±ý¥Ó½Ðºò«æ¨Ï¥Î±ÂÅvªº¥ø·~¡A¥²¶·´£¨ÑÁ{§É¤@¡B¤G´Á©Ò¦³¸ê®Æ¡A¥H¤Î¤T´ÁÁ{§É°lÂÜ 2 Ӥ몺´Á¤¤¤ÀªR¼Æ¾Ú¡C ²Ä¤G¡Bµû¦ô¬Ì]®Ä¤Oªº¸ÕÅç¡A»Ý±ÄÀH¾÷¤À°t¡BÂùª¼¤À²Õ¡A¨Ã¦³¬I¥´¦w¼¢¾¯ªº¹ï·Ó²Õ¡A³Ì«áµû¦ô¨â²Õ¸ÕÅç¤Hûªº·P¬V¤ñ¨Ò¡C ²Ä¤T¡B¨ú±o¬Ì]ºò«æ¨Ï¥Î±ÂÅvªº¥ø·~¡A¥²»Ý«ùÄò°õ¦æÁ{§É¸ÕÅç¡A¥H´£¨Ñ¦w¥þ©Ê»P®Ä¤Oªºªø´Á¸ê®Æ¡F¬Ì]»s³y°Ó¤]¥²¶·«ùÄòºÊ´ú¬Ì]¦w¥þ©Ê¡A¥]¬A½Õ¬d±µºØºò«æ±ÂÅv¬Ì]©Ò¦³¦º¤`³ø§i¡B¦í°|±¡ªp¥H¤Î¨ä¥LÁ{§ÉÄY«¤£¨}¤ÏÀ³¡C ²Ä¥|¡BFDA ´Á«Ý¨ú±o¬Ì]ºò«æ±ÂÅvªº·~ªÌ¡A¦¬¶°¦Ü¤Ö 6 Ӥ몺¼Æ¾Ú«á´£¥X¥¿¦¡ÃÄÃҥӽСA¤@¥¹¦³¬Ì]Àò¥¿¦¡ÃÄÃÒ®Öã¡AFDA ±N¤£¦A³q¹L·s¬Ì]ªººò«æ¨Ï¥Î±ÂÅv¥Ó½Ð¡A°£«DÃÒ©ú¯S©w±Ú¸s¦³§ó¦nªº®ÄªG¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤U¤È 04:14:55²Ä 1548 ½g¦^À³
|
°ê¹©«ç¤£´£¨Ñ¹ï·Ó²Õ¼Æ¾Ú? ©³¤U¸Á»e©M¶ÂºØ¯ó¡]¤]ºÙ¬°¶Â§¶µM¡^3´ÁÁ{§É¸ê®Æ(µLªk½Æ»s¶K¤W«¥¤j·§¼g¤@¤U): »P¹ï·Ó²Õªº7¤Ñ»P13¤Ñ¬Û¤ñ,µo²{¥ÎÃIJզb¤¤¦Ü«¯g¯f¨Ò¤¤¤À§O¦b4¤Ñ»P6¤Ñ¤º½w¸Ñ·s«a¯gª¬(P<0.0001)¡C »P¹ï·Ó²Õ¬Û¤ñ,¥ÎÃIJզb¤¤¦Ü«¯g¯f¨Ò¤¤ªº¯f¬r²M°£¤]´£¦4¤Ñ¡C ¥ÎÃIJÕÁÙ°§C¤F«¯g¯f¨Òªº¦º¤`²v(P=0.029) ¦b¤¤«×¯f¨Ò¤¤,96.26%ªº¤¤«×¯f¨Ò±wªÌ¦b²Ä10¤é«ì´_¤é±`¬¡°Ê,¦Ó¹ï·Ó²Õ¬°68.93%¡C ¦bÄY«¯f¨Ò¤¤,¥ÎÃIJկf¨Ò¦b²Ä10¤Ñ¥X°|,¦ÓÆ[¹î¨ì¹ï·Ó²Õ¤´»Ý¦í°|ªvÀø»P»Ýn®ñ®ð¡C ¹ï·Ó²Õªº30¤Ñ¦º¤`²v¬°18.87%, ¦Ó¥ÎÃIJլ°4%¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤W¤È 08:24:14²Ä 1544 ½g¦^À³ ¸Á»e©M¶ÂºØ¯ó¡]¤]ºÙ¬°¶Â§¶µM¡^ªvÀø·s«aÁ{§É: ªvÀøµo²{¥i¦b6¤Ñ¤º½w¸Ñ·s«aªÍª¢¯gª¬¡A¦Ó¹ï·Ó²Õ«h¬°13¤Ñ. 2020.11.25 www.nutraingredients-asia.com/Article/2020/11/25/Covid-19-RCT-Honey-and-black-cumin-seed-help-speed-up-recovery-in-Covid-19-patients |
|
|
·|û¡G¤p´²¤á10148935 µoªí®É¶¡:2022/1/5 ¤U¤È 04:13:45²Ä 1547 ½g¦^À³
|
§ë¸ê¤£´N¬°¤FÁÈ¿ú¶Ü¡H¬°¤°»ò¤£¬Û«H§O¤Hªº¼Æ¾Ú©O¡H¤£µM§A»¡»¡þ®a¤ñ¸ûȱo§ë¸ê |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤U¤È 03:56:05²Ä 1546 ½g¦^À³
|
¬ü°êFDAªºEUA¾÷¨î¦³¥|¶µ¹ê¦æì«h: ²Ä¤@¡B±ý¥Ó½Ðºò«æ¨Ï¥Î±ÂÅvªº¥ø·~¡A¥²¶·´£¨ÑÁ{§É¤@¡B¤G´Á©Ò¦³¸ê®Æ¡A¥H¤Î¤T´ÁÁ{§É°lÂÜ 2 Ӥ몺´Á¤¤¤ÀªR¼Æ¾Ú¡C ----------------------------------------------------------------------------------------------- ½Ð°ÝÁٯʤT´Á´Á¤¤¼Æ¾Ú¡A¸ê®Æ¤£»ô¥þ¦p¦ó¥Ó½ÐEUA? FDA·|Åý¬ü°ê¤]µo¥Í[°ªºÝ¤§¶Ã]? §ó¦óªp¤w¦³10¤äªvÀøÃĪ«¤W¥«¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/1/5 ¤U¤È 03:16:38²Ä 1545 ½g¦^À³
|
°ê¹©¡u·s«aªÍª¢ÃÄ¡v¸Ñª¼¦¨¥\¡I¥ÎÃIJÄ28¤Ñ±d´_²v100%¡@±N¦b¬ü¥Ó½ÐEUA ©ú¤Ñ¨g¼Q100¤¸¡A¯uªº½ä¿ù¡C»¡¨S¤ºÀ`§Ú¬O¤£«H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤W¤È 08:24:14²Ä 1544 ½g¦^À³
|
ªÑ²¼§ë¸ê¤Ó²z©Ê¡A¦³®É¤ÏÁȤ£¨ì¿ú¡A¥xÆW¶}µo·s«aÃĪ«´N¬O¨£³ø¨º´X®a¤½¥q¡C(«¥¨SÀ£¥ô¦ó¤@®a) ±z¬Ý¸Á»e©M¶ÂºØ¯ó¦aÀø®Ä¡A°ê¹©¤G´Á¸Ñª¼«e¦³½Ö»¡±o·Ç? «ÂI¦b²Ä3´ÁÁ{§É!!! ¸Á»e©M¶ÂºØ¯ó¡]¤]ºÙ¬°¶Â§¶µM¡^ªvÀø·s«aÁ{§É: ªvÀøµo²{¥i¦b6¤Ñ¤º½w¸Ñ·s«aªÍª¢¯gª¬¡A¦Ó¹ï·Ó²Õ«h¬°13¤Ñ.(¤£¹L³oÓ3´Á¥Ó½Ð¤£¤FFDA EUA¡A¤£¬O¼Æ¾Ú°ÝÃD¡Aì¦]¤w¶K¦b¬Q¤é¶K¤å ) ¸Á»e©M¶ÂºØ¯ó(HNS) ¨ã¦³§Ü¯f¬r¡B§Üµß¡B§Üª¢©M§K¬Ì½Õ¸`¯S©Ê¡C 2020.11.25 www.nutraingredients-asia.com/Article/2020/11/25/Covid-19-RCT-Honey-and-black-cumin-seed-help-speed-up-recovery-in-Covid-19-patients ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/17 ¤W¤È 07:50:32²Ä 1523 ½g¦^À³ ..¸Á»e¤]¯àªv·s«aªÍª¢¡AÁÙ¬O3´ÁÁ{§É³á! ¤£¬Û«H? Honey & Nigella Sativa Trial Against COVID-19 (HNS-COVID-PK) Phase 3 clinicaltrials.gov/ct2/show/NCT04347382?term=Honey+%26+Nigella+Sativa&draw=2&rank=1 |
|
|
·|û¡G¤p´²¤á10148935 µoªí®É¶¡:2022/1/5 ¤W¤È 08:07:52²Ä 1543 ½g¦^À³
|
½Ð°Ý¨º·s«aªºÃĪ«¥i¥H§ë¸êþ¤@ÀÉ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤W¤È 05:47:21²Ä 1542 ½g¦^À³
|
¤£¬O¼â§N¤ô¬O®Â½Ã¯u¬Û! ¬Ý¤£ºD°ê¹©°ª¼h»~¾É§ë¸ê¤H¥H¬°¥Î²Ä2´Á¼Æ¾Ú´N¥i¥Ó½ÐFDA EUA¡A¸Ø¤jÀø®Ä! ¯u¬Û: 2020¦~·s«aªÍª¢¨S¦³ªvÀøÃĪ«¡A¥þ²y²Ä¤@ÓÀòFDA EUA¥Î©óªvÀø¡u·s«aªÍª¢¡vªºÃĪ«Gileadªº·ç¼w¦è³¡A´N¬O«ö³¡´N¯Z°õ¦æ²Ä3´ÁÁ{§É ¡A¥H²Ä3´Áªº´Á¤¤¼Æ¾Ú¥Ó½ÐEUA ---------------------------------------------------------------------------------------------------- 1.2020 ¦~ 5 ¤ë 1 ¤é¡A®Ú¾Ú ²Ä3 ´Á¸ÕÅ窺ªì¨Bµ²ªG¡A¬ü°ê¹«~©MÃĪ«ºÞ²z§½ (FDA) ¹{µo¤Fºò«æ¨Ï¥Î±ÂÅv (EUA) ¤¹³\¨Ï¥Î·ç¼w¦è³ªvÀø·s«a±wªÌwww.nejm.org/doi/full/10.1056/NEJMp2032369 2.²{¦b¥þ²y¦Ü¤Ö¦³10¤ä¥Î©óªvÀø¡u·s«aªÍª¢¡vªºÃĪ«(¬OªvÀøÃĪ«¤£¬O¬Ì]) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/4 ¤U¤È 10:21:27²Ä 1541 ½g¦^À³
|
¯¬ºÖ°ê¹©©ú¤Ñ¤G´Á¸Ñª¼¦¨¥\¡AÅý«¥¶}¶}²´¬É¬Ý¬Ý«ç»ò¥Î¤@´Á»P¤G´Á¼Æ¾Ú¥Ó½ÐFDA EUA! 2021.12.31---¥þ²y¶W10´Ú·s«aªv疗药ª«¤W¥«(4´Ú¤fªAÃĪ«»P6´Ú¤¤©M§ÜÅéÀøªk¡A¨ä¤¤7®aÀò±oFDA EUA¡A¨S¦³¤@®a¬O¥Î¤G´ÁÁ{§É¼Æ¾Ú¥Ó½ÐEUA) www.drugtimes.cn/2021/12/31/quanqiuchao10kuanxinguanzhiliaoyaowushangshikaituoyaoyepukel/ ¤T´ÁÁ{§ÉÃĪ«~30¤ä |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/4 ¤W¤È 11:03:17²Ä 1540 ½g¦^À³
|
°ê¹©³ÌÁo©ú¡A¥ÍµØ¬O¶Ì¤l? ¥ÍµØ·s«aÃĪ«Silmitasertib¤G´ÁÁ{§É¸ÕÅç¼Æ¾Ú¤ÀªR¦¨ªG¡A¨ã²Îp¤WÅãµÛ®t²§¡A°ª¼h¡¨§b¡¨¨ì¤T´Á¸ÕÅ窺´Á¤¤¤À¤~¥Ó½Ð¬ü°êºò«æ¨Ï¥Î±ÂÅv (EUA)¡C 2021.10.20 news.cnyes.com/news/id/4749712 Ä~4147«á¡A4132¬O«¥³Ì·Q¦R¼Ñ£x! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/1/4 ¤W¤È 10:56:34²Ä 1539 ½g¦^À³
|
¬Ý¤£²n°ê³»¡A¦ý¬OªÑ»ù»¡¸Ü¨Ó¬Ý¡A2022¦~·sÃÄÁÙ¬O¬Ý¤£¨ì¨®§À¿O¡A2021¤p§Ì³QªB¤Í¯º´«¿ùªÑ¡C¬Ý¬Ý¤µ¦~¦³¨S¦³¾÷·|¤Ï±Ñ¬°³Ó¡A¥u¦³ÁȨì¿ú¤~¬O¯uªº |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/4 ¤W¤È 09:02:32²Ä 1538 ½g¦^À³
|
¦P²z¥iÃÒ¡A¦bÀq¨FªF»P½÷·çªº·s«aªÍª¢¤fªAÃĨú±oÃÄÃÒ«á¡A¤]±NÃö³¬·s«aÃĪ«EUA¤jªù!!! --------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/4 ¤W¤È 08:50:13²Ä 1537 ½g¦^À³ ²Ä¥|¡BFDA .....¤@¥¹¦³¬Ì]Àò¥¿¦¡ÃÄÃÒ®Öã¡AFDA ±N¤£¦A³q¹L·s¬Ì]ªººò«æ¨Ï¥Î±ÂÅv¥Ó½Ð¡A°£«DÃÒ©ú¯S©w±Ú¸s¦³§ó¦nªº®ÄªG¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/4 ¤W¤È 08:50:13²Ä 1537 ½g¦^À³
|
¤G´ÁEUA¬O¥xÆW¯S¦³!!! «ç·|³Q¬~¸£¨ì¤Ñ¯u¥H¬°°ê¹©¥i¥Î¤G´Á®³¨ìFDA EUA(ºò«æ¨Ï¥Î±ÂÅv)? ¬Ì]EUA: 2020.11.20 ½÷·ç¡þBNT¬Ì]¦b¡u§¹¦¨¤G´Á¸ÕÅç¡A¥¿¦b¶i¦æ¤T´Á¸ÕÅç¡v®É¡A¥H¤T´Á¸ÕÅç³ø§i¤¤¼Æ¶µ«DÁ{§É¡BÁ{§É¸ÕÅç¼Æ¾Ú¤Î»s³y¸ê°T¡A¨ú±o¬ü°êFDAªººò«æ¨Ï¥Î±ÂÅv¡C ªvÀøÃĪ«EUA: Àq¨FªF»P½÷·çªº·s«aªÍª¢¤fªAÃĤÀ§O¦b2021.10.11»P2021.11.16¥H¤T´ÁÁ{§É¸ÕÅç´Á¤¤¼Æ¾Ú¦VFDA¥Ó½ÐEUA¡C ------------------------------------------------------------------------------------------------ ¬ü°êFDAªºEUA¾÷¨î¦³¥|¶µ¹ê¦æì«h: ²Ä¤@¡B±ý¥Ó½Ðºò«æ¨Ï¥Î±ÂÅvªº¥ø·~¡A¥²¶·´£¨ÑÁ{§É¤@¡B¤G´Á©Ò¦³¸ê®Æ¡A¥H¤Î¤T´ÁÁ{§É°lÂÜ 2 Ӥ몺´Á¤¤¤ÀªR¼Æ¾Ú¡C ²Ä¤G¡Bµû¦ô¬Ì]®Ä¤Oªº¸ÕÅç¡A»Ý±ÄÀH¾÷¤À°t¡BÂùª¼¤À²Õ¡A¨Ã¦³¬I¥´¦w¼¢¾¯ªº¹ï·Ó²Õ¡A³Ì«áµû¦ô¨â²Õ¸ÕÅç¤Hûªº·P¬V¤ñ¨Ò¡C ²Ä¤T¡B¨ú±o¬Ì]ºò«æ¨Ï¥Î±ÂÅvªº¥ø·~¡A¥²»Ý«ùÄò°õ¦æÁ{§É¸ÕÅç¡A¥H´£¨Ñ¦w¥þ©Ê»P®Ä¤Oªºªø´Á¸ê®Æ¡F¬Ì]»s³y°Ó¤]¥²¶·«ùÄòºÊ´ú¬Ì]¦w¥þ©Ê¡A¥]¬A½Õ¬d±µºØºò«æ±ÂÅv¬Ì]©Ò¦³¦º¤`³ø§i¡B¦í°|±¡ªp¥H¤Î¨ä¥LÁ{§ÉÄY«¤£¨}¤ÏÀ³¡C ²Ä¥|¡BFDA ´Á«Ý¨ú±o¬Ì]ºò«æ±ÂÅvªº·~ªÌ¡A¦¬¶°¦Ü¤Ö 6 Ӥ몺¼Æ¾Ú«á´£¥X¥¿¦¡ÃÄÃҥӽСA¤@¥¹¦³¬Ì]Àò¥¿¦¡ÃÄÃÒ®Öã¡AFDA ±N¤£¦A³q¹L·s¬Ì]ªººò«æ¨Ï¥Î±ÂÅv¥Ó½Ð¡A°£«DÃÒ©ú¯S©w±Ú¸s¦³§ó¦nªº®ÄªG¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/29 ¤U¤È 10:29:51²Ä 1536 ½g¦^À³
|
AteaÀË°QÁ{§É¹êÅ祢±Ñì¦]¡Aקï±Æ°£¤w¸g±µºØ¬Ì]±wªÌ¦AÄ~ÄòÁ{§É! °ê¹©??? ------------------------------------------------------------------------------------------------- COVID-19 ªvÀø¡nAtea §Ü¯f¬r·sÃÄ¡uAT-527¡vªvÀø»´¤¤¯g¤G´ÁÁ{§É¥¢±Ñ www.genetinfo.com/international-news/item/53239.html ... 3.¼vÅT¥¼¹F¼ÐÅܼÆ: ©Û¶Òªº±wªÌ¤¤¦³¤w¸g±µºØ¬Ì]ªº¤ñ²v°ª.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/29 ¤U¤È 03:52:10²Ä 1535 ½g¦^À³
|
¦pªG±wªÌ¦³ª`®g¹L·s«a¬Ì]¡A¥i¹w¨¾«¯g¡B¦í°|¡B¦º¤`ªº«OÅ@¤O¡C °ê¹©Á{§É¹êÅç«ç»ò¤£±Æ°£¦³ª`®g·s«a¬Ì]ªº±wªÌ? °ê¹©Á{§É:clinicaltrials.gov/ct2/show/NCT04523181?term=Antroquinonol&draw=2&rank=6 ½÷·çÁ{§É:clinicaltrials.gov/ct2/show/NCT04960202?term=PF-07321332&draw=2&rank=5 Àq§JÁ{§É:clinicaltrials.gov/ct2/show/NCT04405570?term=NCT04405570&draw=2&rank=1 (½÷·ç»PÀq§J¦³±Æ°£³á!) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/29 ¤U¤È 01:47:04²Ä 1534 ½g¦^À³
|
1¤äÃĪ«ªºÁ{§É¹êÅç«ç»ò¸ÑŪ? 1.¦pªG©úÅãÀu©ó(«D±`ÅãµÛ)¹ï·Ó²Õ---FDA·|´£«e²×¤î 2021.07.28¥_·¥¬P - KY(6550-TE) ¤µ (28) ¤éªí¥Ü¡A¦¬¨ì¬ü°ê FDA ¨Ó¨ç³qª¾¡AªvÀø´c½èªÍ¶¡¥ÖÀù·sÃÄ ADI-PEG20 ¤T ´ÁÁ{§É¸ÕÅç¡A¥i°±¤î¦¬¨ú¯f±w¡B´£¦µ²§ô¸ÕÅç¨Ã¶i¦æ¸Ñª¼¡A«Ý§¹¦¨Á{§É¸Ñª¼«á¡A±N¥Ó½ÐÃÄÃÒ¡C 2.¦pªG©úÅã®t©ó(«D±`ÅãµÛ)¹ï·Ó²Õ---FDA¤]·|´£«e²×¤î 2017.7.6 ¸ÕÅçªÌ¦º¤` FDA ©R¥OÀq§J°±¤î¤T¶µ Keytruda ÃöÁä¬ã¨s read01.com/Q3Aogyk.html#.Ycvx0GhBzcs FDA «Øij¨ü¸ÕªÌ¥ß¨è©ñ±ó°Ñ»P Keytruda ªº¨â¶µ III ´Á¬ã¨s¡A¨Ã©R¥OÀq§J¥ß§Y°±¤î KEYNOTE-023 ¶¤¦C 1 ¤¤ªº±wªÌ¹ê Åç¡C 3.¤ð¶·×§ïÄ~ÄòÁ{§É¬O¥Ã 2021.8.31--¥ÍµØ¬ì·sÃÄSilmitasertib(CX-4945)¥Î©ó·s«aªÍª¢¤G´Á«¯g¤HÅé¡A¤µ(31)¤é«Å¥¬Á{§É¸ÕÅç´Á¤¤¼Æ¾Ú¡A¸g¿W ¥ßÁ{§É¼Æ¾ÚºÊ¹î©eû·|(Data Monitoring Committee¡ADMC)¼f¬d³q¹L¡A¤ð¶·×§ï¥ô¦óÁ{§É¸ÕÅç³]p¡A¥i«ùÄò¶i¦æ·s«a« ¯g±wªÌ¦¬®×¡C 4.¶·×§ï¤Ï˦³¤F¤£½T©w? (»´¤¤¯g¦º¤£¤F¤H¡A©Ò¥H¤£¥i¯à³Q²×¤î) °ê¹©:DMC«Øij¼W¥[¦¬ªv»Ýn®ñ®ð¤ä«ù¤§«¯g¦í°|¯f±w¡C(«D«I¤J©Ê³q®ð¡B°ª¬y¶q®ñ®ð©Î¸§J½¤) ³o®É¦³2ºØ¥i¯à©Ê:¤@¬O¦³®Ä©Ò¥H¥[¤J«¯g±wªÌ¡A¤G¬O¥i¯à»´¤¤¯g¦³®Ä©Ê¤£©úÅã¡A©Ò¥H¥[¤J«¯g±wªÌÁ{§É¬Ý¬Ý¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/12/22 ¤U¤È 06:16:06²Ä 1533 ½g¦^À³
|
n¤j¨S°ÝÃD¡I¨Ì§Ú¬ÝªYÄ£2023¦~©³¡A·|¬ð¯}«e°ª176¤¸¡F¦bªYÄ£¥´ºuªº³£¦³¿úÁÈ¡AÁȦhÁȤÖÀH¦]½t¡C©ñÓ¤¦~¤G¨t¦C¤jÃÄ¥þ±ÂÅv¥X¥h¡A«O¦u¦ô300¤¸¥H¤W¡I¤j®a·í°Ñ¦Ò¡I |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2021/12/22 ¤U¤È 04:12:53²Ä 1532 ½g¦^À³
|
Healthcare+ Expo ¥xÆWÂåÀø¬ì§Þ®iªºFB¬Ý¨ìªº¡A¸ò¤j®a¤À¨É ----------------------------------------------------------------------------------- #ªYÄ£¥ÍÂå »EµJ¤G¶µÃøÃD¡A¶}µo¥þ²yº¨Ò¡uµL¨x¬rªº¤îµhÃÄ¡v¤Î¡uªvÀø©M¹w¨¾¯×ªÕ¨xª¢¡v¯e¯f·sÃÄ ibmi.pse.is/3xm7nx • SNP-810 (µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ)¡G¬ü°êFDA OTC Monograph®Öã¤W¥«¡A¥xÆW½ÃºÖ³¡®Öã¤W¥« ✅¼x¨D°ê¤º¥~¾P°â/§ÞÂà/¶}µo¹Ù¦ñ • SNP-610/630 (¯×ªÕ¨x¯e¯f·sÃÄ)¡G§¹¦¨Á{§É¤G´Á ✅´M¨D°ê»Ú§ÞÂà»P¬ãµo¹Ù¦ñ 📌´x´¤§ó¦hB2B°Ó¾÷ ibmi.pse.is/3qd2zh ½u¤W°Ó¬¢¶}©ñ¦Ü2022/01¡A§â´¤¾÷·|¥D°Ê¥XÀ»¡I |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2021/12/22 ¤U¤È 03:11:09²Ä 1531 ½g¦^À³
|
±À½²¤j¡A¤£¹L¤]¤@¦~¹L¥h¤F¡A¤£ª¾¹DªYÄ£¶}ªáµ²ªGªº¨º¤Ñ¤j®a¬O§_ÁÙ¦b~ |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/12/22 ¤U¤È 02:56:58²Ä 1530 ½g¦^À³
|
Ó¤H¥Í§Þ§ë¸ê¬O²Ä¤@¦¸¡F¥H©¹¦]¤£À´¦Ó©Ä¨B¡C¥Í§ÞªÑµÛ«ªø´Á¥¬¸p¡A»P¹q¤lªÑ¤]¤£¦P¡C¹q¤lªÑn«Ø¼tªá¿ú¡A¤]¦³«d»ù竸ª§©M²£«~¹L®É²^¨Oµ¥¥~¦]¡C¥Í§ÞªÑ¦pªYÄ£¬ãµo610¬O®ÄªG¡m·¥ÅãµÛ¡n¡A630§óÀu©ó610¡A±N¨Ó³£¬Oȱo´Á³\¡C·Qn»¡ªº¬O§ÚÓ¤Hµoªíªº¸Ü¬OÓ¤H¹ïªYÄ£ªº¬Ý¦n¡A¨Ã¨S¦³¹ªÀy¶RªÑ¡A¶R½æn¦Ût¤@¤Á¿éĹ¡C¤d¸U¤£¯à¥ÏÁçµ¹§O¤H¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/19 ¤U¤È 08:08:03²Ä 1529 ½g¦^À³
|
¡§º×¤¼ºÖ¤§©ÒÊ¡AºÖ¤¼º×¤§©Ò¥ñ¡C¡¨ 1. 2021.7.15Âd¶R¡G°ê¹©¥Í§Þ¤½¥q¹H¤Ï«°T¥Ó³ø¡@¾D³B¹H¬ùª÷40¸U¤¸ °OªÌ§E©¶§®¡þ¥x¥_³ø¾É Âd¶R¤¤¤ß¤µ¡]15¡^¤é«ü¥X¡A°ê¹©¥Íª«¬ì§ÞªÑ¥÷¦³¤½¥q¡]4132¡^±µ¨ü´CÅé±M³X¡]´CÅéµo¥¬¤é110¦~7¤ë2¤é¡^¡A¹H¤Ï«¤j°T®§¬ÛÃö³W©w¡A¦]¦¹¨Ìªk³B¥H40¸U¤¸¹H¬ùª÷¡C Âd¶R¤¤¤ßªí¥Ü¡A°ê¹©¥Íª«¬ì§ÞªÑ¥÷¦³¤½¥q¦b7¤ë2¤é±µ¨ü´CÅé±M³X®É¡A¹ï¨äÁ{§É¸ÕÅ礤·sÃīź٥¼¸gÃҹꪺÀø®Ä¡A¹ï¨äÁ{§É¸ÕÅ礤·sÃīź٥¼¸gÃҹꪺÀø®Ä¡A¨Ã´£¤Î¦¬¨ì¬ü°êFDA«Øij³qª¾¯Ç¤J«¯g±wªÌ»P¹w´Á³Ð³y¤§Àç·~ÃBµ¥»P¨Æ¹ê¤£²Å³¯z©Î©|¥¼½T©w®ø®§¡A®Ö¦³¹H¤Ï«¤j°T®§¬ÛÃö³W©w¡AÂd¶R¤¤¤ß¬¸¨Ì¿³ÂdªÑ²¼¼f¬d·Ç«h²Ä62±ø³W©w¹ï¸Ó¤½¥q³B¥H·s»O¹ô¥|¤Q¸U¤¸¤§¹H¬ùª÷¡C 2. 2021.7.15 ¦Û¥Ñ°]¸g¼ÐÃD§óª½¥Õ:°ê¹© [¸Ø¤j] ·sÃħܬ̫¤O Âd¶R¶}»@40¸U ec.ltn.com.tw/article/breakingnews/3604937 --------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/17 ¤W¤È 07:50:32²Ä 1523 ½g¦^À³ °ê¹©¤fªA·s«aªÍª¢·sÃÄAntroquinonolÁ{§ÉÀò¬üFDA¦P·NÂX¤j·s¼W¦¬»Ý®ñ¤ä«ù«¯g¯f±w (¤º®e¦h¬Ý´X¦^¿W¥ß«ä¦Ò¤@¤U) |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/12/18 ¤W¤È 11:46:02²Ä 1528 ½g¦^À³
|
R¤j¡A§Ú¤]¬O¾a³o²Ä¤»·P¥X²M³¡¥÷¡A´N¤jöt¯Söt ¹B®ð¤£¨Î´«¨ì³o °ê³»³Ñ¤Uªº90¤]³Q¬~¥X¥h °ê³»ªº¸gÀç¤H´N©M±z´£ªº·|p®v¼gªº¤@¼Ë¡A¯uªº¨C¦¸³£¦LªÑ²¼´«¿ú¡A¦ýªø´Á¨Ó¬Ý¥Ø«e¨Ó»¡ÁÙ¬OÁÈ¿ú ¥u¯à»¡°]°È¾Þ§@¤]¬O¦³¾Ç°Ý¡A¦ý¸g¤£°_¤@¦¸ªº«À» --------------- 3¨¥2»y»¡¤£²M¡A²Ä6·Pn«¥¯à¸ú¦h»·°{¦h»·! |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2021/12/17 ¤U¤È 11:58:04²Ä 1527 ½g¦^À³
|
Æp¥Û¥Í§Þªº«ùªÑ¡A¥¦¤£¬O¸³¨Æ¤F |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2021/12/17 ¤U¤È 11:48:23²Ä 1526 ½g¦^À³
|
½Ð°Ý¤Q¤@¤ë«D¿W¥ß¸³¨Æ«ùªÑ´î¤Ö6725±i¡A¶]¥hþ? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/17 ¤W¤È 09:01:34²Ä 1525 ½g¦^À³
|
FDA¦P·NÂX¤j·s¼W¦¬»Ý®ñ¤ä«ù«¯g¯f±w¡C µ´¤j¦h¼Æ¤H·|¸ÑŪ¦¨§Q¦h¡A¦ý¤£n¤H¤ª¥ç¤ª¡A¦³¤H¸ÑªRªº¸Ô²Óº}«G¡A«¥´NµL»ÝÂب¥¤F¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/17 ¤W¤È 08:43:07²Ä 1524 ½g¦^À³
|
2020.9.26¦X¤@ªk»¡·|¦]½pÀq´ÁÁ{®É³Û¥d¡I 2021-12-14 °ê¹©¤fªA·s«aªÍª¢·sÃÄAntroquinonolÁ{§ÉÀò¬üFDA¦P·NÂX¤j·s¼W¦¬»Ý®ñ¤ä«ù«¯g¯f±w-³o¬O¦ó·N??? ªÑ´Úú¯Ç´Á¶¡:110/12/13~110/12/17¡A»ù®t³o»ò¤j¡AÁ٩ȤpªÑªF¤£»{¶Ü? ----------------------------------------------------------------------------------------------- ¤½¥q¦WºÙ¡G°ê¹© µo¨¥¤é´Á¡G2021/11/10 ... 5.µo¦æ»ù®æ:¨CªÑ·s¥x¹ô58¤¸ 16.ªÑ´Úú¯Ç´Á¶¡: ìªÑªF¤Îû¤uú¯Ç´Á¶¡:110/12/13~110/12/17 ¯S©w¤HªÑ´Úú¯Ç´Á¶¡:110/12/20~110/12/22 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/17 ¤W¤È 07:50:32²Ä 1523 ½g¦^À³
|
ì¨Ó¬Oöt12/14·s»D§Q¦h°Ú¡A©Ò¥H¤U¦¸·s»D§Q¦h¬O¶i¤J3´ÁÁ{§É!(¨S¦³ÃĪ«¦w¥þ©Ê°ÝÃD¨S²z¥Ñ³Q°h¥ó¡A«¥´N¹j©¤§¤µÛÆ[½à·Ï¤õ¨q) ------------------------------------------------------------------------------------------------ µo§G¤é´Á¡G2021-12-14 °ê¹©¤fªA·s«aªÍª¢·sÃÄAntroquinonolÁ{§ÉÀò¬üFDA¦P·NÂX¤j·s¼W¦¬»Ý®ñ¤ä«ù«¯g¯f±w (¤º®e¦h¬Ý´X¦^¿W¥ß«ä¦Ò¤@¤U!) ------------------------------------------------------------------------------------------------- ¸Á»e¤]¯àªv·s«aªÍª¢¡AÁÙ¬O3´ÁÁ{§É³á! ¤£¬Û«H? Honey & Nigella Sativa Trial Against COVID-19 (HNS-COVID-PK) Phase 3 clinicaltrials.gov/ct2/show/NCT04347382?term=Honey+%26+Nigella+Sativa&draw=2&rank=1 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/16 ¤U¤È 05:21:57²Ä 1522 ½g¦^À³
|
3¨¥2»y»¡¤£²M¡A²Ä6·Pn«¥¯à¸ú¦h»·°{¦h»·! -------------------------------------------------------------------------------------------- ¤½¥q¦WºÙ¡G°ê¹© µo¨¥¤é´Á¡G2021/11/25 µo¨¥®É¶¡¡G16:29:53 µo¨¥¤H¡G´¿¤ì¼W 1.¸³¨Æ·|³q¹L¤é´Á(¨Æ¹êµo¥Í¤é):110/11/25 ... 8.Åܧó·|p®v¤§ì¦]:¥»¤½¥qÀç¹B¤ÎºÞ²zµ¥¾ãÅé¦Ò¶q 11.³Ìªñ¤G¦~«×¤w¥Ó³ø©Î§Y±N½s»s¤§°]°È³ø§i¬O§_´¿¸g·|p®v½Õ¾ã©Î´£¥X¤º ³¡±±¨î«¤j§ï¶i¨Æ¶µ¤§«Øij: ¬O¡C«e¥ô¸ê¸Û·|p®v©ó°õ¦æ109¦~¦~«×°]°È³øªí¬d®Ö¥~¶Ô´Á¶¡¡A«Øij¥»¤½¥qÀ³¸¨¹ê Ãö«Y¤H¿ëÃѤκ޲z¡BÀ³±j¤Æ¹ï¤l¤½¥q¤§ºÊ·þ»PºÞ²z§@·~¡B¥Ó½Ð¶U´Ú«e¨Ì¨î«×¹w¦ô¸ê ª÷»Ý¨D¡BÀ³¸¨¹ê¾P°âq³æ³B²z¤Î¥æ³f§@·~¡BÀ³¸¨¹ê§ë¸ê§@·~°lÂܤΦs³f¤§²¾°ÊÀ³¥ß §Y¥¿½T¬ö¿ý¡C¥t¨ä©ó¶i¦æ109¦~¦~«×¤º±±¨î«×¹ê¦a¬d®Ö§@·~¡A«Øij¥»¤½¥qÀ³¸¨¹ê¸³ ¨Æ·|¤Î¼fp©eû·|¤§¥l¶°µ{§Ç¤Î¤å¥ó»P¬ö¿ý§@·~¡BÀ³¸¨¹êÁ~¹SºÞ²z©eû·|§@·~¡BÀ³ ¸¨¹ê¹ï¤l¤½¥q¤§ºÊ·þ»PºÞ²z§@·~¡BÂç²M¦L¥§¤l¤½¥q¤§§ë¸ê¡BÀ³¸¨¹êÃö«Y¤H¥æ©öºÞ²z §@·~¡BÀ³¸¨¹ê¾P°â´`Àô§@·~¡B«Ø¥ß¦U¶µ¶O¥Î³ø¤ä¤§ºÞ²z§@·~¡BÀ³¥[±j¤º³¡½]®Ö¤§Â¾ ¯à(§t¤º±±¦Ûµû¤§¾É¤J)¤ÎÀ³¸¨¹ê¦LŲºÞ²z§@·~¡C ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/20 ¤W¤È 07:06:12²Ä 533 ½g¦^À³ ·|û¡Gdk10140377 µoªí®É¶¡:2021/1/19 ¤U¤È 03:25:56²Ä 523 ½g¦^À³ ..°ê³»¤]¬O¦³°w¹ï¯×ªÕ¨x³o¤@³¡¥÷¡C -------------------------------------------------------------------------------------- ªü¯÷®üÀq¯g³Ð·sÃĪ«¤j¼ú¦n§l¤Þ¤H! °÷¸Þ²§ªº....3¨¥2»y»¡¤£²M¡A«¥¦¥X²M¨SÁȨS½ß¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/12/16 ¤U¤È 05:06:27²Ä 1521 ½g¦^À³
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/12/16 ¤U¤È 02:58:40²Ä 1519 ½g¦^À³ ©Z¥Õ»¡¤p§Ì¦³°±·l¤@¥b,¤GÓ¤ë«e¶]¥h¨ºº¦±o¤£n¤£nªº¨º°¦ötªÑ~ ---------------------------------------- ®¥³ß¦h¤j Ãĵؤ§«e¤H¤H¥´¡A¯u¬OÃø¹w®Æ ¤dª÷Ãø¶R °e¤F¤j¬õ¥] ·sÃijs°ê¹©³£¨S¶W¨®¡A¬Ý¬Ý§O¤H²{¼W®t¦h¤Ö |
|
|
·|û¡Gonly10135877 µoªí®É¶¡:2021/12/16 ¤U¤È 03:27:29²Ä 1520 ½g¦^À³
|
¤@¯ë·sÃĸѪ¼¦¨¥\¨ì®³¨ìFDAÃÄÃÒ¥§¡n¤@¦~¥b ªYÄ£¥un¤j¼tÅçÃÒ¦¨¥\°¨¤W¥i¥H¥Ñ¤j¼t¨Ó½æ µ¥©ó¥Ø«e ¬O¦b¥Ó½ÐÃÄÃÒ ªº®ÄªG §Æ±æªñ´Á©Î©ú¦~¯à ¤£n¤£nªº |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/12/16 ¤U¤È 02:58:40²Ä 1519 ½g¦^À³
|
¯uªºµhWªü,Wµ¥¤@¦~¤F,¥h¦~ªº12/21©M°ê»Ú¤jÃļt¦X§@±Nº¡©P¦~~ ¤@°ï·sÃĤ½¥q³£±Ò°Ê¤W¥«©Î§Y±N¤W¥«¦æ±¡,ªYÄ£¤]¦³«D³B¤èÃÄÀH®É¥i¤W¥«ªü ¦n¹³ÀH®Éªº¤ñ¸û¤£È¿ú,«¢«¢~ ©Z¥Õ»¡¤p§Ì¦³°±·l¤@¥b,¤GÓ¤ë«e¶]¥h¨ºº¦±o¤£n¤£nªº¨º°¦ötªÑ~ ¥h¦~¦¹®É¸Ó°¦¤£n¤£nªº¥i¬OÅý¤p§Ì½ß¤£¤Ö,¥þ´«¨ìªYÄ£µ²ªG¤£°Ê´N¬O¤£°Ê ¥Í§ÞªÑ¯u¬O¶ø§®,«ÜÃøª±~ ´Á«Ý·Ç³Æ¥Ó½Ð¤WÂd,¬Û«H¤j§Q¦h§Y±N¨ì¨Ó,¦]¬°n¥Ó½Ð¤u·~§½¬ì§Þ¨Æ·~ÃÒ©ú¤~¯àÂà¤WÂd Á{®ÉªÑªF·|¦b©ú¦~¤@¤ë,¦pªG´£¥X¥Ó½Ð¤u·~§½¬ì§Þ¨Æ·~ÃÒ©ú¥i¥H»°¦b¤G¤ë©³°e¥X ¨º¥i±À´ú©ú¦~¤G¤ë©³«e·|¦³¦n®ø®§~³Ì¦n¬OªÑªFÁ{®É·|«e´N¦³¦n®ø®§ªü~ ¥[ªo¤F~ §ÚÁÙ¦³¤@¥bªº²¼µ¥µÛ§Aªíºtªü! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/14 ¤U¤È 03:50:45²Ä 1518 ½g¦^À³
|
§A°L¤F¸Ñ§ÚªºµhW~ µì¥|·U·Q·U´d«s ¥Ø«Ë¼·°LÂ÷~ ½Ð±qÀY¬Ý¤@¹M |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/12/14 ¤U¤È 03:25:39²Ä 1517 ½g¦^À³
|
6446 «á¨Ó©~¤W!! R¤j¤jÁȤF |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/13 ¤U¤È 12:39:13²Ä 1516 ½g¦^À³
|
1¤ä³ÌÁV¿|ªº¤îµhÃÄ»P1¤ä³Ì¦MÀIªº¤îµhÃĪº¹L¶q¤¤¬r¦º¤`»P´N¶E¦¸¼Æ: ³ÌÁV¿|ªº¤þ®ñªâ¤îµhÃÄ: ¦Û 1972 ¦~ 9 ¤ë¥H¨Ó¡A³oºØÃĪ«»P¦Ü¤Ö 7109 ¤H³ø§iªº¦º¤`¦³Ãö¡A¨ä¤¤ 2110 ¤H¬O·N¥~¦º¤`¡A«æ¶E«Ç´N¶E¦¸¼Æ¼W¥[¤F³\¦h¿¡A³o¬O¤@ÓÄY«ªº¤½¦@½Ã¥Í°ÝÃD ³Ì¦MÀIªºAPAP¤îµhÃÄ: Clinical and economic characteristics of emergency department visits due to acetaminophen toxicity in the USA bmjopen.bmj.com/content/5/9/e007368 Á`Åé¦Ó¨¥¡A¥H©¹ªº¬ã¨s... [¨C¦~] 56 000 ¡V 78 000´N¶E¦¸¼Æ¡A 26 000 ¡V 34 000»Ýn¦í°|»P¦ôp¦³ 500 ¤H¦º¤`¡C ¤j¬ù¦³¦h¤Ö¦º¤`¤H¼Æ¦Û1972 ¦~ 9 ¤ë¥H¨Ó? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/13 ¤W¤È 10:49:55²Ä 1515 ½g¦^À³
|
¤µ¤Ñ«¥±ýúµL²\¡A±µ³s2¦¸§â¤j°]¯«°e¨Óªº»õ¸U°]´I©¹¥~±À¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/5/6 ¤W¤È 02:24:56²Ä 8507 ½g¦^À³ ·|û¡GROGER588910148151 µoªí®É¶¡:2020/5/5 ¤W¤È 09:14:13²Ä 8481 ½g¦^À³ ...±z¤~¹Ã®ð ªL¦Ñ®v§Ú¬O¹Ã¦º!´¿¸g«À£¦X¤@±i¼Æ>>Ãĵز{¦b¬O¦X¤@±i¼Æ<<ÃÄµØ ................................................................. ¦X¤@¼È°±¥æ©ö«e¤@¤é,¤S¤â½â3±i4743´«¤@±i6446,¤µ¤Ñ¯uªº·|®ð¦º!!! .................................................................. ¨º®ÉÕt«ü¤@ºâ,¶â,¥xÆWÃÄÃÒ¤]¸Ó¤U¨Ó¤F,·Q¨Ó¤äµu¥´,µ²ªG¬O°½Âû¤£µÛ»k§â¦Ì,¤Hºâ¤£¦p¤Ñºâ!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/13 ¤W¤È 10:30:50²Ä 1514 ½g¦^À³
|
¡§¥v¤W³ÌÁV¿|ªºÃĪ«¡¨¤þ®ñªâ¬O¤@ÓÄY«ªº¤½¦@½Ã¥Í°ÝÃD¡A¡§¨´¤µ¬°¤î³Ì¦MÀIªºÃĪ«Acetaminophen¡¨ ¤]¬OÄY«ªº¤½¦@½Ã¥Í°ÝÃD¡C FDA¦b2009¤U¬[¤þ®ñªâ!!! 2006.2.28 ¸T¤î©Ò¦³¤þ®ñªâ (Darvon) ²£«~ªº½ÐÄ@®Ñ www.citizen.org/article/petition-to-ban-all-propoxyphene-darvon-products/ ...°·±d¬ã¨s¤p²Õ³q¹L¸Ó½ÐÄ@®Ñ´°«P¥ß§Y¤À¶¥¬q±q¬ü°ê³B¤èÃÄ¥«³õºM¥X©Ò¦³§t¤þ®ñªâªº²£«~¡C³oÀ³¸Ó¥ß§Y¶}©l¡A¦]¬°³oºØÃĪ«¨ã¦³¬Û·í¤jªº¤HÃþ¬r©Ê¡B¦¨Å}¼ç¤O¡BÀݥζɦV¡A¦ýªvÀø¥Î³~«D±`¦³¡C¦Û 1972 ¦~ 9 ¤ë¥H¨Ó¡A³oºØÃĪ«»P¦Ü¤Ö 7109 ¤H³ø§iªº¦º¤`¦³Ãö¡A¨ä¤¤ 2110 ¤H¬O·N¥~¦º¤`¡A«æ¶E«Ç´N¶E¦¸¼Æ¼W¥[¤F³\¦h¿¡A³o¬O¤@ÓÄY«ªº¤½¦@½Ã¥Í°ÝÃD¡A³o¤@ÂI¬OµL¥iª§Ä³ªº¡C¥u¦³¸T¥Î¤þ®ñªâ¤~¯à®ø°£³oºØ¦MÀI¡C --------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/12/23 ¤U¤È 10:39:12²Ä 415 ½g¦^À³ ¤@¥¹¦w¥þµL¨x¬rSNP-810®Öã¤W¥«¡A¥un±ÂÅvÃļt¹BÄw±cØò¤@µf¡AÄ~2009«áFDA¦A¦¸ªí¨M³q¹Lacetaminophen¤îµhÃĦb¬ü°ê¤U¥«¾÷²v¦³¦h¤j? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/13 ¤W¤È 09:18:21²Ä 1513 ½g¦^À³
|
^°ê©M¼Ú·ù¸T¤î¹F¦ÓÂ×(¥k¤þ®ñ×ôpropoxyphene)¡A¥Dn¬O¦]¬°«Ü¦h¤H¥H¦¹ÃĦ۱þ¡A©ÎªA¥Î¹L¶qP¦º¡C FDA´X¸g©ì©µ¡A¦³Óì¦]¬O¦Ò¼{¥Ø«e¥«¤Wªº¤îµhÃĤ£¦h¡A§Æ±æµ¹¦³»Ýnªº¯f¤H¦h¤@ÂI¿ï¾Ü! assets-global.website-files.com/5e332a62c703f653182faf47/5e332a62c703f6dbb12fdd47_gallagher.pdf Suicide by poisoning in New Zealand¡Xa toxicological analysis .... More than 40% of suicide events among women in UK ... The most common chemicals used in UK suicides in 2001 were Coproxamol (combined dextropropoxephene 2010.11.20¡iÁp¦X±ß³ø¢¬½sĶ´^²a´É/ºî¦X³ø¾É¡j m.xuite.net/blog/sun2769111/immortal/40082914 ¬ü°ê¹«~ÃĪ«ºÞ²z§½ (FDA)19¤éªí¥Ü¡A°Ý¥@¤w50¦~¡A¨Ï¥Î¬Æ¼sªº¤îµh¿õ¹F¦ÓÂץѩó¥i¯à¾É¦ÜP©Rªº¤ß«ß¤£¾ã¡A¤w¸g¤U¬[¡C^°ê©M¼Ú·ù¦¤w¤À§O¦b2005©M2009¦~¸T¤î¸ÓÃÄ¡C ...FDAªí¥Ü¡A2009¦~¬ü°ê¦³¤@¤d¸U¯f¤HªA¥Î¹F¦ÓÂסAÂå®v¶}¤F1800¸U±i§t¦³¹F¦ÓÂתº³B¤è³æ¡C ^°ê©M¼Ú·ù¸T¤î¹F¦ÓÂסA¥Dn¬O¦]¬°«Ü¦h¤H¥H¦¹ÃĦ۱þ¡A©ÎªA¥Î¹L¶qP¦º¡C FDA´X¸g©ì©µ¡A¦³Óì¦]¬O¦Ò¼{¥Ø«e¥«¤Wªº¤îµhÃĤ£¦h¡A§Æ±æµ¹¦³»Ýnªº¯f¤H¦h¤@ÂI¿ï¾Ü ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/11 ¤U¤È 07:11:49²Ä 1512 ½g¦^À³ ...¤þ®ñªâ 5 ¦~«e¦b^°ê³Q¸T¤î¨Ï¥Î¡A¦]¬°¥¦¦³¦Û±þ·ÀI¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/11 ¤U¤È 07:11:49²Ä 1512 ½g¦^À³
|
¡§¥v¤W³ÌÁV¿|ªºÃĪ«¡¨¤w¸g®ø¥¢(1957¦~¤W¥«¡A2009¦~¤U¬[) VS ¡§¨´¤µ¬°¤î³Ì¦MÀIªºÃĪ«Acetaminophen¡¨¬O¤£¬O¤]¸Ó®ø¥¢¤F? (1955±À¥X¡A202X¤U¬[?) 2012.01.18 toxicologyexpert.net/dr.-gustin-s-blog/darvon-pulled-from-the-market-in-2011.html ...¸Ó²£«~©ó 1957 ¦~º¦¸Àò±o¬ü°ê¹«~©MÃĪ«ºÞ²z§½ (FDA) ªº§åã¡C ...¤þ®ñªâ 5 ¦~«e¦b^°ê³Q¸T¤î¨Ï¥Î¡A¦]¬°¥¦¦³¦Û±þ·ÀI¡C2009 ¦~¡A¥Ñ©ó¾á¤ßP©Rªº¹L¶qªA¥Î¡A¥¦¦b¼Ú¬w¥«³õ¤U¬[¡A²{¦b¦b¬ü°ê¦]¤ß«ß¥¢±`¦Ó¤U¬[¡C ¡§§Ú¦P·N¤þ®ñªâ¬O¾ú¥v¤W³ÌÁV¿|ªºÃĪ«¤§¤@¡A¡¨¬ü°ê¯kµhÂå¾Ç·|¥D®u Eduardo Fraifeld Âå¾Ç³Õ¤h ...¦Û 1978 ¦~¥H¨Ó¡AFDA ¤w¦¬¨ì 2 ¶µn¨D±N¤þ®ñªâ±q¥«³õ¤W²¾°£ªº½Ð¨D¡C2009 ¦~ 1 ¤ë¡A¿Ô¸ß©eû·|¥H 14 ²¼¹ï 12 ²¼¤Ï¹ïÄ~Äò¾P°â¤þ®ñªâ²£«~¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/12/10 ¤U¤È 06:54:07²Ä 1511 ½g¦^À³
|
¦Û¤vÁ`¬O«ä¦Ò¤½¥q¡mÂX¤j¦X§@¡n¥Î»y¡A·|¤£·|¬O830¤@°_»P¤jÃļt¦X§@±ÂÅv¡F¦]¬°¤îµh¾¯¤j¼t´N³o´X®a¡A¤]¹ïµL¬r¤îµh¾¯´Á«Ý¤w¤[¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/10 ¤W¤È 08:19:57²Ä 1510 ½g¦^À³
|
¤@¥¹±ÂÅv¥i§Ö³t¨É¦³OTCÀ禬¤À¼í¡C ¤@¥¹FDA¡BEMA¡BPMDAµ¥±N¨ã¨x¬r©Ê¤§¤AñQÓi×ô³vº¥²^¨O¡A¥«¦û²v¸Ó¦û¦³¦h¤j? ----------------------------------------------------------------------------------------- ¤½¥qQ&A:½Ð°ÝSNP-810²£«~¬ãµoµ¦²¤¬°¦ó¡H ... ¥i¥ý¥H±M§Q¤Îµoªíªº½×¤å¶}©l¡A¨Ã¥i±ÂÅv¥HOTC¤è¦¡³c½æ¡C SNP-810¥Ó½ÐUS FDA ¤ÎTFDA¤W¥«¡A¤]¯à¼W¥[¹ï¥@¬É¤jÃļt±ÂÅv½Í§PÄw½X¡A¨Ã¦³§U©ó½Æ¤è¤îµhÃĪº¬ãµo¡A¬O¾P°âµ¦²¤¤§¤@¡I ---------------------------------------------------------------------------------------------------- 110/05/31¥»¤½¥q»P¥@¬É«e¤Q¤j°ê»ÚÃļtñqSNP-810¦X§@¨óij ...´°«P¦U°êÃĪ«¦w¥þºÊºÞ³æ¦ì(¦pFDA¡BEMA¡BPMDAµ¥)±N¨ã¨x¬r©Ê¤§¤AñQÓi×ô³vº¥²^¨O¡A¥H§¹¥þµL¨x¬r©Ê¤§·sÃÄSNP-810¨ú¥N¤§¡C |
|
|
|